Query 010304
Match_columns 513
No_of_seqs 265 out of 1453
Neff 5.9
Searched_HMMs 46136
Date Thu Mar 28 22:57:48 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/010304.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/010304hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 PLN02456 citrate synthase 100.0 2E-128 4E-133 1028.8 45.2 441 47-487 14-455 (455)
2 cd06115 AthCS_per_like Arabido 100.0 1E-120 3E-125 958.6 42.7 408 75-482 3-410 (410)
3 PRK05614 gltA type II citrate 100.0 3E-119 6E-124 951.4 44.3 411 54-475 4-419 (419)
4 TIGR01798 cit_synth_I citrate 100.0 3E-116 7E-121 925.7 40.5 406 64-480 1-412 (412)
5 cd06116 CaCS_like Chloroflexus 100.0 3E-115 7E-120 912.1 40.5 384 93-483 1-384 (384)
6 COG0372 GltA Citrate synthase 100.0 3E-114 7E-119 900.8 39.1 379 91-486 10-390 (390)
7 cd06107 EcCS_AthCS-per_like Es 100.0 1E-112 3E-117 892.0 40.6 381 93-474 1-382 (382)
8 PRK14036 citrate synthase; Pro 100.0 3E-109 6E-114 865.8 40.5 376 95-487 2-377 (377)
9 PRK12351 methylcitrate synthas 100.0 1E-108 3E-113 860.3 39.7 369 98-486 9-378 (378)
10 PRK14035 citrate synthase; Pro 100.0 3E-107 6E-112 849.1 40.4 368 97-486 3-371 (371)
11 cd06114 EcCS_like Escherichia 100.0 6E-107 1E-111 854.4 40.7 388 77-474 10-400 (400)
12 cd06108 Ec2MCS_like Escherichi 100.0 7E-107 1E-111 843.7 39.7 362 99-483 1-363 (363)
13 PRK14037 citrate synthase; Pro 100.0 8E-107 2E-111 847.5 40.1 373 96-486 3-377 (377)
14 cd06112 citrate_synt_like_1_1 100.0 2E-106 4E-111 844.8 40.0 372 97-483 1-373 (373)
15 cd06117 Ec2MCS_like_1 Subgroup 100.0 4E-106 9E-111 839.2 39.9 364 100-483 2-366 (366)
16 PRK14032 citrate synthase; Pro 100.0 1E-105 3E-110 852.3 37.0 396 65-486 8-447 (447)
17 PRK14034 citrate synthase; Pro 100.0 5E-105 1E-109 832.3 39.3 369 96-486 2-371 (372)
18 cd06109 BsCS-I_like Bacillus s 100.0 2E-104 4E-109 823.2 37.7 347 99-474 1-349 (349)
19 cd06105 ScCit1-2_like Saccharo 100.0 2E-103 4E-108 830.9 37.1 382 80-475 14-423 (427)
20 PRK12350 citrate synthase 2; P 100.0 3E-103 6E-108 812.3 34.1 345 97-479 1-351 (353)
21 cd06106 ScCit3_like Saccharomy 100.0 9E-102 2E-106 817.8 38.1 380 81-471 15-423 (428)
22 PRK12349 citrate synthase 3; P 100.0 2E-101 4E-106 805.7 39.5 363 96-478 4-367 (369)
23 PRK09569 type I citrate syntha 100.0 9E-102 2E-106 819.8 37.0 366 97-480 38-431 (437)
24 TIGR01800 cit_synth_II 2-methy 100.0 6E-101 1E-105 802.8 40.7 368 99-486 1-368 (368)
25 PRK14033 citrate synthase; Pro 100.0 7E-101 1E-105 802.9 40.2 367 97-483 9-375 (375)
26 cd06103 ScCS-like Saccharomyce 100.0 4E-101 8E-106 813.4 36.8 363 96-471 35-421 (426)
27 cd06111 DsCS_like Cold-active 100.0 3E-100 6E-105 795.4 40.1 361 99-479 1-361 (362)
28 cd06118 citrate_synt_like_1 Ci 100.0 2.3E-98 5E-103 781.4 39.9 358 99-472 1-358 (358)
29 cd06110 BSuCS-II_like Bacillus 100.0 7.7E-98 2E-102 776.7 39.8 356 99-474 1-356 (356)
30 TIGR01793 cit_synth_euk citrat 100.0 5.8E-98 1E-102 787.9 36.1 362 97-472 39-423 (427)
31 cd06113 citrate_synt_like_1_2 100.0 1.4E-97 3E-102 784.4 37.3 359 102-474 9-406 (406)
32 PF00285 Citrate_synt: Citrate 100.0 9.8E-98 2E-102 776.4 34.2 355 100-468 1-356 (356)
33 cd06101 citrate_synt Citrate s 100.0 1.4E-83 3E-88 645.2 28.7 263 99-472 1-265 (265)
34 KOG2617 Citrate synthase [Ener 100.0 3.9E-83 8.4E-88 651.8 19.5 443 20-486 2-456 (458)
35 cd06102 citrate_synt_like_2 Ci 100.0 4.1E-74 9E-79 579.4 29.4 272 94-474 11-282 (282)
36 cd06099 CS_ACL-C_CCL Citrate s 100.0 2.3E-65 5.1E-70 498.6 22.7 211 254-472 1-213 (213)
37 PRK06224 citrate synthase; Pro 100.0 3E-62 6.5E-67 490.7 23.8 243 104-480 6-262 (263)
38 cd06100 CCL_ACL-C Citryl-CoA l 100.0 8.2E-54 1.8E-58 421.2 21.0 204 252-469 10-220 (227)
39 PLN02522 ATP citrate (pro-S)-l 100.0 3.8E-53 8.3E-58 462.2 22.1 175 277-459 399-591 (608)
40 KOG1254 ATP-citrate lyase [Ene 99.4 1.4E-13 2.9E-18 145.2 4.6 176 276-459 390-583 (600)
41 cd06100 CCL_ACL-C Citryl-CoA l 98.1 6.8E-05 1.5E-09 74.4 14.6 72 125-198 1-78 (227)
42 cd06099 CS_ACL-C_CCL Citrate s 81.3 38 0.00083 33.3 13.4 58 136-196 1-63 (213)
43 cd06111 DsCS_like Cold-active 61.8 1.1E+02 0.0023 32.8 12.1 62 134-197 146-211 (362)
44 PRK14037 citrate synthase; Pro 60.7 35 0.00075 36.7 8.2 70 125-196 140-213 (377)
45 PRK14035 citrate synthase; Pro 59.7 1.2E+02 0.0026 32.7 12.0 62 134-197 149-214 (371)
46 PRK14034 citrate synthase; Pro 59.4 1.1E+02 0.0023 33.0 11.6 63 133-197 148-214 (372)
47 PRK14033 citrate synthase; Pro 57.3 1.8E+02 0.0039 31.3 12.9 61 134-196 156-220 (375)
48 TIGR01800 cit_synth_II 2-methy 57.0 2.6E+02 0.0057 29.9 14.1 61 135-197 147-211 (368)
49 PRK12349 citrate synthase 3; P 55.9 2.6E+02 0.0056 30.0 13.8 60 135-196 153-216 (369)
50 PF09350 DUF1992: Domain of un 52.5 44 0.00095 27.4 5.7 59 346-404 2-64 (71)
51 PRK14036 citrate synthase; Pro 51.2 1.9E+02 0.0041 31.2 11.9 62 134-197 151-216 (377)
52 PTZ00096 40S ribosomal protein 49.4 14 0.0003 34.5 2.6 24 120-144 14-37 (143)
53 PRK04038 rps19p 30S ribosomal 46.2 16 0.00035 33.7 2.4 24 120-144 6-29 (134)
54 PRK10203 hypothetical protein; 44.7 73 0.0016 29.0 6.4 57 346-402 8-67 (122)
55 KOG2617 Citrate synthase [Ener 43.2 16 0.00034 39.6 2.2 56 78-134 38-96 (458)
56 TIGR01025 rpsS_arch ribosomal 39.5 23 0.00049 32.8 2.3 24 120-144 4-27 (135)
57 PLN03085 nucleobase:cation sym 38.7 95 0.002 31.0 6.6 60 346-405 93-155 (221)
58 cd06112 citrate_synt_like_1_1 37.3 68 0.0015 34.5 5.9 73 123-197 139-215 (373)
59 PRK12351 methylcitrate synthas 37.2 5.2E+02 0.011 27.9 12.6 60 135-196 157-220 (378)
60 PRK14032 citrate synthase; Pro 35.7 1.2E+02 0.0026 33.5 7.6 63 132-196 201-269 (447)
61 PF13946 DUF4214: Domain of un 34.6 78 0.0017 25.9 4.6 32 135-166 22-53 (75)
62 cd06109 BsCS-I_like Bacillus s 31.9 6.5E+02 0.014 26.8 13.8 62 134-197 135-200 (349)
63 cd06113 citrate_synt_like_1_2 30.2 2.5E+02 0.0054 30.6 8.8 64 132-197 171-240 (406)
64 PF00285 Citrate_synt: Citrate 28.8 2.5E+02 0.0054 29.8 8.5 72 124-197 136-213 (356)
65 cd06108 Ec2MCS_like Escherichi 28.2 2E+02 0.0044 30.8 7.6 62 133-196 143-208 (363)
66 PF07583 PSCyt2: Protein of un 26.5 53 0.0012 32.4 2.7 36 125-160 15-50 (208)
67 cd06118 citrate_synt_like_1 Ci 23.1 4.3E+02 0.0092 28.1 9.0 61 135-197 147-211 (358)
68 KOG1182 Branched chain alpha-k 22.1 55 0.0012 34.6 1.9 19 117-135 146-164 (432)
69 cd06110 BSuCS-II_like Bacillus 21.1 4.8E+02 0.01 27.8 8.8 61 134-196 146-210 (356)
70 PF11591 2Fe-2S_Ferredox: Ferr 20.3 47 0.001 23.0 0.7 10 296-305 7-16 (34)
No 1
>PLN02456 citrate synthase
Probab=100.00 E-value=1.7e-128 Score=1028.76 Aligned_cols=441 Identities=67% Similarity=1.109 Sum_probs=424.3
Q ss_pred CCCCCCCccEEEEeccCCeEEEeeeeeCCCcchhhhhhhhcCCCCcceeeecCCCcccceeeeeeeeEeCCCCeeEEccc
Q 010304 47 PPPGNLKGSLTVVDERTGKRYQIPVSQEGTVKATDFKKITTGKNDKGLKLYDPGYLNTAPVRSSICYIDGDEGILRYRGY 126 (513)
Q Consensus 47 ~~~~~~~~~l~~~~~r~g~~~~~pi~~~~~~~a~di~~l~~~~~~~g~~~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy 126 (513)
.++++++++|||+||||||+|++||.+.++++++||++|++...++|+++|||||.||++|+|+||+|||++|+|+||||
T Consensus 14 ~~~~~~~~~~~~~~~r~g~~~~~~i~~~~~~~~~~~~~l~~~~~~~g~~~~d~Gl~~~~~~~s~IS~iDg~~G~L~YRGy 93 (455)
T PLN02456 14 AAPGGGSGSLTIVDNRTGKDYESPLSELGPVQAERLKKIKAGKDDLGLKTVDPGYRNTAPVLSEISLIDGDEGILRFRGY 93 (455)
T ss_pred ccCCCCCCcEEEEECCCCcEEEEehhccCCcccchhhhcccCcCccCCEecCcccCCceeeeeeceEEeCCCCEEEECCc
Confidence 55677788999999999999999999547899999999998777889999999999999999999999999999999999
Q ss_pred CHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHhCCCCCChhhHHHHHHHHhhccCCCCCCc
Q 010304 127 PIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQAMPHDAHPMGVLVSAMSALSIFHPDANPA 206 (513)
Q Consensus 127 ~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa 206 (513)
+|+||+++++||||+||||+|+|||++|+++|+.+|.+++.+|+.+.++++.||+++|||.+|++++++|++++++.++.
T Consensus 94 ~I~dLa~~~~feevayLLl~G~LPt~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vsal~~~~~~~~~~ 173 (455)
T PLN02456 94 PIEELAEKSPFEEVAYLLLYGNLPTKEQLADWEAELRQHSAVPEHVLDVIDALPHDAHPMTQLVSGVMALSTFSPDANAY 173 (455)
T ss_pred cHHHHHhcCCHHHHHHHHHcCcCCCHHHHHHHHHHHHHhcCCCHHHHHHHHhCCCcCCcHHHHHHHHHhhhhcCcchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998877
Q ss_pred ccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHH
Q 010304 207 LKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFI 286 (513)
Q Consensus 207 ~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LI 286 (513)
..|.+++.+++...++++|||||+|+|+|++||++.|++++.|++++||++|||+||++.+...++|+|..+++||++||
T Consensus 174 ~~g~~~~~~~~~~~~~a~rliAk~p~iaA~~yr~~~g~~~~~P~~~ls~a~Nfl~Ml~~~~~~~~~p~~~~~~~l~~~Li 253 (455)
T PLN02456 174 LRGQHKYKSWEVRDEDIVRLIGKLPTLAAAIYRRMYGRGPVIPDNSLDYAENFLYMLGSLGDRSYKPDPRLARLLDLYFI 253 (455)
T ss_pred hcccCcccCHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHHe
Confidence 77777766677778999999999999999999999999999999999999999999999888889999999999999999
Q ss_pred HhcCCCCChhhHHHHHHh-ccCCCHHHHHHHHhhcccCCccCChHHHHHHHHHHhCCCCCHHHHHHHHHhcCCcccccCC
Q 010304 287 LHAEHEMNCSTSAARHLA-SSGVDVYTALAGAVGALYGPLHGGANEAVLKMLNEIGTVENIPEFIEGVKNRKRKMSGFGH 365 (513)
Q Consensus 287 LhADHelN~ST~aaRvva-Stgadlyaavaagi~AL~GPlHGGAneav~~mL~eI~~~~~i~~~i~~~~~~~~rl~GFGH 365 (513)
||||||+|||||++|+++ ||++|+|+||+|||+|||||+||||||+|++||++|++++++++||++++++|++||||||
T Consensus 254 LhADHe~n~ST~aar~~a~St~ad~ysavaAgi~aL~GPlHGGA~e~v~~~l~ei~~~~~v~~~v~~~l~~~~~l~GFGH 333 (455)
T PLN02456 254 IHADHEGGCSTAAARHLVGSSGVDPYTSVAAGVNALAGPLHGGANEAVLKMLKEIGTVENIPEYVEGVKNSKKVLPGFGH 333 (455)
T ss_pred eeccCCCCchhHHHHHHHhccCCCHHHHHHHHhhhcCCCcccChHHHHHHHHHHhCCHHHHHHHHHHHHhCCCcccCCCC
Confidence 999999999999999999 9999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccCCCCchhhHHHHHHHHcCCCCCchhhHhhhh
Q 010304 366 RVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIP 445 (513)
Q Consensus 366 rVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~LyPNVDfysg~i~~alGiP~~~~t~lFai~ 445 (513)
||||++||||++|+++|+++++..+.+|+++++++||+++..|+||+.|++|||||||+|+||++||||+++||++|+++
T Consensus 334 rvyk~~DPRa~~L~~~a~~l~~~~~~~~~~~ia~~le~~~~~~~~~~~r~l~pNVDfysg~l~~~lGip~~~~t~lFais 413 (455)
T PLN02456 334 RVYKNYDPRAKCIREFALEVFKHVGDDPLFKVASALEEVALLDEYFKVRKLYPNVDFYSGVLLRALGFPEEFFTVLFAVS 413 (455)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCCCCCCcCcHHHHHHHHHHcCcChhhccchhhhh
Confidence 99999999999999999999877778899999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhHHHHHhhhcCCCCCccCCcccccCCCCcccccccccc
Q 010304 446 RMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPLKERM 487 (513)
Q Consensus 446 R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~~~R~ 487 (513)
|++||+|||+||+.+|.+||+||||+|+|+..|+|+|+++|.
T Consensus 414 R~~Gw~AH~~E~~~~~~~ri~RP~~~Y~G~~~~~~~p~~~R~ 455 (455)
T PLN02456 414 RAAGYLSQWDEALGLPDERIMRPKQVYTGEWLRHYCPKAERT 455 (455)
T ss_pred hHHHHHHHHHHHHhCCcccccCCCccccCCCcccccCcccCC
Confidence 999999999999998888999999999999999999999984
No 2
>cd06115 AthCS_per_like Arabidopsis thaliana (Ath) peroxisomal (Per) CS_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. This group contains three Arabidopsis peroxisomal CS proteins, CYS1, -2, and -3 which are involved in the glyoxylate cycle. AthCYS1, in addition to a peroxisomal targeting sequence, has a predicted secretory signal peptide; it may be targeted to both the secretory pathway and the peroxisomes and is thought to be located in the extracellular matrix. AthCSY1 is expr
Probab=100.00 E-value=1.2e-120 Score=958.61 Aligned_cols=408 Identities=87% Similarity=1.398 Sum_probs=393.0
Q ss_pred CCcchhhhhhhhcCCCCcceeeecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHH
Q 010304 75 GTVKATDFKKITTGKNDKGLKLYDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQ 154 (513)
Q Consensus 75 ~~~~a~di~~l~~~~~~~g~~~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~e 154 (513)
|+++++||++|++..+++|+++|||||.||++|+|+||+|||++|+|+||||+|+||+++++||||+||||+|+|||++|
T Consensus 3 ~~~~~~d~~~~~~~~~~~g~~~~~~Gl~~~~~~~t~Is~iDg~~G~L~YRGy~I~dLa~~~~feEv~~LLl~G~LPt~~e 82 (410)
T cd06115 3 GTVKATDFKKIKAGKDDKGLRLYDPGYLNTAVVRSKISYIDGDKGILRYRGYPIEELAEKSTFLEVAYLLIYGNLPTKSQ 82 (410)
T ss_pred CCcceeeHHHhcCCcccCCCcccCCccCCceEEEeeCeeEeCCCCeEEECCccHHHHHhcCCHHHHHHHHHcCCCcCHHH
Confidence 78999999999987889999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhcCCCcHHHHHHHHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHH
Q 010304 155 LTDWEFAVSQHSAVPQGILDIIQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIA 234 (513)
Q Consensus 155 l~~f~~~l~~~~~l~~~v~~~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptia 234 (513)
+++|+++|.+++.+|+.++++|+.||+++|||.+|++++++|++|+++.+++..|.++|++.....++++||+||+|+|+
T Consensus 83 l~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vs~l~~~~~~~~~~~~~~~~~~~~~~~~~~a~rliA~~p~i~ 162 (410)
T cd06115 83 LSDWEFAVSQHTAVPTGVLDMIKSFPHDAHPMGMLVSAISALSAFHPEANPALAGQDIYKNKQVRDKQIVRILGKAPTIA 162 (410)
T ss_pred HHHHHHHHHHccCCCHHHHHHHHhCCCCCCHHHHHHHHHHHHhccCccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999887766677776665667788899999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHH
Q 010304 235 AAAYLRMAGRPPVLPSNNLSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTAL 314 (513)
Q Consensus 235 A~~y~~~~G~~~~~p~~~lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaav 314 (513)
|++||++.|+++++|+++++|++|||+||++.+.+.++|+|..+++||++||||||||+|+||||+|++|||++|+|+||
T Consensus 163 A~~~r~~~g~~~~~p~~~ls~a~NFl~Ml~g~~~~~~~p~~~~~~~l~~~liL~ADH~~naSTfaarv~aSt~ad~ysav 242 (410)
T cd06115 163 AAAYRRRAGRPPNLPSQDLSYTENFLYMLDSLGERKYKPNPRLARALDILFILHAEHEMNCSTAAVRHLASSGVDVYTAV 242 (410)
T ss_pred HHHHHHHcCCCCcCCCCCCCHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHHHHhhccCCCchHHHHHHHHhcCCCHHHHH
Confidence 99999999999999999999999999999998888899999999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCccCChHHHHHHHHHHhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcH
Q 010304 315 AGAVGALYGPLHGGANEAVLKMLNEIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPL 394 (513)
Q Consensus 315 aagi~AL~GPlHGGAneav~~mL~eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~l 394 (513)
+|||+||+||+||||||+|++||++|++++++++||++.+++|++||||||||||++||||++|+++++++.+..+.+++
T Consensus 243 ~agi~aL~GplHGGA~e~v~~~l~ei~~~~~~~~~v~~~~~~~~ri~GFGHrvYk~~DPRa~~L~~~~~~l~~~~~~~~~ 322 (410)
T cd06115 243 AGAVGALYGPLHGGANEAVLRMLAEIGTVENIPAFIEGVKNRKRKLSGFGHRVYKNYDPRAKIIKKLADEVFEIVGKDPL 322 (410)
T ss_pred HHHHhhccCCcccchHHHHHHHHHHhCChHHHHHHHHHHHhcCCcccCCCCCCCCCCCccHHHHHHHHHHHHhhcCCcHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998766677899
Q ss_pred HHHHHHHHHHHhccccccccCCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccC
Q 010304 395 IEVAVALEKAALSDEYFVKRKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTG 474 (513)
Q Consensus 395 l~iA~~lE~~a~~d~yf~~r~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G 474 (513)
+++|+++|+++.+++||+.|++|||||||+|+||++||||+++||++|+++|++||+|||+||+.++++||+||++.|+|
T Consensus 323 ~~~a~~~e~~~~~~~~~~~k~l~pNVD~ysa~l~~~lG~p~~~~t~lFa~sR~~Gw~AH~~Eq~~~~~~~i~RP~~~Y~G 402 (410)
T cd06115 323 IEIAVALEKAALSDEYFVKRKLYPNVDFYSGLIYRAMGFPTDFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQLYTG 402 (410)
T ss_pred HHHHHHHHHHHHhhhhhcccCCCCChHHHHHHHHHHcCCChHhhhhHHHHHhhhhHHHHHHHHHhCCCCcccCcccccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999998766899999999999
Q ss_pred CCCccccc
Q 010304 475 VWMRHYMP 482 (513)
Q Consensus 475 ~~~r~~~p 482 (513)
+.+|+|+|
T Consensus 403 ~~~~~~~p 410 (410)
T cd06115 403 VWLRHYVP 410 (410)
T ss_pred CCCCCCCC
Confidence 99999986
No 3
>PRK05614 gltA type II citrate synthase; Reviewed
Probab=100.00 E-value=2.6e-119 Score=951.40 Aligned_cols=411 Identities=50% Similarity=0.858 Sum_probs=387.9
Q ss_pred ccEEEEeccCCeEEEeeeeeCCC--cchhhhhhhhcCCCCcceeeecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHH
Q 010304 54 GSLTVVDERTGKRYQIPVSQEGT--VKATDFKKITTGKNDKGLKLYDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEEL 131 (513)
Q Consensus 54 ~~l~~~~~r~g~~~~~pi~~~~~--~~a~di~~l~~~~~~~g~~~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eL 131 (513)
.++++++++|||+|++||.. +| ++++||++|++ ++|+.+|||||.||++|+|+||+|||++|+|+||||+|+||
T Consensus 4 ~~~~~~~~~~~~~~~~~~~~-~t~~~~~~~~~~~~~---~~~~~~~~~Gl~~~~~~~S~Is~iDg~~G~L~YRGy~i~dL 79 (419)
T PRK05614 4 KKATLTLNGGEASVELPILK-GTLGPDVIDIRKLYG---STGYFTYDPGFTSTASCESKITYIDGDKGILLYRGYPIEQL 79 (419)
T ss_pred ceEEEEECCCCcEEEeeeec-CCCCCcceehHhhhh---ccCCcccCCccCCceeeeeeceeEeCCCCEEEECCccHHHH
Confidence 35778889999999999999 77 67999999976 57889999999999999999999999999999999999999
Q ss_pred hhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCC
Q 010304 132 AESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQD 211 (513)
Q Consensus 132 a~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~ 211 (513)
+++++||||+||||+|+||+++|+++|+.+|.+++.+|+.+.++++.||+++|||.+|++++++|++++++...
T Consensus 80 a~~~~feEva~LLl~G~LP~~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vs~l~~~~~~~~~------ 153 (419)
T PRK05614 80 AEKSDFLEVCYLLLYGELPTAEQKAEFDTTVTRHTMVHEQLKRFFRGFRRDAHPMAVLCGVVGALSAFYHDSLD------ 153 (419)
T ss_pred HhcCCHHHHHHHHHcCcCCCHHHHHHHHHhHhhccCCCHHHHHHHHhcCCCCCHHHHHHHHHHHHhhcCccccC------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999865421
Q ss_pred cccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCC
Q 010304 212 IYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEH 291 (513)
Q Consensus 212 ~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADH 291 (513)
. .+.....++++||||++|+|+|++||++.|+++++|++++||++|||+||++.+...++|+|..+++||++|||||||
T Consensus 154 ~-~~~~~~~~~a~rlia~~p~i~A~~~r~~~g~~~~~p~~~ls~a~nfl~ml~g~~~~~~~~~~~~~~~ld~~LiL~ADH 232 (419)
T PRK05614 154 I-NDPEHREIAAIRLIAKMPTLAAMAYKYSIGQPFVYPRNDLSYAENFLRMMFATPCEEYEVNPVLVRALDRIFILHADH 232 (419)
T ss_pred C-CCHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCCCCCCCccCHHHHHHHHHhCCCCccCCCCHHHHHHHHHHHhhhccC
Confidence 1 123344567899999999999999999999999999999999999999999988888999999999999999999999
Q ss_pred CCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHHHhCCCCCHHHHHHHHHhc--CCcccccCCCCCC
Q 010304 292 EMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLNEIGTVENIPEFIEGVKNR--KRKMSGFGHRVYK 369 (513)
Q Consensus 292 elN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~eI~~~~~i~~~i~~~~~~--~~rl~GFGHrVYk 369 (513)
|+||||||+|+++||++|+|+||+|||+|||||+||||||+|++||++|++++++++||++++++ |++||||||||||
T Consensus 233 ~~n~STfa~RvvaSt~adlysav~agi~aL~GplHGGA~e~v~~~l~~i~~~~~~~~~i~~~~~~~~~~~i~GFGHrvyk 312 (419)
T PRK05614 233 EQNASTSTVRLAGSSGANPFACIAAGIAALWGPAHGGANEAVLKMLEEIGSVDNIPEFIARAKDKNDGFRLMGFGHRVYK 312 (419)
T ss_pred CCCcchHHHhhhhccCCCHHHHHHHHHhhcCCCcccChHHHHHHHHHHhCCchhHHHHHHHHHhccCCccccCCCCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999764 4599999999999
Q ss_pred CCCchHHHHHHHHHHHHHHhC-CCcHHHHHHHHHHHHhccccccccCCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhh
Q 010304 370 NYDPRAKVIRKLAEEVFSIVG-RDPLIEVAVALEKAALSDEYFVKRKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMA 448 (513)
Q Consensus 370 ~~DPRA~iL~~~a~~l~~~~~-~~~ll~iA~~lE~~a~~d~yf~~r~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~ 448 (513)
++||||++|+++|+++++..+ .++++++++++|+++.+|+||+.|++|||||||+|+||++||||+++||++|+++|++
T Consensus 313 ~~DPRa~~l~~~a~~l~~~~~~~~~~~~ia~~ie~~~~~~~~~~~r~l~pNvD~~s~~l~~~lG~p~~~~t~lFa~~R~~ 392 (419)
T PRK05614 313 NYDPRAKIMRETCHEVLKELGLNDPLLEVAMELEEIALNDEYFIERKLYPNVDFYSGIILKALGIPTSMFTVIFALARTV 392 (419)
T ss_pred CCCCCHHHHHHHHHHHHHHcCCCcHHHHHHHHHHHHHhhhhhhccCCCCcChHHHHHHHHHHcCcChhhhcchHHhHhHH
Confidence 999999999999999988777 6889999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHHHHhhhcCCCCCccCCcccccCC
Q 010304 449 GYLAHWRESLDDPDTKIMRPQQVYTGV 475 (513)
Q Consensus 449 GwiAH~~Eq~~~~~~ki~RPr~~Y~G~ 475 (513)
||+|||+||+.+|++||+||||+|+|+
T Consensus 393 Gw~AH~~Eq~~~~~~~iiRPr~~Y~G~ 419 (419)
T PRK05614 393 GWIAHWNEMHSDPEQKIGRPRQLYTGY 419 (419)
T ss_pred HHHHHHHHHHhccCCcccCCCccccCC
Confidence 999999999998889999999999995
No 4
>TIGR01798 cit_synth_I citrate synthase I (hexameric type). This model describes one of several distinct but closely homologous classes of citrate synthase, the protein that brings carbon (from acetyl-CoA) into the TCA cycle. This form, class I, is known to be hexameric and allosterically inhibited by NADH in Escherichia coli, Acinetobacter anitratum, Azotobacter vinelandii, Pseudomonas aeruginosa, etc. In most species with a class I citrate synthase, a dimeric class II isozyme is found. The class II enzyme may act primarily on propionyl-CoA to make 2-methylcitrate or be bifunctional, may be found among propionate utilization enzymes, and may be constitutive or induced by propionate. Some members of this model group as class I enzymes, and may be hexameric, but have shown regulatory properties more like class II enzymes.
Probab=100.00 E-value=3e-116 Score=925.70 Aligned_cols=406 Identities=50% Similarity=0.866 Sum_probs=383.3
Q ss_pred CeEEEeeeeeCCC--cchhhhhhhhcCCCCcceeeecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHH
Q 010304 64 GKRYQIPVSQEGT--VKATDFKKITTGKNDKGLKLYDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVA 141 (513)
Q Consensus 64 g~~~~~pi~~~~~--~~a~di~~l~~~~~~~g~~~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva 141 (513)
||+|++||.. +| ++++||+++.. ++|+++|||||.||++|+|+||+|||++|+|+||||+|+||+++++||||+
T Consensus 1 ~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~GL~~v~~~~s~Is~iDg~~G~L~YRGy~I~dL~~~~~feEv~ 76 (412)
T TIGR01798 1 NKSVELPIYS-GTLGPDVIDIRKLYK---QTGLFTFDPGFTSTASCESKITFIDGDKGILLYRGYPIDQLATKSDYLEVC 76 (412)
T ss_pred CCeeecceec-CcCCCcchhhHhhhh---cCCCCcCCCCCCCceeEeeeCeeEeCCCCEEEECCccHHHHhccCCHHHHH
Confidence 6899999999 77 67999999976 568888999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHH
Q 010304 142 YLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDK 221 (513)
Q Consensus 142 ~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~ 221 (513)
||||+|+|||++|+++|+.+|.+++.+|+.+.++|++||+++|||.+|++++++|++|+++.. +. .+.+....
T Consensus 77 yLLl~G~LPt~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vs~l~~~~~~~~------~~-~~~~~~~~ 149 (412)
T TIGR01798 77 YLLLNGELPTAEQKDEFDDTVTRHTMVHEQVTRFFNGFRRDAHPMAVMVGVVGALSAFYHDSL------DI-NDPRHREI 149 (412)
T ss_pred HHHHcCCCCCHHHHHHHHHHHHHccCCCHHHHHHHHhCCCcCChHHHHHHHHHHHhhhCcccc------cc-CCHHHHHH
Confidence 999999999999999999999999999999999999999999999999999999999987642 11 12334466
Q ss_pred HHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHH
Q 010304 222 QIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAAR 301 (513)
Q Consensus 222 ~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaR 301 (513)
+++||+||+|+|+|++||++.|+++++|++++||++|||+||++.+...++|++..+++||++||||||||+|+||||+|
T Consensus 150 ~a~~liA~~p~i~A~~yr~~~g~~~i~p~~~ls~a~Nfl~Ml~g~~~~~~~p~~~~~~~l~~~LiL~aDHg~n~STfaaR 229 (412)
T TIGR01798 150 AAIRLIAKIPTLAAMSYKYSIGQPFVYPRNDLSYAENFLHMMFATPCEDYKVNPVLARAMDRIFILHADHEQNASTSTVR 229 (412)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCcCCCCCCCHHHHHHHHhcCCCCccCCCCHHHHHHHHHHHHHhhcCCCCcccceee
Confidence 88999999999999999999999999999999999999999999877888999999999999999999999999999999
Q ss_pred HHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHHHhCCCCCHHHHHHHHHhcC--CcccccCCCCCCCCCchHHHHH
Q 010304 302 HLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLNEIGTVENIPEFIEGVKNRK--RKMSGFGHRVYKNYDPRAKVIR 379 (513)
Q Consensus 302 vvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~eI~~~~~i~~~i~~~~~~~--~rl~GFGHrVYk~~DPRA~iL~ 379 (513)
+++||++|+|+||+|||+||+||+||||||+|++||++|++++++++||++.++++ ++||||||||||..||||++|+
T Consensus 230 v~aSt~ad~ysav~agi~aL~GplHGGA~e~v~~ml~ei~~~~~~~~~v~~~~~~~~~~~i~GFGHrvyk~~DPRa~~L~ 309 (412)
T TIGR01798 230 LAGSSGANPFACIAAGIAALWGPAHGGANEAALKMLEEIGSVKNIPEFIKKVKDKNDPFRLMGFGHRVYKNYDPRAKVMR 309 (412)
T ss_pred eeecCCCCHHHHHHHHhhhccCccccchHHHHHHHHHHhCChhHHHHHHHHHHhcCCCccccCCCCCCCCCCCccHHHHH
Confidence 99999999999999999999999999999999999999999999999999998887 4999999999999999999999
Q ss_pred HHHHHHHHHhCC--CcHHHHHHHHHHHHhccccccccCCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhh
Q 010304 380 KLAEEVFSIVGR--DPLIEVAVALEKAALSDEYFVKRKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRES 457 (513)
Q Consensus 380 ~~a~~l~~~~~~--~~ll~iA~~lE~~a~~d~yf~~r~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq 457 (513)
++++++.+..+. ++++++++++|+++.+++||..|++|||||||+|+||++||||+++||++|+++|++||+|||+||
T Consensus 310 ~~a~~l~~~~g~~~~~~~~~a~~~e~~~~~~~~~~~k~l~pNvD~~sa~l~~~lG~p~~~~t~lFaisR~~Gw~AH~~Eq 389 (412)
T TIGR01798 310 ETCHEVLKELGLHDDPLFKLAMELEKIALNDPYFIERKLYPNVDFYSGIILKAMGIPTSMFTVIFALARTVGWISHWSEM 389 (412)
T ss_pred HHHHHHHHHcCCCccHHHHHHHHHHHHHHhhhhhccCCCCcChHHHHHHHHHHcCCChhhhhhHHHHHhhhhHHHHHHHH
Confidence 999998877663 689999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCccCCcccccCCCCccc
Q 010304 458 LDDPDTKIMRPQQVYTGVWMRHY 480 (513)
Q Consensus 458 ~~~~~~ki~RPr~~Y~G~~~r~~ 480 (513)
+.+++++|+||+++|+|+.+|+|
T Consensus 390 ~~~~~~~l~RP~~~Y~G~~~~~~ 412 (412)
T TIGR01798 390 ISDPGQKIGRPRQLYTGEEQRDY 412 (412)
T ss_pred HhCCCCcccCchhccCCCCCCCC
Confidence 99876899999999999999886
No 5
>cd06116 CaCS_like Chloroflexus aurantiacus (Ca) citrate synthase (CS)_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). This group is similar to gram-negative Escherichia coli (Ec) CS (type II, gltA) and Arabidopsis thaliana (Ath) peroxisomal (Per) CS. However EcCS and AthPerCS are not found in this group. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. There are two types of CSs: type I CS and type II CSs. Type I CSs are found in eukarya, gram-positive bacteria, archaea, and in some gram-negative bacteria and are homodimers w
Probab=100.00 E-value=3.2e-115 Score=912.07 Aligned_cols=384 Identities=61% Similarity=1.052 Sum_probs=366.4
Q ss_pred ceeeecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHH
Q 010304 93 GLKLYDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGI 172 (513)
Q Consensus 93 g~~~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v 172 (513)
|+++|||||.||++|+|+||+|||++|+|+||||+|+||+++++||||+||||+|+|||++|+++|+.+|.+++.+|+.+
T Consensus 1 g~~~~~~Gl~~v~~~~t~Is~iDg~~G~L~YRGy~I~dL~~~~~feEv~yLLl~G~lPt~~el~~f~~~L~~~~~lp~~v 80 (384)
T cd06116 1 GLMTYDPAYLNTASCKSAITYIDGEKGILRYRGYPIEQLAEQSSYLEVAYLLLHGELPTKERLAQWVYDITRHTMTHENL 80 (384)
T ss_pred CCCCCCCCcCCeeEEeeEeeeEeCCCCeEEECCccHHHHhccCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHccCCCHHH
Confidence 67889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCC
Q 010304 173 LDIIQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNN 252 (513)
Q Consensus 173 ~~~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~ 252 (513)
.++++.||+++|||++|++++++|++++++.. +. .+.+....+++||+||+|+|+|++||++.|+++++|+++
T Consensus 81 ~~~l~~~p~~~hPM~~L~~~vs~l~~~~~~~~------~~-~~~~~~~~~~~rliA~~p~i~A~~~r~~~g~~~~~p~~~ 153 (384)
T cd06116 81 KKFMDGFRYDAHPMGILISSVAALSTFYPEAK------NI-GDEEQRNKQIIRLIGKMPTIAAFAYRHRLGLPYVLPDND 153 (384)
T ss_pred HHHHHhcCcCCCcHHHHHHHHHhhhhcCcccc------cc-CCHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCccCCCCC
Confidence 99999999999999999999999999987652 11 233344667899999999999999999999999999999
Q ss_pred CCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHH
Q 010304 253 LSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEA 332 (513)
Q Consensus 253 lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAnea 332 (513)
+||++|||+||++.+...|+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+||+||+||||||+
T Consensus 154 ls~a~Nfl~Ml~g~~~~~~~p~~~~~~~l~~~LiL~ADH~~n~STfaarv~aSt~ad~ysav~agi~aL~GplHGGA~e~ 233 (384)
T cd06116 154 LSYTGNFLSMLFKMTEPKYEPNPVLAKALDVLFILHADHEQNCSTSAMRSVGSSRADPYTAVAAAVAALYGPLHGGANEA 233 (384)
T ss_pred CCHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHhhhccCCCCchhHHHhhhhccCCCHHHHHHHHHHhccCCcccchHHH
Confidence 99999999999998888899999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhcccccc
Q 010304 333 VLKMLNEIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFV 412 (513)
Q Consensus 333 v~~mL~eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~ 412 (513)
|++||++|++++++++||++.+++|++||||||||||+.||||++|+++++++.+..+.++++++++++|+++.+++||.
T Consensus 234 v~~~l~ei~~~~~~~~~v~~~~~~~~ri~GFGHrvyk~~DPRa~~L~~~~~~l~~~~~~~~~~~ia~~~e~~~~~~~~~~ 313 (384)
T cd06116 234 VLRMLQQIGSPKNIPDFIETVKQGKERLMGFGHRVYKNYDPRARIIKKIADEVFEATGRNPLLDIAVELEKIALEDEYFI 313 (384)
T ss_pred HHHHHHHhCChHHHHHHHHHHHhcCCcccCCCCCCCCCCChHHHHHHHHHHHHHHhhCCCHHHHHHHHHHHHHHHhhhhc
Confidence 99999999999999999999998889999999999999999999999999999776667789999999999999999999
Q ss_pred ccCCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCcccccc
Q 010304 413 KRKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPL 483 (513)
Q Consensus 413 ~r~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~ 483 (513)
.|++|||||||+|+||+.||||+++||++|++||++||+|||+||+.++++||+||+++|+|+..|+|+|+
T Consensus 314 ~k~l~pNvD~ysa~l~~~lGip~~~~t~lf~isR~~Gw~AH~~Eq~~~~~~~i~RP~~~Y~G~~~~~~~p~ 384 (384)
T cd06116 314 SRKLYPNVDFYSGLIYQALGFPTEAFTVLFAIPRTSGWLAQWIEMLRDPEQKIARPRQVYTGPRDRDYVPI 384 (384)
T ss_pred ccCCCCChHHHHHHHHHHhCCChhhccchhhhhhhchHHHHHHHHHhCcCCcccCccccccCCCCCCCCCC
Confidence 99999999999999999999999999999999999999999999998877899999999999999999985
No 6
>COG0372 GltA Citrate synthase [Energy production and conversion]
Probab=100.00 E-value=3.2e-114 Score=900.82 Aligned_cols=379 Identities=51% Similarity=0.883 Sum_probs=360.5
Q ss_pred CcceeeecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcH
Q 010304 91 DKGLKLYDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQ 170 (513)
Q Consensus 91 ~~g~~~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~ 170 (513)
+++...|++||.++.+|+|+||+|||++|+|+||||+|+||+++++||||+||||+|+||+.+|++.|..++..++.+|+
T Consensus 10 ~~~~~~~~~Gl~~v~~~~t~is~id~~~g~L~yrGy~i~dla~~~~feev~~LLl~G~lPt~~el~~~~~~~~~~~~~~~ 89 (390)
T COG0372 10 DVGRFTYDPGLEGVAACETAISYIDGDGGILRYRGYDIEDLAEKSSFEEVAYLLLYGELPTKAELAAFFAKLAARRTLPE 89 (390)
T ss_pred CccccccCCcccccceeeeeeeEecCCCceEEECCccHHHHHhhcCHHHHHHHHHcCcCCChHHHHHHHHHHHHhcCccH
Confidence 46889999999999999999999999999999999999999999999999999999999999999999999988888999
Q ss_pred HHHHHHHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCC
Q 010304 171 GILDIIQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPS 250 (513)
Q Consensus 171 ~v~~~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~ 250 (513)
.+.+++..+|.+.|||++|++++++|++++++... .+. ....+.|++|++|+|+|++||.+.|.+++.|+
T Consensus 90 ~~~~~~~~~p~~~hpm~~l~~~vs~l~~~~~~~~~--------~~~--~~~~a~rlia~~pti~a~~yr~~~g~~~i~p~ 159 (390)
T COG0372 90 QVIRLLESLPRDAHPMAVLRTAVSALSAFYPDKLD--------LND--RREAALRLIAKLPTIAAAVYRYSRGEPPIAPD 159 (390)
T ss_pred HHHHHHHhCCCCcCcHHHHHHHHHHhccccccccc--------cch--hHHHHHHHHHHhhHHHHHHHHHhcCCCCccCC
Confidence 99999999999999999999999999999876531 111 45678999999999999999999999999999
Q ss_pred CCCCHHHHHHHHhhcCCCCCCCCC-HHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCCh
Q 010304 251 NNLSYSENFLYMLDSLGNRAYKPN-PRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGA 329 (513)
Q Consensus 251 ~~lsy~eNfL~ml~~~~~~~~~p~-p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGA 329 (513)
++++|++|||+||++. .|+ |..+++||++||||||||+|+||||+||+|||++|+|+||+|||+|||||+||||
T Consensus 160 ~~~s~a~nfL~ml~g~-----~p~~~~~~~a~d~~LiL~ADHe~NASTftarvvaST~sd~ys~i~agi~aL~GPlHGGA 234 (390)
T COG0372 160 PDLSYAENFLYMLFGE-----PPSPPVEARAMDRALILHADHELNASTFTARVVASTGSDLYACIAAGIGALKGPLHGGA 234 (390)
T ss_pred CCccHHHHHHHHHcCC-----CCCcHHHHHHHHHHHHHHhccCCCcHHHHHHHHHhcCCcHHHHHHHHHHHcCCCccCCh
Confidence 9999999999999973 566 6999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCC-HHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhcc
Q 010304 330 NEAVLKMLNEIGTVEN-IPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSD 408 (513)
Q Consensus 330 neav~~mL~eI~~~~~-i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d 408 (513)
||+|++||+||++..+ +++||++.+++|++||||||||||++||||++||++++++.++.|+++++++|+++|++++++
T Consensus 235 ne~v~~ml~ei~~~~~~~~~~v~~~l~~~~~imGFGHRVYk~~DPRa~~lk~~a~~l~~~~g~~~~~~~a~~~e~~~l~~ 314 (390)
T COG0372 235 NEAVMKMLEEIGSSGESAEAYVRKALDRKERIMGFGHRVYKNYDPRAKVLKELAEKLGKELGDLKLYEIAEELEEIALED 314 (390)
T ss_pred HHHHHHHHHHHcccchhHHHHHHHHHhCCCCcCCCCCCCCCCCCchHHHHHHHHHHHHhhcCchhHHHHHHHHHHHHHHh
Confidence 9999999999997654 999999999999999999999999999999999999999998888678999999999999999
Q ss_pred ccccccCCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCccccccccc
Q 010304 409 EYFVKRKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPLKER 486 (513)
Q Consensus 409 ~yf~~r~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~~~R 486 (513)
.|| .||+|||||||||++|++||||.+|||+||++||++||+|||+||..++ +||+|||+.|+|+.+|.|+|+++|
T Consensus 315 ~~~-~k~l~PNvDfysg~v~~~lGiP~~~fT~lFaiaR~~GW~AH~~Eq~~~~-~riiRPr~~Y~G~~~r~~~~~~~r 390 (390)
T COG0372 315 LGF-EKKLYPNVDFYSGIVYRALGIPTDMFTPLFAIARTVGWIAHWIEQKEDG-NKIIRPRALYTGPEERDYVPIEER 390 (390)
T ss_pred hhc-ccCCCCccccchHHHHHHcCCCHHhhhhhhhhhhHHHHHHHHHHHHhcc-CCccCChhhhcCccccccccccCC
Confidence 999 9999999999999999999999999999999999999999999999975 899999999999999999999987
No 7
>cd06107 EcCS_AthCS-per_like Escherichia coli (Ec) citrate synthase (CS) gltA and Arabidopsis thaliana (Ath) peroxisomal (Per) CS_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. There are two types of CSs: type I CS and type II CSs. Type I CSs are found in eukarya, gram-positive bacteria, archaea, and in some gram-negative bacteria and are homodimers with both subunits participating in the active site. Type II CSs are unique to gram-negative bacteria and are homohexamers of ide
Probab=100.00 E-value=1.2e-112 Score=892.02 Aligned_cols=381 Identities=64% Similarity=1.079 Sum_probs=361.3
Q ss_pred ceeeecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHH
Q 010304 93 GLKLYDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGI 172 (513)
Q Consensus 93 g~~~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v 172 (513)
|+++|||||.||++|+|+||+|||++|+|+||||+|+||+++++||||+||||+|+|||++|+++|+.+|..++.+|+.+
T Consensus 1 g~~~~~~GL~~v~~~~t~Is~iDg~~G~L~YRGy~I~dLa~~~~feev~yLLl~G~LPt~~el~~f~~~L~~~~~lp~~v 80 (382)
T cd06107 1 GLRVYDPGYLNTAVCESSITYIDGDKGILLYRGYPIEQLAESSTYEEVAYLLLWGELPTQEQYDEFQRRLSEHMMVPESV 80 (382)
T ss_pred CCCCCCCCcCCeeeEeeeCeeEeCCCCeEEECCccHHHHHhcCCHHHHHHHHhCCCCCCHHHHHHHHHHHHHccCCCHHH
Confidence 67889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCccc-chhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCC
Q 010304 173 LDIIQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYK-SKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSN 251 (513)
Q Consensus 173 ~~~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~-~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~ 251 (513)
.++++.||+++|||++|++++++|++++++..+...| +.|. +.+...++++||+||+|+|+|++||++.|+++++|++
T Consensus 81 ~~~i~~~p~~~hPM~~L~~~vs~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~liA~~p~i~A~~yr~~~g~~~~~P~~ 159 (382)
T cd06107 81 HRLIQTFPRDAHPMGILCAGLSALSAFYPEAIPAHTG-DLYQNNPEVRDKQIIRTLAKMPTIAAAAYCHRIGRPFVYPRA 159 (382)
T ss_pred HHHHHhCCCCCCcHHHHHHHHHhhcccCccccchhhc-cccccCHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999999999999876544344 3443 4455567889999999999999999999999999999
Q ss_pred CCCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHH
Q 010304 252 NLSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANE 331 (513)
Q Consensus 252 ~lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAne 331 (513)
++||++|||+||++.+..+++|+|+.+++||++||||||||+|+||||+|+++||++|+|+|++||++||+||+|||||+
T Consensus 160 ~ls~a~NFL~Ml~g~~~~~~~p~~~~~~~l~~~LiL~aDHg~n~ST~aaRv~aSt~ad~~s~v~aai~al~GplHGGA~e 239 (382)
T cd06107 160 NLSYIENFLYMMGYVDQEPYEPNPRLARALDRLWILHADHEMNCSTSAARHTGSSLADPISCMAAAIAALYGPLHGGANE 239 (382)
T ss_pred CCCHHHHHHHHhcCCCcCCCCCCHHHHHHHHHHHHHhcccCCcchhHHHHHHHhcCCcHHHHHHHHHhhccCCcccchHH
Confidence 99999999999998765667899999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccc
Q 010304 332 AVLKMLNEIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYF 411 (513)
Q Consensus 332 av~~mL~eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf 411 (513)
+|++||++|++++++++||++.+++|++||||||||||..|||+++|+++++++.+..+.+++++++++||+++.+++||
T Consensus 240 ~v~~~l~ei~~~~~~~~~v~~~~~~~~ri~GFGHrvyk~~DPRa~~L~~~~~~l~~~~~~~~~~~~a~~ie~~~~~~~~~ 319 (382)
T cd06107 240 AALKMLREIGTPENVPAFIERVKNGKRRLMGFGHRVYKNYDPRAKVIREILHEVLTEVEKDPLLKVAMELERIALEDEYF 319 (382)
T ss_pred HHHHHHHHhCChHHHHHHHHHHHhcCCCcCCCCCCCCCCCCccHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHhhh
Confidence 99999999999999999999999999999999999999999999999999999976666789999999999999999999
Q ss_pred cccCCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccC
Q 010304 412 VKRKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTG 474 (513)
Q Consensus 412 ~~r~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G 474 (513)
+.|++|||||||+|+||++||||+++||++|++||++||+|||+||+.++.++|+||+++|+|
T Consensus 320 ~~k~l~pNvD~~sa~~~~~lG~p~~~~t~lf~~sR~~Gw~AH~~Eq~~~~~~~i~RP~~~Y~G 382 (382)
T cd06107 320 VSRKLYPNVDFYSGFIYKALGFPPEFFTVLFAVARTSGWMAHWREMMEDPLQRIWRPRQVYTG 382 (382)
T ss_pred ccCCCCcChHHHHHHHHHHcCCChhhhhHHHHHHHHHHHHHHHHHHHhCCCCceeCcccccCC
Confidence 999999999999999999999999999999999999999999999998755799999999998
No 8
>PRK14036 citrate synthase; Provisional
Probab=100.00 E-value=3e-109 Score=865.80 Aligned_cols=376 Identities=48% Similarity=0.834 Sum_probs=358.4
Q ss_pred eeecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHH
Q 010304 95 KLYDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILD 174 (513)
Q Consensus 95 ~~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~ 174 (513)
.+|||||.||++|+|+||+|||++|+|+||||+|+||+++++||||+||||+|+||+++|++.|...|.+++.+|+.+.+
T Consensus 2 ~~~~~Gl~gv~~~~t~Is~idg~~G~L~yRGy~i~dL~~~~~Feev~~LLl~G~lP~~~el~~f~~~L~~~~~lp~~v~~ 81 (377)
T PRK14036 2 CEYRPGLEGVPATQSSISYVDGQKGILEYRGYPIEELAEKSSFLETAYLLIWGELPTAEELEEFEQEVRMHRRVKYRIRD 81 (377)
T ss_pred CCCCCccCCCeeeeeeceEEECCCCEEEECCccHHHHHccCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHccCCCHHHHH
Confidence 46999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 010304 175 IIQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLS 254 (513)
Q Consensus 175 ~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~ls 254 (513)
+++.||++.|||.+|++++++|++++++.+. .+.+...++++||+|++|+|+|++||++.|++++.|++++|
T Consensus 82 ~i~~~p~~~hpm~~L~~~vs~l~~~~~~~~~--------~~~~~~~~~~~rliA~~p~i~a~~~r~~~g~~~~~p~~~l~ 153 (377)
T PRK14036 82 MMKCFPETGHPMDALQASAAALGLFYSRRAL--------DDPEYIRDAVVRLIAKIPTMVAAFQLIRKGNDPIQPRDDLD 153 (377)
T ss_pred HHHhCCCCCCHHHHHHHHHHHhhhcCccccc--------CCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Confidence 9999999999999999999999999876521 23344567889999999999999999999999999999999
Q ss_pred HHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHH
Q 010304 255 YSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVL 334 (513)
Q Consensus 255 y~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~ 334 (513)
|++|||+||++ .+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+||+||+||||||+|+
T Consensus 154 ~a~nfl~ml~g-----~~p~~~~~~~l~~~Lil~ADHg~naST~aaRv~aSt~ad~ys~v~agi~aL~GplHGGA~e~v~ 228 (377)
T PRK14036 154 YAANFLYMLTE-----REPDPLAARIFDRCLILHAEHTINASTFSARVTASTLTDPYAVIASAVGTLAGPLHGGANEDVL 228 (377)
T ss_pred HHHHHHHHhcC-----CCCCHHHHHHHHHHHhhhccCCCCchHHHHHHHHhcCCcHHHHHHHHHHHccCccccChHHHHH
Confidence 99999999986 5899999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhcccccccc
Q 010304 335 KMLNEIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKR 414 (513)
Q Consensus 335 ~mL~eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r 414 (513)
+||++|++++++++||++.+++|++||||||||||..|||+++|+++++++.+..+.++++++++++|+++. ++|..|
T Consensus 229 ~ml~~i~~~~~~~~~v~~~~~~~~~i~GFGHrvyk~~DPRa~~L~~~~~~l~~~~~~~~~~~~a~~~e~~~~--~~~~~k 306 (377)
T PRK14036 229 AMLEEIGSVENVRPYLDERLANKQKIMGFGHREYKVKDPRATILQKLAEELFARFGHDEYYEIALELERVAE--ERLGPK 306 (377)
T ss_pred HHHHHhCChhhHHHHHHHHHHCCCceecCCCCCCCCCCccHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHH--HHhccC
Confidence 999999999999999999999999999999999999999999999999999877777899999999999884 578889
Q ss_pred CCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCcccccccccc
Q 010304 415 KLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPLKERM 487 (513)
Q Consensus 415 ~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~~~R~ 487 (513)
++|||||||+|++|++||||+++||++|+++|++||+|||+||+.+ +||+||++.|+|+.+|+|+|+++|.
T Consensus 307 ~l~pNvD~~sa~l~~~lGip~~~~t~lf~~sR~~Gw~AH~~Eq~~~--~~l~RP~~~Y~G~~~~~~~p~~~r~ 377 (377)
T PRK14036 307 GIYPNVDFYSGLVYRKLGIPRDLFTPIFAIARVAGWLAHWREQLGA--NRIFRPTQIYTGSHNRRYIPLEERS 377 (377)
T ss_pred CCCcChHHHHHHHHHHcCCChhhhhhHHHHHhHHHHHHHHHHHHhc--CcccCCCceecCCCCCCCCCccccC
Confidence 9999999999999999999999999999999999999999999984 7999999999999999999999984
No 9
>PRK12351 methylcitrate synthase; Provisional
Probab=100.00 E-value=1.2e-108 Score=860.28 Aligned_cols=369 Identities=33% Similarity=0.556 Sum_probs=347.7
Q ss_pred cCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHH
Q 010304 98 DPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQ 177 (513)
Q Consensus 98 dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~ 177 (513)
+|||+|+.+++|+||+|||+.|+|+||||+|+||+++++||||+||||+|+||+++|+++|+.+|..++.+|+.+.++++
T Consensus 9 ~~GL~gv~~~~T~is~i~~~~g~L~YRGy~I~dLa~~~~feeva~LL~~G~LP~~~el~~f~~~L~~~~~lp~~v~~~i~ 88 (378)
T PRK12351 9 SVALSGVVAGNTALCTVGKSGNDLHYRGYDILDLAEHCEFEEVAHLLVHGKLPTQAELAAYKTKLKALRGLPAAVKTVLE 88 (378)
T ss_pred CCCCCCeeeccccCeeEecCCCEEEECCccHHHHHhcCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHhCCCCHHHHHHHH
Confidence 79999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCC-CCCCCCHH
Q 010304 178 AMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVL-PSNNLSYS 256 (513)
Q Consensus 178 ~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~-p~~~lsy~ 256 (513)
+||+++|||++|++++++|++++++... .+......+++||||++|+|+|++||++.|..++. |++++||+
T Consensus 89 ~~p~~~hPM~~L~~~vs~l~~~d~~~~~--------~~~~~~~~~a~rliA~~p~i~a~~~r~~~~~~~~~p~~~~ls~a 160 (378)
T PRK12351 89 AIPAAAHPMDVMRTGVSVLGCLLPEKED--------HNFSGARDIADRLLASLGSILLYWYHYSHNGRRIEVETDDDSIG 160 (378)
T ss_pred hCCccCCHHHHHHHHHHhhcccCccccc--------CChHHHHHHHHHHHHHHHHHHHHHHHHHhCCCccCCCCCcCCHH
Confidence 9999999999999999999999877531 12233456789999999999999999999766555 46779999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHH
Q 010304 257 ENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKM 336 (513)
Q Consensus 257 eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~m 336 (513)
+|||+||++ .+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+|||||+||||||+|++|
T Consensus 161 ~Nfl~ml~g-----~~p~~~~~~~l~~~LvL~ADH~~naST~aaRvvaSt~ad~~sav~agi~aL~GplHGGA~e~v~~m 235 (378)
T PRK12351 161 GHFLHLLHG-----KKPSESWVKAMHTSLILYAEHEFNASTFTARVIAGTGSDMYSAITGAIGALRGPKHGGANEVAFEI 235 (378)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHhcccCCchHHHHHHHHhccCCCHHHHHHHHHHhccCCccCchHHHHHHH
Confidence 999999986 479999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccCC
Q 010304 337 LNEIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRKL 416 (513)
Q Consensus 337 L~eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~L 416 (513)
|++|++++++++||++++++|++||||||||||++|||+++|+++++++.+..+.+++++++++||+++.+ .||+
T Consensus 236 l~~i~~~~~~~~~v~~~l~~~~~l~GFGHrvyk~~DPRa~~L~~~~~~l~~~~~~~~~~~~a~~ie~~~~~-----~k~l 310 (378)
T PRK12351 236 QQRYDTPDEAEADIRRRVENKEVVIGFGHPVYTISDPRNKVIKEVAKKLSKEAGDTKLYDIAERLETVMWE-----EKKM 310 (378)
T ss_pred HHHhCCHHHHHHHHHHHHhCCCccccCCCCCCCCCCccHHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHH-----HhCC
Confidence 99999999999999999999999999999999999999999999999998777778999999999998864 6899
Q ss_pred CCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCccccccccc
Q 010304 417 YPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPLKER 486 (513)
Q Consensus 417 yPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~~~R 486 (513)
|||||||+|+||++||||+++||++|+++|++||+|||+||+.+ ++|+||+++|+|+..|+|+|+++|
T Consensus 311 ~pNvD~ysg~l~~~lG~p~~~~t~lF~~sR~~Gw~AH~~Eq~~~--~~~iRP~~~Y~G~~~~~~~p~~~r 378 (378)
T PRK12351 311 FPNLDWFSAVSYHMMGVPTAMFTPLFVISRTTGWAAHVIEQRQD--NKIIRPSANYTGPEDRKFVPIEKR 378 (378)
T ss_pred CCChHHHHHHHHHHcCCCHHhhhhHHHHHHHHHHHHHHHHHHhc--CCccCCcceecCCCCCCCCCcCcC
Confidence 99999999999999999999999999999999999999999974 799999999999999999999987
No 10
>PRK14035 citrate synthase; Provisional
Probab=100.00 E-value=2.5e-107 Score=849.13 Aligned_cols=368 Identities=38% Similarity=0.643 Sum_probs=348.4
Q ss_pred ecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHH
Q 010304 97 YDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDII 176 (513)
Q Consensus 97 ~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i 176 (513)
+||||.||++|+|+||+|||+ .|+||||+|+||+++++||||+||||+|+|||++|+++|+.+|..++.+|+.+.+++
T Consensus 3 ~~~Gl~~v~~~~s~Is~id~~--~L~YRGy~i~dLa~~~~Feeva~LLl~G~lP~~~el~~f~~~L~~~~~lp~~v~~~i 80 (371)
T PRK14035 3 LQRGLEGVIAAETKISSIIDS--QLTYAGYDIDDLAENASFEEVIFLLWNYRLPTEEELAHLKGKLRKYMTLNDRVYQHF 80 (371)
T ss_pred CCCCCCCceEeeeeeeEecCC--EeEECCccHHHHHhcCCHHHHHHHHHCCcCCCHHHHHHHHHHHHHcCCCCHHHHHHH
Confidence 689999999999999999985 599999999999999999999999999999999999999999999999999999999
Q ss_pred HhCC-CCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCH
Q 010304 177 QAMP-HDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSY 255 (513)
Q Consensus 177 ~~~p-~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy 255 (513)
..+| .++|||++|++++++|++++++... .+.....++++||+||+|+|+|++||++.|+++++|++++||
T Consensus 81 ~~~~~~~~hpm~~l~~~vs~l~~~~~~~~~--------~~~~~~~~~a~rliA~~p~i~A~~~r~~~g~~~~~p~~~ls~ 152 (371)
T PRK14035 81 EEYSTDHVHPMTALRTSVSYLAHFDPDAEE--------ESDEARYERAIRIQAKVASLVTAFARVRQGKEPLKPRPDLSY 152 (371)
T ss_pred HhcCCcCCCHHHHHHHHHHHHhccCccccc--------CCHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCCCCCCCCCCH
Confidence 8875 6899999999999999999876531 133445778999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHH
Q 010304 256 SENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLK 335 (513)
Q Consensus 256 ~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~ 335 (513)
++|||+||++ .+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+||+||+||||||+|++
T Consensus 153 ~~nfl~ml~g-----~~p~~~~~~~l~~~LvL~ADHg~naST~aaRv~aSt~ad~~sav~Agi~al~GplHGGA~e~v~~ 227 (371)
T PRK14035 153 AANFLYMLRG-----ELPTDIEVEAFNKALVLHADHELNASTFTARCAVSSLSDMYSGVVAAVGSLKGPLHGGANERVMD 227 (371)
T ss_pred HHHHHHHhcc-----CCCCHHHHHHHHHHHHHhccCCCCchHHHHHHHHhcCCcHHHHHHHHHHhccCccccChHHHHHH
Confidence 9999999987 48999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccC
Q 010304 336 MLNEIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRK 415 (513)
Q Consensus 336 mL~eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~ 415 (513)
||++|++++++++||++.+++|++||||||||||+.|||+++|+++++++.+..+.+++++++++||+++.+ .||
T Consensus 228 ~l~~i~~~~~~~~~v~~~~~~~~~l~GFGHrvyk~~DPRa~~L~~~~~~l~~~~~~~~~~~~a~~ie~~~~~-----~k~ 302 (371)
T PRK14035 228 MLSEIRSIGDVDAYLDEKFANKEKIMGFGHRVYKDGDPRAKYLREMSRKITKGTGREELFEMSVKIEKRMKE-----EKG 302 (371)
T ss_pred HHHHhCChHHHHHHHHHHHhcCCcccCCCCCCCCCCCccHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHH-----hcC
Confidence 999999999999999999999999999999999999999999999999997666678999999999998875 589
Q ss_pred CCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCccccccccc
Q 010304 416 LYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPLKER 486 (513)
Q Consensus 416 LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~~~R 486 (513)
+|||||||+|+|+++||||+++||++|+++|++||+|||+||+.+ +||+||+++|+|+.+|+|+|+++|
T Consensus 303 l~pNvD~~s~~l~~~lG~p~~~~t~lf~i~R~~Gw~AH~~Eq~~~--~~l~RP~~~Y~G~~~~~~~p~~~r 371 (371)
T PRK14035 303 LIPNVDFYSATVYHVMGIPHDLFTPIFAVSRVAGWIAHILEQYKD--NRIMRPRAKYIGETNRKYIPIEER 371 (371)
T ss_pred CCCChHHHHHHHHHHcCCChHhhhhHHHHHhHHHHHHHHHHHHhc--CCccCCCccccCCCCCCCCCcCCC
Confidence 999999999999999999999999999999999999999999974 799999999999999999999987
No 11
>cd06114 EcCS_like Escherichia coli (Ec) citrate synthase (CS) GltA_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. There are two types of CSs: type I CS and type II CSs. Type I CSs are found in eukarya, gram-positive bacteria, archaea, and in some gram-negative bacteria and are homodimers with both subunits participating in the active site. Type II CSs are unique to gram-negative bacteria and are homohexamers of identical subunits (approximated as a trimer of dimers). Some typ
Probab=100.00 E-value=5.6e-107 Score=854.38 Aligned_cols=388 Identities=50% Similarity=0.917 Sum_probs=362.8
Q ss_pred cchhhhhhhhcCCCCcceeeecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHH
Q 010304 77 VKATDFKKITTGKNDKGLKLYDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLT 156 (513)
Q Consensus 77 ~~a~di~~l~~~~~~~g~~~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~ 156 (513)
++.+++.++.. ++|+..|||||.||++++|+||+|||++|+|+||||+|+||+++++||||+||||+|+||+++|++
T Consensus 10 ~~~~~~~~~~~---~~~~~~~~~GL~gv~v~~S~Is~idg~~G~L~YRGy~i~dLa~~~sfEEva~LL~~G~lP~~~el~ 86 (400)
T cd06114 10 EKVIDISSLRK---KTGVFTYDPGFMNTASCESAITYIDGEKGILRYRGYPIEQLAEKSSFLEVCYLLLYGELPTAEQLQ 86 (400)
T ss_pred CcceehHhhhh---hcCCccCCCCCCCceeEeeeCeEEeCCCCEEEECCccHHHHHhcCCHHHHHHHHHcCcCCCHHHHH
Confidence 56678888764 457778999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCcHHHHHHHHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHH
Q 010304 157 DWEFAVSQHSAVPQGILDIIQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAA 236 (513)
Q Consensus 157 ~f~~~l~~~~~l~~~v~~~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~ 236 (513)
+|..+|..++.+|+.+.++++.+|.+.|||.+|++++++|++++++.... .+......++++||+++|+|+|+
T Consensus 87 ~f~~~L~~~~~lp~~v~~~i~~~p~~~~pm~~l~~~vs~l~~~d~~~~~~-------~~~~~~~~~a~~lia~~p~i~a~ 159 (400)
T cd06114 87 EFREEITRHTLVHEQMKRFFNGFPRDAHPMAILSAMVNALSAFYPDSLDV-------NDPEQRELAAIRLIAKVPTIAAM 159 (400)
T ss_pred HHHHHHHHccCCCHHHHHHHHhcccCCCHHHHHHHHHHHHhhcCcccccc-------CCHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999988765321 12333467799999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHH
Q 010304 237 AYLRMAGRPPVLPSNNLSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAG 316 (513)
Q Consensus 237 ~y~~~~G~~~~~p~~~lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaa 316 (513)
+|+++.|++++.|++++||++|||+|+++.....++|++..+++||++||||||||+|+||||+|+++||++|+|+||+|
T Consensus 160 ~~r~~~g~~~~~p~~~ls~a~nfl~ml~g~~~~~~~p~~~~~~~l~~~LvL~aDH~~n~STfaaRv~aSt~adl~sav~a 239 (400)
T cd06114 160 AYRYSIGQPFIYPDNDLSYVENFLHMMFAVPYEPYEVDPVVVKALDTILILHADHEQNASTSTVRMVGSSGANLFASISA 239 (400)
T ss_pred HHHHHcCCCCCCCCCCcCHHHHHHHHhcCCCCccCCCCHHHHHHHHHHHeeeccCCCcchHHHHHHHhccCCcHHHHHHH
Confidence 99999999999999999999999999998766667899999999999999999999999999999999999999999999
Q ss_pred HhhcccCCccCChHHHHHHHHHHhCCCCCHHHHHHHHHhcC--CcccccCCCCCCCCCchHHHHHHHHHHHHHHhCC-Cc
Q 010304 317 AVGALYGPLHGGANEAVLKMLNEIGTVENIPEFIEGVKNRK--RKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGR-DP 393 (513)
Q Consensus 317 gi~AL~GPlHGGAneav~~mL~eI~~~~~i~~~i~~~~~~~--~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~-~~ 393 (513)
||+||+||+|||||+.|++||++|++++++++||++.+++| ++||||||||||..|||+++|+++++++.++.+. ++
T Consensus 240 gl~al~GplHGGA~~~v~~~l~~i~~~~~~~~~v~~~l~~~~~~~ipGfGH~vyk~~DPRa~~L~~~~~~l~~~~~~~~~ 319 (400)
T cd06114 240 GIAALWGPLHGGANEAVLEMLEEIGSVGNVDKYIAKAKDKNDPFRLMGFGHRVYKNYDPRAKILKKTCDEVLAELGKDDP 319 (400)
T ss_pred HHHhccCCcccChHHHHHHHHHHhcCcccHHHHHHHHHhcCCCccccCCCCCCCCCCCccHHHHHHHHHHHHHHhCCCcH
Confidence 99999999999999999999999999999999999999877 5999999999999999999999999998776664 68
Q ss_pred HHHHHHHHHHHHhccccccccCCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCccccc
Q 010304 394 LIEVAVALEKAALSDEYFVKRKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYT 473 (513)
Q Consensus 394 ll~iA~~lE~~a~~d~yf~~r~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~ 473 (513)
++++++++|+++.+++||+.||+|||||||+|+||++||||+++|+++|+++|++||+|||+||+.++++||+||+++|+
T Consensus 320 ~~~~~~~ie~~~~~~~~~~~~~l~pNvD~~~a~l~~~lG~p~~~~~~lFa~sR~~Gw~AH~~Eq~~~~~~~liRP~~~Yv 399 (400)
T cd06114 320 LLEIAMELEEIALKDDYFIERKLYPNVDFYSGIILRALGIPTEMFTVLFALGRTPGWIAQWREMHEDPELKIGRPRQLYT 399 (400)
T ss_pred HHHHHHHHHHHHHHhhhhcccCCCCChHHHHHHHHHHcCCChHhhhhhHHHHhHHHHHHHHHHHHhCCCCceeCcccccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999876679999999999
Q ss_pred C
Q 010304 474 G 474 (513)
Q Consensus 474 G 474 (513)
|
T Consensus 400 G 400 (400)
T cd06114 400 G 400 (400)
T ss_pred C
Confidence 8
No 12
>cd06108 Ec2MCS_like Escherichia coli (Ec) 2-methylcitrate synthase (2MCS)_like. 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and oxalacetate (OAA) to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and OAA to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). This group contains proteins similar to the E. coli 2MCS, EcPrpC. EcPrpC is one of two CS isozymes in the gram-negative E. coli. EcPrpC is a dimeric (type I ) CS; it is induced during growth on propionate and prefers PrCoA as a substrate though it has partial CS activity with AcCoA. This group also includes Salmonella typhimurium PrpC and Ralstonia eutropha (Re) 2-MCS1 which are also induced during growth on propionate and prefer PrCoA as substrate, but can also use AcCoA. Re 2-MCS1 can use butyryl-CoA and valeryl-CoA at a lower rate. A second Ralstonia eutropha 2MC
Probab=100.00 E-value=6.9e-107 Score=843.75 Aligned_cols=362 Identities=34% Similarity=0.582 Sum_probs=342.7
Q ss_pred CCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHh
Q 010304 99 PGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQA 178 (513)
Q Consensus 99 pG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~ 178 (513)
|||+|+++|+|+||+|||++|+|+||||||+||+++++||||+||||+|+|||++|+++|+.+|..++.+|+.+.+++++
T Consensus 1 ~GL~gv~~~~t~is~id~~~g~L~yRGy~i~dLa~~~sfeeva~LLl~G~lPt~~el~~f~~~L~~~~~lp~~v~~~i~~ 80 (363)
T cd06108 1 GGLAGVVAGQTAISTVGKGGKGLTYRGYDIEDLAENATFEEVAYLLLYGKLPTRKQLDAYKTKLVALRRLPAALKTVLEL 80 (363)
T ss_pred CCCCCCeeeeeeCceEeCCCCEEEECCccHHHHHhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHhcCCCHHHHHHHHh
Confidence 79999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCC-CCCCCHHH
Q 010304 179 MPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLP-SNNLSYSE 257 (513)
Q Consensus 179 ~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p-~~~lsy~e 257 (513)
||+++|||.+|++++++|++++++... .....+++||||++|+|+|++||++.|..++.| ++++||++
T Consensus 81 ~p~~~hpm~~L~~~vs~l~~~d~~~~~-----------~~~~~~a~rlia~~p~i~a~~~r~~~~~~~~~p~~~~~s~a~ 149 (363)
T cd06108 81 IPKDSHPMDVMRTGCSMLGCLEPENEF-----------SQQYEIAIRLLAIFPSILLYWYHYSHSGKRIETETDEDSIAG 149 (363)
T ss_pred CCCCCChHHHHHHHHHhhhhcCCcccc-----------HHHHHHHHHHHHHHHHHHHHHHHHHcCCCccCCCCCCCCHHH
Confidence 999999999999999999999876531 223568899999999999999999987766655 77899999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHH
Q 010304 258 NFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKML 337 (513)
Q Consensus 258 NfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL 337 (513)
|||+||++ .+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+||+||+||||||+|++||
T Consensus 150 nfl~ml~g-----~~p~~~~~~~l~~~LvL~ADH~~n~St~aaRv~aSt~ad~~sav~agi~al~GplHGGA~e~v~~~l 224 (363)
T cd06108 150 HFLHLLHG-----KKPGELEIKAMDVSLILYAEHEFNASTFAARVTASTLSDFYSAITGAIGTLRGPLHGGANEAAMELI 224 (363)
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHhhhhccCCCcchHHHHHHHhccCCCHHHHHHHHHHhccCCcccchHHHHHHHH
Confidence 99999987 4789999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccCCC
Q 010304 338 NEIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRKLY 417 (513)
Q Consensus 338 ~eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~Ly 417 (513)
++|++++++++||++.+++|++||||||||||+.||||++|+++++++.+..+.++++++++++|+++.+ .||+|
T Consensus 225 ~~i~~~~~~~~~v~~~l~~~~~i~GFGHrvyk~~DPRa~~L~~~a~~l~~~~~~~~~~~~a~~ie~~~~~-----~~~l~ 299 (363)
T cd06108 225 ERFKSPEEAEQGLLEKLERKELIMGFGHRVYKEGDPRSDIIKKWSKKLSEEGGDPLLYQISERIEEVMWE-----EKKLF 299 (363)
T ss_pred HHhCCHHHHHHHHHHHHhcCCeecCCCCCCCCCCCccHHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHH-----hcCCC
Confidence 9999999999999999999999999999999999999999999999987766778999999999998875 58999
Q ss_pred CchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCcccccc
Q 010304 418 PNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPL 483 (513)
Q Consensus 418 PNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~ 483 (513)
||||||+|+|+++||||+++||++|+++|++||+|||+||+.+ ++++||+++|+|+.+|+|+|+
T Consensus 300 pNvD~~sa~l~~~lG~p~~~~t~iF~i~R~~Gw~AH~~Eq~~~--~~~iRP~~~Y~G~~~~~~~p~ 363 (363)
T cd06108 300 PNLDFYSASAYHFCGIPTELFTPIFVMSRVTGWAAHIMEQRAN--NRLIRPSADYIGPEPRPFVPI 363 (363)
T ss_pred cChHHHHHHHHHHcCCChhhhhhHHHHHHHHHHHHHHHHHHhc--CCCcCccceecCCCCCCCCCC
Confidence 9999999999999999999999999999999999999999874 799999999999999999986
No 13
>PRK14037 citrate synthase; Provisional
Probab=100.00 E-value=7.9e-107 Score=847.54 Aligned_cols=373 Identities=37% Similarity=0.674 Sum_probs=350.8
Q ss_pred eecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHH
Q 010304 96 LYDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDI 175 (513)
Q Consensus 96 ~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~ 175 (513)
.+||||.|+++++|+||+||+++|+|+||||||+||+++++||||+||||+|+||+++|+++|..+|..++.+|+.+.++
T Consensus 3 ~~~~GL~gv~~~~t~is~id~~~g~L~yRGy~i~dL~~~~~Feev~~LLl~G~lP~~~e~~~f~~~L~~~~~lp~~v~~~ 82 (377)
T PRK14037 3 VISKGLENVIIKVTNLTFIDGEKGILRYRGYNIEDLVNYGSYEETIYLMLYGELPTKKELNDLKEKLNEEYEVPQEVIDS 82 (377)
T ss_pred CCCCCCCCCeeeeeeceEEeCCCCEEEECCccHHHHHccCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHhcCCCHHHHHH
Confidence 37999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCH
Q 010304 176 IQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSY 255 (513)
Q Consensus 176 i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy 255 (513)
+++||.++|||.+|++++++|++++++.. . .....++++||||++|+|+|++||++.|+++++|++++||
T Consensus 83 ~~~~p~~~hpm~~l~~~vs~l~~~~~~~~---------~-~~~~~~~a~~liA~~p~i~a~~yr~~~g~~~~~p~~~~s~ 152 (377)
T PRK14037 83 IYLMPRDSDAIGLMEAAFAALASIDKNFK---------W-KENDKEKAISIIAKMATIVANVYRRKEGNKPRIPEPSDSF 152 (377)
T ss_pred HHhCCccCCcHHHHHHHHHhhhccCCccc---------c-cHHHHHHHHHHHHHHHHHHHHHHHHHcCCCCCCCCCCCCH
Confidence 99999999999999999999999876541 1 1223567899999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHH
Q 010304 256 SENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLK 335 (513)
Q Consensus 256 ~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~ 335 (513)
++|||+||+| .+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+|||||+||||||+|++
T Consensus 153 a~nfl~ml~G-----~~p~~~~~~~l~~~Lil~ADHg~naST~aarv~aSt~ad~ysav~agi~al~GplHGGA~e~v~~ 227 (377)
T PRK14037 153 AESFLLASFA-----REPTAEEIKAMDAALILYTDHEVPASTTAALVAASTLSDMYSCITAALAALKGPLHGGAAEEAFK 227 (377)
T ss_pred HHHHHHHHhc-----cCCcHHHHHHHHHHHhHhcccCCchHhHHHHHhhccCCCHHHHHHHHHHhccCcccCChHHHHHH
Confidence 9999999986 47899999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHH-hcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhC-CCcHHHHHHHHHHHHhccccccc
Q 010304 336 MLNEIGTVENIPEFIEGVK-NRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVG-RDPLIEVAVALEKAALSDEYFVK 413 (513)
Q Consensus 336 mL~eI~~~~~i~~~i~~~~-~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~-~~~ll~iA~~lE~~a~~d~yf~~ 413 (513)
||++|++++++++|+++.+ ++|++||||||||||+.||||++|+++++++.+..+ .+++++++.++|+++. +||..
T Consensus 228 ~l~ei~~~~~~~~~~~~~~~~~~~~i~GFGHrvyk~~DPRa~~L~~~~~~~~~~~~~~~~~~~ia~~~e~~~~--~~~~~ 305 (377)
T PRK14037 228 QFVEIGDPNNVEMWFNDKIINGKKRLMGFGHRVYKTYDPRAKIFKELAETLIERNSEAKKYFEIAQKLEELGI--KQFGS 305 (377)
T ss_pred HHHHhcChhhHHHHHHHHHhcCCCeecCCCCCCCCCCCccHHHHHHHHHHHHHhcCCccHHHHHHHHHHHHHH--HHhhc
Confidence 9999999999999998754 556899999999999999999999999999876666 3789999999999876 57888
Q ss_pred cCCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCccccccccc
Q 010304 414 RKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPLKER 486 (513)
Q Consensus 414 r~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~~~R 486 (513)
|++|||||||+|+||++||||+++||++|++||++||+|||+||+.+ +++|+|||++|+|+.+|+|+|+++|
T Consensus 306 k~l~pNvD~~sa~l~~~lG~p~~~~t~lf~isR~~Gw~AH~~Eq~~~-~~~~~RP~~~Y~G~~~~~~~p~~~r 377 (377)
T PRK14037 306 KGIYPNTDFYSGIVFYALGFPVYMFTALFALSRTLGWLAHIIEYVEE-QHRLIRPRALYVGPEHREYVPIDKR 377 (377)
T ss_pred cCCCCChHHHHHHHHHHcCCChhhcchhHHhhhhhHHHHHHHHHHhc-CCccccCcceecCCCCCCCCCcCcC
Confidence 99999999999999999999999999999999999999999999975 4699999999999999999999987
No 14
>cd06112 citrate_synt_like_1_1 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, an
Probab=100.00 E-value=1.8e-106 Score=844.77 Aligned_cols=372 Identities=45% Similarity=0.799 Sum_probs=352.9
Q ss_pred ecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHH
Q 010304 97 YDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDII 176 (513)
Q Consensus 97 ~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i 176 (513)
|||||.||++|+|+||+|||++|+|+||||+|+||+++++||||+||||+|++|+++|++.|...|.+++.+|+.+.+++
T Consensus 1 ~~~Gl~gv~~~~t~is~id~~~G~L~yRGy~i~dL~~~~~Feev~~LLl~G~lP~~~el~~~~~~L~~~~~lp~~v~~~i 80 (373)
T cd06112 1 YIPGLAGVPAAESSISYIDGKNGILEYRGYDIEELAEYSSFEEVALLLLDGDLPTAAELEEFDKELRQHRRVKYNIRDMM 80 (373)
T ss_pred CCCccCCCeeeeeeceEEeCCCCEEEECCccHHHHhcCCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHhcCCCHHHHHHH
Confidence 69999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHH
Q 010304 177 QAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYS 256 (513)
Q Consensus 177 ~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~ 256 (513)
+.||+++|||.+|++++++|++++++.+. ...+.+...++++||+|++|+|+|++||++.|.+++.|++++||+
T Consensus 81 ~~~p~~~hpm~~L~~~vs~l~~~~~~~~~------~~~~~~~~~~~a~~liA~~p~i~a~~~r~~~g~~~~~p~~~ls~~ 154 (373)
T cd06112 81 KCFPETGHPMDMLQATVAALGMFYPKPEV------LKPNPDYIDAATVKLIAKMPTLVAMWARIRNGDDPIEPRPDLDYA 154 (373)
T ss_pred HhCCCCCCHHHHHHHHHHhhhccCccccc------ccCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCcCCCCCCCHH
Confidence 99999999999999999999999876531 111344456789999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHH
Q 010304 257 ENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKM 336 (513)
Q Consensus 257 eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~m 336 (513)
+|||+||++ .+|++..+++||++||||||||+|+||||+|+++||++|+|+|++||+++|+||+||||||+|++|
T Consensus 155 ~nfl~ml~g-----~~p~~~~~~~l~~~Lil~aDHg~n~STfaaRvvaSt~ad~~s~~~aai~al~GplHGGA~e~~~~~ 229 (373)
T cd06112 155 ENFLYMLFG-----EEPDPATAKILDACLILHAEHTMNASTFSALVTGSTLADPYAVISSAIGTLSGPLHGGANEDVLEM 229 (373)
T ss_pred HHHHHHHhC-----CCCCHHHHHHHHHHHhhcccCCCCchHHHHHHHHhcCCcHHHHHHHHHHhccCccccchHHHHHHH
Confidence 999999986 478999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhC-CCcHHHHHHHHHHHHhccccccccC
Q 010304 337 LNEIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVG-RDPLIEVAVALEKAALSDEYFVKRK 415 (513)
Q Consensus 337 L~eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~-~~~ll~iA~~lE~~a~~d~yf~~r~ 415 (513)
|++|++++++++||++.+++|++||||||||||+.|||+++|+++++++++..+ .++++++++++|+++. ++|+.|+
T Consensus 230 l~~i~~~~~~~~~v~~~l~~~~~i~GfGH~vyk~~DPRa~~L~~~~~~l~~~~~~~~~~~~i~~~~e~~~~--~~~~~k~ 307 (373)
T cd06112 230 LEEIGSPENVKAYLDKKLANKQKIWGFGHRVYKTKDPRATILQKLAEDLFAKMGELSKLYEIALEVERLCE--ELLGHKG 307 (373)
T ss_pred HHHhCCHHHHHHHHHHHHhcCCeeeCCCCccCCCCCcHHHHHHHHHHHHHhhcCCccHHHHHHHHHHHHHH--HHhCcCC
Confidence 999999999999999999999999999999999999999999999999987666 5789999999999886 5788899
Q ss_pred CCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCcccccc
Q 010304 416 LYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPL 483 (513)
Q Consensus 416 LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~ 483 (513)
+|||||||+|++|++||||+++||++|+++|++||+|||+||+++ +||+||+++|+|+.+|+|+|+
T Consensus 308 l~pNvd~~s~~l~~~lG~p~~~~t~lF~isR~~Gw~AH~~Eq~~~--~~l~RP~~~YvG~~~~~~~p~ 373 (373)
T cd06112 308 VYPNVDFYSGIVYKELGIPADLFTPIFAVARVAGWLAHWKEQLGD--NRIFRPTQIYIGEIDRKYVPL 373 (373)
T ss_pred CCcChHHHHHHHHHHhCcChHhhchHHHHHhHHHHHHHHHHHHhc--cCccCCCceecCCCCCCCCCC
Confidence 999999999999999999999999999999999999999999984 799999999999999999986
No 15
>cd06117 Ec2MCS_like_1 Subgroup of Escherichia coli (Ec) 2-methylcitrate synthase (2MCS)_like. 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and oxalacetate (OAA) to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and OAA to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). This group contains proteins similar to the E. coli 2MCS, EcPrpC. EcPrpC is one of two CS isozymes in the gram-negative E. coli. EcPrpC is a dimeric (type I ) CS; it is induced during growth on propionate and prefers PrCoA as a substrate, but has a partial CS activity with AcCoA. This group also includes Salmonella typhimurium PrpC and Ralstonia eutropha (Re) 2-MCS1 which are also induced during growth on propionate, prefer PrCoA as substrate, but can also can use AcCoA. Re 2-MCS1 at a low rate can use butyryl-CoA and valeryl-CoA. A second Ralstonia eu
Probab=100.00 E-value=4.2e-106 Score=839.19 Aligned_cols=364 Identities=32% Similarity=0.538 Sum_probs=342.2
Q ss_pred CCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHhC
Q 010304 100 GYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQAM 179 (513)
Q Consensus 100 G~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~~ 179 (513)
||+|+.+++|+||+|||++|+|+||||+|+||+++++||||+||||+|+|||++|+++|+++|.+++.+|+.+.+++++|
T Consensus 2 GL~gv~~~~T~is~v~~~~g~L~YRGy~i~dLa~~~~FEeva~LL~~G~lPt~~el~~f~~~L~~~~~lp~~v~~~i~~~ 81 (366)
T cd06117 2 ALSGVAAGNTALCTVGRSGNDLHYRGYDILDLAEKCEFEEVAHLLVHGKLPTKSELAAYKTKLKSLRGLPANVKTALEQL 81 (366)
T ss_pred CCCCeeEecccCeeeecccCEEEECCccHHHHHhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHccCCCHHHHHHHHhC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCC-CCCCCHHHH
Q 010304 180 PHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLP-SNNLSYSEN 258 (513)
Q Consensus 180 p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p-~~~lsy~eN 258 (513)
|+++|||.+|++++++|++++++... . +......+++|+||++|+|+|++||++.|..++.| ++++||++|
T Consensus 82 p~~~hpm~~l~~~vs~l~~~~~~~~~------~--~~~~~~~~a~rlia~~p~i~a~~~r~~~~~~~i~p~~~~~s~a~N 153 (366)
T cd06117 82 PAAAHPMDVMRTGVSVLGCVLPEKED------H--PVSGARDIADRLMASLGSILLYWYHYSHNGKRIEVETDDDSIGGH 153 (366)
T ss_pred CccCCHHHHHHHHHhhhcccCccccc------C--ChHHHHHHHHHHHHHHHHHHHHHHHHhcCCCccCCCCCcCCHHHH
Confidence 99999999999999999999877532 1 22223457899999999999999999888777776 557999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHH
Q 010304 259 FLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLN 338 (513)
Q Consensus 259 fL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~ 338 (513)
||+||++ .+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+||+||+||||||+|++||+
T Consensus 154 fl~ml~g-----~~p~~~~~~~l~~~LvL~ADHg~n~ST~aarv~aSt~ad~~sav~agi~aL~GplHGGA~e~v~~~l~ 228 (366)
T cd06117 154 FLHLLHG-----EKPSESWEKAMHISLILYAEHEFNASTFTARVIAGTGSDMYSAITGAIGALRGPKHGGANEVAFEIQQ 228 (366)
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHhcccCCchHHHHHHHHHccCCcHHHHHHHHHHhccCCccCchHHHHHHHHH
Confidence 9999986 36999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccCCCC
Q 010304 339 EIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRKLYP 418 (513)
Q Consensus 339 eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~LyP 418 (513)
+|+++++++++|++++++|++||||||||||.+|||+++|+++++++.+..+.++++++++++|+++.+ .||+||
T Consensus 229 ~i~~~~~~~~~i~~~~~~~~~i~GFGHrvyk~~DPRa~~L~~~~~~l~~~~~~~~~~~~~~~ie~~~~~-----~k~l~p 303 (366)
T cd06117 229 RYESADEAEADIRRRVENKEVVIGFGHPVYTIADPRNQVIKEVAKQLSKEGGDMKMFDIAERLETVMWE-----EKKMFP 303 (366)
T ss_pred HhCCHHHHHHHHHHHHhcCCcccCCCCCCCCCCCchHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHH-----HhCCCc
Confidence 999999999999999999999999999999999999999999999998766777899999999998864 589999
Q ss_pred chhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCcccccc
Q 010304 419 NVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPL 483 (513)
Q Consensus 419 NVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~ 483 (513)
|||||+|+||++||||+++||++|+++|++||+|||+||+.+ ++|+||+++|+|+.+|+|+|+
T Consensus 304 NvD~~s~~l~~~lG~p~~~~t~lf~isR~~Gw~AH~~Eq~~~--~~~~RP~~~Y~G~~~~~~~p~ 366 (366)
T cd06117 304 NLDWFSAVSYHMMGVPTAMFTPLFVIARTTGWSAHIIEQRQD--GKIIRPSANYTGPEDLKFVPI 366 (366)
T ss_pred CcHHHHHHHHHHcCcChhhhhHHHHHHHHHHHHHHHHHHHhc--CCCccccceecCCCCCCCCCC
Confidence 999999999999999999999999999999999999999874 799999999999999999985
No 16
>PRK14032 citrate synthase; Provisional
Probab=100.00 E-value=1.4e-105 Score=852.33 Aligned_cols=396 Identities=34% Similarity=0.547 Sum_probs=359.9
Q ss_pred eEEEeeeeeCCCcchhhhhhhhcCCCCcceeeecCCCc-----ccceeeeeeeeEeCC----------CCeeEEcccCHH
Q 010304 65 KRYQIPVSQEGTVKATDFKKITTGKNDKGLKLYDPGYL-----NTAPVRSSICYIDGD----------EGILRYRGYPIE 129 (513)
Q Consensus 65 ~~~~~pi~~~~~~~a~di~~l~~~~~~~g~~~~dpG~~-----~t~~~~S~IT~Idg~----------~G~L~YRGy~i~ 129 (513)
+.|++||.. |.+++.|.++.+- ++||. |+.+++|+||+|||+ +|+|+||||+|+
T Consensus 8 ~~~~~~~~~-~~~~~~~~~~~~~----------~~GL~~~~~~gv~~~~t~is~v~~~~~~dg~~~~~~G~L~YRGy~I~ 76 (447)
T PRK14032 8 ELSELCEKN-NKIDPELYDKYDV----------KRGLRNEDGTGVLVGLTNIGDVHGYEIDDGEKIPDEGKLYYRGYDIK 76 (447)
T ss_pred HHHHHHHHc-CCcCHHHHHHhCC----------CcccccCCCCCeEEeeeEEeeeeceeecCCcccCCCCceeECCccHH
Confidence 678999999 9999999998863 56666 788888888888873 499999999999
Q ss_pred HHhhcC------CHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHH-HHHHHHhCCCCCChhhHHHHHHHHhhccCCC
Q 010304 130 ELAESS------SFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQG-ILDIIQAMPHDAHPMGVLVSAMSALSIFHPD 202 (513)
Q Consensus 130 eLa~~~------sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~-v~~~i~~~p~~~hPm~~l~a~v~al~~~~~~ 202 (513)
||++++ +||||+||||+|+|||++|++.|+++|.+++.+|+. +.++++++| ++|||++|++++++|++++++
T Consensus 77 dLa~~~~~~~~~~FeEv~~LLl~G~LPt~~el~~f~~~L~~~~~lp~~~v~~~i~~~p-~~hPM~~L~a~vsaL~~~~~~ 155 (447)
T PRK14032 77 DLVNGFLKEKRFGFEEVAYLLLFGELPTKEELAEFTELLGDYRELPDGFTRDMILKAP-SKDIMNSLARSVLALYSYDDN 155 (447)
T ss_pred HHHhhcccccCCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHhcCCCHHHHHHHHHhCC-CcCHHHHHHHHHHhhhhcCCC
Confidence 999996 999999999999999999999999999999999999 889999999 799999999999999999877
Q ss_pred CCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHH---Hc-CCC--CCCCCCCCCHHHHHHHHhhcCCCCCCCCCHH
Q 010304 203 ANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLR---MA-GRP--PVLPSNNLSYSENFLYMLDSLGNRAYKPNPR 276 (513)
Q Consensus 203 ~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~---~~-G~~--~~~p~~~lsy~eNfL~ml~~~~~~~~~p~p~ 276 (513)
... .+.....++++||||++|+|+|++||. .. |.+ +.+|++++||++|||+||++. .+|++.
T Consensus 156 ~~~--------~~~~~~~~~a~rLiA~~p~i~A~~yr~~~~~~~g~~~~~~~p~~~ls~a~nfl~ml~g~----~~p~~~ 223 (447)
T PRK14032 156 PDD--------TSIDNVLRQSISLIARFPTLAVYAYQAYRHYHDGKSLYIHPPKPELSTAENILYMLRPD----NKYTEL 223 (447)
T ss_pred ccc--------CCHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhcCCCccccCCCCCCCHHHHHHHHhccC----CCCCHH
Confidence 531 133445678999999999999999984 44 766 568999999999999999852 278999
Q ss_pred HHHHHHHHHHHhcCCC-CChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHHHhC-------CCCCHHH
Q 010304 277 LARVLDVLFILHAEHE-MNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLNEIG-------TVENIPE 348 (513)
Q Consensus 277 ~~~~Ld~~LILhADHe-lN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~eI~-------~~~~i~~ 348 (513)
.+++||++|||||||| +|+||||+|++|||++|+|+||+|||+|||||+||||||+|++||++|+ +++++++
T Consensus 224 ~~~~ld~~LiL~ADHg~~naSTfaaRv~aSt~ad~ysavaagi~aL~GplHGGA~e~v~~~l~ei~~~~~~~~s~~~v~~ 303 (447)
T PRK14032 224 EARLLDLALVLHAEHGGGNNSTFTTRVVSSSGTDTYSAIAAAIGSLKGPKHGGANIKVMEMFEDIKENVKDWEDEDEIAD 303 (447)
T ss_pred HHHHHHHHHHHHhccCCCchhHHHHHHHHccCCcHHHHHHHHHHhccCccccCHHHHHHHHHHHHHhhccCCCCHHHHHH
Confidence 9999999999999999 8999999999999999999999999999999999999999999999997 5678999
Q ss_pred HHHHHHh-----cCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhc---cccccccCCCCch
Q 010304 349 FIEGVKN-----RKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALS---DEYFVKRKLYPNV 420 (513)
Q Consensus 349 ~i~~~~~-----~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~---d~yf~~r~LyPNV 420 (513)
|++++++ +|++||||||||||+.||||++|+++++++.+..+.++++++++++|+++.+ ++||..|++||||
T Consensus 304 ~v~~~l~~~~~~~~~ri~GFGHrvyk~~DPRa~~L~~~~~~l~~~~g~~~~~~~~~~~e~~~~~~~~~~~~~~k~l~pNV 383 (447)
T PRK14032 304 YLTKILNKEAFDKSGLIYGMGHAVYTISDPRAVILKKFAEKLAKEKGREEEFNLYEKIEKLAPELIAEERGIYKGVSANV 383 (447)
T ss_pred HHHHHHhccccccCCcccCCCCCCCCCCCccHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHhhccCCCCCcCh
Confidence 9999886 5589999999999999999999999999998777777889999999987653 6788999999999
Q ss_pred hhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCccccccccc
Q 010304 421 DFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPLKER 486 (513)
Q Consensus 421 Dfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~~~R 486 (513)
|||+|+||++||||+++||++|++||++||+|||+||+.+ +++|+|||+.|+|+ .|+|+|+++|
T Consensus 384 Dfysa~i~~~lGip~~~~t~lFaisR~~Gw~AH~~Eq~~~-~~~i~RP~~~YvG~-~~~~~p~~~r 447 (447)
T PRK14032 384 DFYSGFVYDMLGIPEELYTPLFAIARIVGWSAHRIEELVN-GGKIIRPAYKSVLE-RREYVPLEER 447 (447)
T ss_pred hhHHHHHHHHcCCChhhhhhhHHHHhHHHHHHHHHHHHhc-CCceecccceeeCC-CCCCCCcCCC
Confidence 9999999999999999999999999999999999999954 47999999999999 9999999987
No 17
>PRK14034 citrate synthase; Provisional
Probab=100.00 E-value=4.8e-105 Score=832.27 Aligned_cols=369 Identities=37% Similarity=0.658 Sum_probs=348.8
Q ss_pred eecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHH
Q 010304 96 LYDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDI 175 (513)
Q Consensus 96 ~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~ 175 (513)
+.++||+|+.+++|+||+||++ +|+||||+|+||+++++||||+||||+|+|||++|+++|+++|..++.+|+.+.++
T Consensus 2 ~~~~GL~gv~~~~s~is~i~~~--~L~YRGy~i~dLa~~~~fEeva~LLl~G~lPt~~el~~f~~~L~~~~~lp~~v~~~ 79 (372)
T PRK14034 2 TVTRGLEGVVATTSSVSSIIDD--TLTYVGYNIDDLAENASFEEVVYLLWHRKLPNKQELAEFKEQLSENAKVPGEIIEH 79 (372)
T ss_pred CCCCCCCCceEeeeEeeccCCC--eEEECCccHHHHhccCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHhcCCCHHHHHH
Confidence 5789999999999999999864 69999999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCC-CCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 010304 176 IQAMPH-DAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLS 254 (513)
Q Consensus 176 i~~~p~-~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~ls 254 (513)
++.||+ ++|||++|++++++|++++++... .+.+...++++|++|++|+|+|++|+++.|.++++|++++|
T Consensus 80 l~~~p~~~~hpm~~l~~~vs~l~~~~~~~~~--------~~~~~~~~~a~~liA~~p~i~a~~~r~~~g~~~~~p~~~ls 151 (372)
T PRK14034 80 LKQYDLKKVHPMSVLRTAISMLGLYDEEAEI--------MDEEANYRKAVRLQAKVPTIVAAFSRIRKGLDPVEPRKDLS 151 (372)
T ss_pred HHhCCCcCcCHHHHHHHHHHhhcccCccccc--------CCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Confidence 999997 599999999999999998766531 12334567889999999999999999999999999999999
Q ss_pred HHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHH
Q 010304 255 YSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVL 334 (513)
Q Consensus 255 y~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~ 334 (513)
|++|||+||++ .+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+||+||+||||||+|+
T Consensus 152 ~a~nfl~ml~g-----~~p~~~~~~~l~~~Lvl~aDHg~n~ST~aaRv~aSt~~d~ysav~agi~al~GplHGGA~e~~~ 226 (372)
T PRK14034 152 LAANFLYMLNG-----EEPDEVEVEAFNKALVLHADHELNASTFTARVCVATLSDVYSGITAAIGALKGPLHGGANENVM 226 (372)
T ss_pred HHHHHHHHhcC-----CCCCHHHHHHHHHHHhHhccCCCCccHHHHHHHhccCCcHHHHHHHHhcccCCCccCCHHHHHH
Confidence 99999999986 4799999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhcccccccc
Q 010304 335 KMLNEIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKR 414 (513)
Q Consensus 335 ~mL~eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r 414 (513)
+||++|++++++++||++.+++|++||||||||||+.|||+++|+++++++.+..+.++++++++++|+++.+ .|
T Consensus 227 ~~l~~i~~~~~~~~~v~~~~~~~~~l~GFGHrvyk~~DPRa~~L~~~~~~~~~~~~~~~~~~~a~~~e~~~~~-----~k 301 (372)
T PRK14034 227 KMLTEIGEEENVESYIHNKLQNKEKIMGFGHRVYRQGDPRAKHLREMSKRLTVLLGEEKWYNMSIKIEEIVTK-----EK 301 (372)
T ss_pred HHHHHhCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCcCHHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHH-----cC
Confidence 9999999999999999999999999999999999999999999999999987666678999999999998864 58
Q ss_pred CCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCccccccccc
Q 010304 415 KLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPLKER 486 (513)
Q Consensus 415 ~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~~~R 486 (513)
|+|||||||+|+++++||||+++||++|+++|++||+|||+||+.+ ++|+||+++|+|+.+|+|+|+++|
T Consensus 302 ~l~pNvD~~~a~l~~~lG~p~~~~t~lf~i~R~~Gw~AH~~Eq~~~--~~l~Rp~~~Y~G~~~~~~~p~~~r 371 (372)
T PRK14034 302 GLPPNVDFYSASVYHCLGIDHDLFTPIFAISRMSGWLAHILEQYEN--NRLIRPRADYVGPTHQVYVPIEER 371 (372)
T ss_pred CCCCChHHHHHHHHHHcCCChHhccchhHHHhHHHHHHHHHHHHhc--CCccCCCceecCCCCCCCCChhcc
Confidence 9999999999999999999999999999999999999999999974 899999999999999999999988
No 18
>cd06109 BsCS-I_like Bacillus subtilis (Bs) citrate synthase CS-I_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. This group contains proteins similar to BsCS-I, one of two CS isozymes in the gram-positive B. subtilis. The majority of CS activity in B. subtilis is provided by the other isozyme, BsCS-II (not included in this group). BsCS-
Probab=100.00 E-value=1.6e-104 Score=823.15 Aligned_cols=347 Identities=38% Similarity=0.596 Sum_probs=331.8
Q ss_pred CCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHh
Q 010304 99 PGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQA 178 (513)
Q Consensus 99 pG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~ 178 (513)
|||.||++|+|+||+|||++|+|+||||+|+||+++++||||+||||+|+||+++|+++|+.+|..++.+|+.+.+++++
T Consensus 1 ~Gl~gv~~~~t~Is~idg~~G~L~YRGy~i~dL~~~~~feev~~LLl~G~lP~~~el~~f~~~l~~~~~lp~~v~~~~~~ 80 (349)
T cd06109 1 PGLEGVVAAETVLSDVDGEAGRLIIRGYSVEDLAGSASFEDVAALLWNGFFPDLPELEEFRAALAAARALPDVVAALLPA 80 (349)
T ss_pred CCcCCceeeeeeceeEeCCCCeEEECCccHHHHHhhCCHHHHHHHHHcCCCCCHHHHHHHHHHHHhcCCCCHHHHHHHHh
Confidence 79999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 010304 179 MPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYSEN 258 (513)
Q Consensus 179 ~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~eN 258 (513)
| +++|||.+|++++++++.. ...++++|++|++|+|+|++|+++.|+++++|++++||++|
T Consensus 81 ~-~~~~pm~~l~~~~s~~~~~------------------~~~~~a~~liA~~p~i~a~~~r~~~g~~~~~p~~~ls~a~n 141 (349)
T cd06109 81 L-AGLDPMDALRALLALLPDS------------------PDLATALRLLAAAPVITAALLRLSRGKQPIAPDPSLSHAAD 141 (349)
T ss_pred C-CCcCHHHHHHHHHHhcCch------------------hHHHHHHHHHHHHHHHHHHHHHHHcCCCCcCCCCCCCHHHH
Confidence 9 9999999999999977652 12567899999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHH
Q 010304 259 FLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLN 338 (513)
Q Consensus 259 fL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~ 338 (513)
||+||++ .+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+||+||+||||||+|++||+
T Consensus 142 fl~ml~g-----~~p~~~~~~~l~~~Lvl~ADHg~n~ST~aaRv~aSt~ad~~savaagi~al~GplHGGA~e~v~~~l~ 216 (349)
T cd06109 142 YLRMLTG-----EPPSEAHVRALDAYLVTVADHGMNASTFTARVIASTEADLTSAVLGAIGALKGPLHGGAPGPVLDMLD 216 (349)
T ss_pred HHHHhCC-----CCCChHHHHHHHHHHhHhcccCCCchhhHHHHHhccCCcHHHHHHHHHHhccCCcccChHHHHHHHHH
Confidence 9999986 47899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhc--cccccccCC
Q 010304 339 EIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALS--DEYFVKRKL 416 (513)
Q Consensus 339 eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~--d~yf~~r~L 416 (513)
+|++++++++||++++++|++||||||||||+.|||+++|+++++++.+ .+++++++++||+++.+ ++||.+|++
T Consensus 217 ei~~~~~~~~~v~~~l~~~~~i~GfGH~vyk~~DPRa~~L~~~~~~~~~---~~~~~~~a~~ie~~~~~~~~~~~~~r~l 293 (349)
T cd06109 217 AIGTPENAEAWLREALARGERLMGFGHRVYRVRDPRADVLKAAAERLGA---PDERLEFAEAVEQAALALLREYKPGRPL 293 (349)
T ss_pred HhCChhhHHHHHHHHHHcCCeecCCCCCCCCCCCcCHHHHHHHHHHhcc---CChHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999999999999999999999999999852 46899999999999876 889999999
Q ss_pred CCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccC
Q 010304 417 YPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTG 474 (513)
Q Consensus 417 yPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G 474 (513)
|||||||+|+||++||||+++||++|+++|++||+|||+||+.+ ++|+||++.|+|
T Consensus 294 ~pNvD~~sg~l~~~lGip~~~~t~lF~isR~~Gw~AH~~Eq~~~--~~~~RP~~~Y~G 349 (349)
T cd06109 294 ETNVEFYTALLLEALGLPREAFTPTFAAGRTAGWTAHVLEQART--GRLIRPQSRYVG 349 (349)
T ss_pred CCCchhhHHHHHHHhCCChhhhhhHHHHHhHHHHHHHHHHHHhc--CCCcCCCcccCC
Confidence 99999999999999999999999999999999999999999874 799999999998
No 19
>cd06105 ScCit1-2_like Saccharomyces cerevisiae (Sc) citrate synthases Cit1-2_like. Citrate synthases (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) with oxaloacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). Some CS proteins function as 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. There are two types of CSs: type I CS and type II CSs. Type I CSs are found in eukarya, gram-positive bacteria, archaea, and in some gram-neg
Probab=100.00 E-value=1.6e-103 Score=830.93 Aligned_cols=382 Identities=27% Similarity=0.418 Sum_probs=340.1
Q ss_pred hhhhhhhcCCC--CcceeeecCCC---cccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCC---------HHHHHHHHH
Q 010304 80 TDFKKITTGKN--DKGLKLYDPGY---LNTAPVRSSICYIDGDEGILRYRGYPIEELAESSS---------FLEVAYLLM 145 (513)
Q Consensus 80 ~di~~l~~~~~--~~g~~~~dpG~---~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~s---------FeEva~LL~ 145 (513)
.-+++|++... ..|.+++|+++ .++++++|+||+|||++| |+||||+|+||+++++ ||||+||||
T Consensus 14 ~~~~~~~~~~~~~~~~~~t~d~~~~Gl~g~~~~~t~iS~iDg~~G-l~YRGy~I~dLa~~~~~~~~~~~~~fEev~yLLl 92 (427)
T cd06105 14 ARIKKFRKEHGKTVVGEVTVDMVYGGMRGIKGLVWETSVLDPEEG-IRFRGLSIPECQKLLPKAPGGEEPLPEGLFWLLL 92 (427)
T ss_pred HHHHHHHHHcCCcceeeeecCcccCCCCCceecceeceeEcCCCC-eEECCccHHHHHhhCcccccccccCHHHHHHHHH
Confidence 45666654333 33888888755 556677789999999999 6999999999999986 999999999
Q ss_pred cCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHhCCCCCChhhHHHHHHHHhhccCCC--CCCcccCCCcccchhHhHHHH
Q 010304 146 YGNLPSESQLTDWEFAVSQHSAVPQGILDIIQAMPHDAHPMGVLVSAMSALSIFHPD--ANPALKGQDIYKSKQVRDKQI 223 (513)
Q Consensus 146 ~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~~p~~~hPm~~l~a~v~al~~~~~~--~~pa~~g~~~~~~~~~~~~~~ 223 (513)
+|+|||++|+++|+.+|.+++.+|+.+.+++++||.++|||.+|++++++|+++++. ..+ .+.+.........+++
T Consensus 93 ~G~LPt~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vsaL~~~d~f~~~~~--~~~~~~~~~~~~~~~~ 170 (427)
T cd06105 93 TGEVPTKEQVSALSKEWAARAALPSHVVTMLDNFPTNLHPMSQLSAAITALNSESKFAKAYA--EGIHKSKYWEYVYEDS 170 (427)
T ss_pred cCCCCCHHHHHHHHHHHHHcCCCCHHHHHHHHhCCCCCCHHHHHHHHHHhhhcccchhhhcc--ccccccccHHHHHHHH
Confidence 999999999999999999999999999999999999999999999999999986532 111 1111111234457789
Q ss_pred HHHHhhhHHHHHHHHHHH-cCCCCCCCCCCCCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCC-CChhhHHHH
Q 010304 224 ARILGKAPTIAAAAYLRM-AGRPPVLPSNNLSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHE-MNCSTSAAR 301 (513)
Q Consensus 224 ~rliak~ptiaA~~y~~~-~G~~~~~p~~~lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHe-lN~ST~aaR 301 (513)
++|+||+|+|+|++||++ .|+++++|++++||++|||+||++ + +|..+++||++|||||||| +|+||||+|
T Consensus 171 ~~LiAk~p~i~A~~yr~~~~g~~~~~pd~~ls~a~Nfl~Ml~~------~-~~~~~~~l~~~lvLhADHeg~NaSTfaar 243 (427)
T cd06105 171 MDLIAKLPCVAAKIYRNLYRGGKIIAIDSNLDWSANFANMLGY------T-DPQFTELMRLYLTIHSDHEGGNVSAHTTH 243 (427)
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCcCCCCCCcCHHHHHHHHhcC------C-CHHHHHHHHHHHhhhccccCccchHHHHH
Confidence 999999999999999995 599999999999999999999974 2 4889999999999999999 899999999
Q ss_pred HHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHHHh----C---CCCCHHHHHHHHHhcCCcccccCCCCCCCCCch
Q 010304 302 HLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLNEI----G---TVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPR 374 (513)
Q Consensus 302 vvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~eI----~---~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPR 374 (513)
+||||++|+|+||+|||+||+||+||||||+|++||.+| + +++++++||++.+++|++||||||||||++|||
T Consensus 244 vvaSt~ad~ysav~agi~aL~GplHGGA~e~v~~~l~ei~~~~g~~~~~~~v~~~i~~~l~~g~~i~GFGHrvyk~~DPR 323 (427)
T cd06105 244 LVGSALSDPYLSFAAAMNGLAGPLHGLANQEVLVWLTKLQKEVGKDVSDEQLREYVWKTLNSGRVVPGYGHAVLRKTDPR 323 (427)
T ss_pred HHhccCCCHHHHHHHHHhhcCCCCCCCcHHHHHHHHHHHHHHhCCCCCHHHHHHHHHHHHhCCCcccCCCCCCCCCCCCC
Confidence 999999999999999999999999999999999999765 3 456899999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhc--cccccccCCCCchhhHHHHHHHHcCCC-CCchhhHhhhhhhhhhH
Q 010304 375 AKVIRKLAEEVFSIVGRDPLIEVAVALEKAALS--DEYFVKRKLYPNVDFYSGLIYRAMGFP-TEFFPVLFAIPRMAGYL 451 (513)
Q Consensus 375 A~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~--d~yf~~r~LyPNVDfysg~i~~alGiP-~~~~t~lFai~R~~Gwi 451 (513)
|++|+++|.++. +.++++++++++|+++.+ ++||+.||+|||||||||++|++|||| .++||+||++||++||+
T Consensus 324 a~~lk~~~~~~~---~~~~~~~~~~~ie~~a~~~l~~~~~~~~l~pNVDfysg~l~~~lGip~~~~ft~lFa~sR~~GW~ 400 (427)
T cd06105 324 YTCQREFALKHL---PNDPLFKLVSQLYKIVPPVLTEQGKAKNPWPNVDAHSGVLLQYYGLTEMNYYTVLFGVSRALGVL 400 (427)
T ss_pred cHHHHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHhccCCCCCCChhHHHHHHHHHcCCCchhhhHHHHHHHHHHHHH
Confidence 999999999864 678999999999999877 889999999999999999999999999 69999999999999999
Q ss_pred HHHHhhhcCCCCCccCCcccccCC
Q 010304 452 AHWRESLDDPDTKIMRPQQVYTGV 475 (513)
Q Consensus 452 AH~~Eq~~~~~~ki~RPr~~Y~G~ 475 (513)
|||+||+.+ +.+|+||+|+|++.
T Consensus 401 AH~~Eq~~~-~~~I~RP~s~~~~~ 423 (427)
T cd06105 401 SQLIWDRAL-GLPLERPKSVSTDG 423 (427)
T ss_pred HHHHHHHhC-CCCccCCcchhHHH
Confidence 999999976 37899999999874
No 20
>PRK12350 citrate synthase 2; Provisional
Probab=100.00 E-value=2.8e-103 Score=812.28 Aligned_cols=345 Identities=32% Similarity=0.484 Sum_probs=307.0
Q ss_pred ecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHH-H--HHHHHhhcCCCcHHHH
Q 010304 97 YDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLT-D--WEFAVSQHSAVPQGIL 173 (513)
Q Consensus 97 ~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~-~--f~~~l~~~~~l~~~v~ 173 (513)
|||||.||++|+|+||+|||++|+|+||||||+|||+++|||||+||||+|+|||+.++. . +...+. ..+..+.
T Consensus 1 ~~~GL~~v~~~~s~Is~idg~~G~L~YRGy~i~dLa~~~sFeEva~LL~~G~LP~~~~~~~~~~~~~~~~---~~~~~~~ 77 (353)
T PRK12350 1 FVPGLEGVVAFETEIAEPDGDGGALRYRGVDIEDLVGRVTFEDVWALLVDGRFGPGLPPAEPFPLPVHLG---DARVDVQ 77 (353)
T ss_pred CCCCCCCceeEeeeCcceeCCCCEEEECCccHHHHhccCCHHHHHHHHHCCCCCCcchhhhccchHHHhh---ccchhhh
Confidence 689999999999999999999999999999999999999999999999999999987544 3 332222 1222233
Q ss_pred HHHHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcC-CCCCCCCCC
Q 010304 174 DIIQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAG-RPPVLPSNN 252 (513)
Q Consensus 174 ~~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G-~~~~~p~~~ 252 (513)
..+.. .|||..+.+++ +.+ + .++.+||+||+|||+|++||++.| +++++|+++
T Consensus 78 ~~~~~----~~~~~~l~~~~------~~~------------~----~~~~~rliA~~pti~a~~~r~~~g~~~~i~p~~~ 131 (353)
T PRK12350 78 AALAM----LAPVWGFRPLL------DID------------D----LTARLDLARASVMALSAVAQSARGIGQPAVPQRE 131 (353)
T ss_pred hhHHH----hhHHHHHHhhc------CCC------------C----HHHHHHHHHHHHHHHHHHHHHHcCCCCCcCCCCC
Confidence 22222 34666555532 110 1 235589999999999999999999 899999999
Q ss_pred CCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHH
Q 010304 253 LSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEA 332 (513)
Q Consensus 253 lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAnea 332 (513)
+||++|||+||++.. .++|++..+++||++||||||||+||||||+|+++||++|+|+||+|||+|||||+||||||+
T Consensus 132 ls~a~nfl~ml~g~~--~~~p~~~~~~~ld~~LiL~ADHg~naSTfaaRv~aSt~adlysav~agi~aL~GplHGGA~e~ 209 (353)
T PRK12350 132 IDHAATILERFMGRW--RGEPDPAHVAALDAYWVSAAEHGMNASTFTARVIASTGADVAAALSGAIGALSGPLHGGAPAR 209 (353)
T ss_pred CCHHHHHHHHhccCc--cCCCCHHHHHHHHHHHHHhccCCCCcchHHHHHHhccCCcHHHHHHHHHhhcCCCcccChHHH
Confidence 999999999998632 357899999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhcc--cc
Q 010304 333 VLKMLNEIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSD--EY 410 (513)
Q Consensus 333 v~~mL~eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d--~y 410 (513)
|++||++|++++++++||++++++|++||||||||||++|||+++|+++++++. ++++++++++|+++.++ +|
T Consensus 210 v~~ml~ei~~~~~~~~~v~~~l~~~~ri~GFGHrvYk~~DPRa~~L~~~~~~l~-----~~~~~ia~~le~~~~~~~~~~ 284 (353)
T PRK12350 210 VLPMLDAVERTGDARGWVKGALDRGERLMGFGHRVYRAEDPRARVLRATAKRLG-----APRYEVAEAVEQAALAELRER 284 (353)
T ss_pred HHHHHHHhCChhhHHHHHHHHHHCCCccccCCCCCCCCCCCCHHHHHHHHHHhC-----ChHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999999999999999999999999999973 58999999999999885 79
Q ss_pred ccccCCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCcc
Q 010304 411 FVKRKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRH 479 (513)
Q Consensus 411 f~~r~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~ 479 (513)
|.+|+||||||||+|++|++||||+++||++|+++|++||+|||+||+.+ ++|+||++.|+|+.+|.
T Consensus 285 ~~~r~l~pNVDfysa~v~~~lGip~~~ft~lFai~R~~Gw~AH~~Eq~~~--~~i~RP~~~Y~G~~~~~ 351 (353)
T PRK12350 285 RPDRPLETNVEFWAAVLLDFAGVPAHMFTAMFTCGRTAGWSAHILEQKRT--GRLVRPSARYVGPAPRS 351 (353)
T ss_pred cCCCCCCcChHHHHHHHHHHcCcChhhhcchHHhhhHHHHHHHHHHHHhc--CCCcCCCcceeCCCCCC
Confidence 99999999999999999999999999999999999999999999999974 79999999999998775
No 21
>cd06106 ScCit3_like Saccharomyces cerevisiae (Sc) 2-methylcitrate synthase Cit3-like. 2-methylcitrate synthase (2MCS) catalyzes the condensation of propionyl-coenzyme A (PrCoA) and oxaloacetate (OAA) to form 2-methylcitrate and CoA. Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) with OAA to form citrate and CoA, the first step in the citric acid cycle (TCA or Krebs cycle). The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. There are two types of CSs: type I CS and type II CSs. Type I CSs are found in eukarya, gram-positive bacteria, archaea, and in some gram-negative bacteria and are homodimers with both subunits participating in the a
Probab=100.00 E-value=9.2e-102 Score=817.78 Aligned_cols=380 Identities=24% Similarity=0.376 Sum_probs=334.2
Q ss_pred hhhhhhcCCCCc--ceee---ecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhc-------CCH--HHHHHHHHc
Q 010304 81 DFKKITTGKNDK--GLKL---YDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAES-------SSF--LEVAYLLMY 146 (513)
Q Consensus 81 di~~l~~~~~~~--g~~~---~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~-------~sF--eEva~LL~~ 146 (513)
-+++|++...++ |-.| +..||.|+++++|+||+|||++| |+||||+|+||+++ ++| |||+||||+
T Consensus 15 ~~~~l~~~~~~~~~~~~t~~~~~~GL~gv~~~~t~is~idg~~G-l~YRGy~I~dLa~~~~~~~~~~~f~~Eev~yLLl~ 93 (428)
T cd06106 15 QLKKLKAEYGETVVGDVKVSNVLGGMRGLKSMLWEGSVLDAEEG-IRFHGKTIPECQKELPKAPIGGEMLPESMLWLLLT 93 (428)
T ss_pred HHHHHHHHcCCCeeeeeeHHHhcccccCCeeeeecCeEECCCCC-eeECCCcHHHHHhhCccccccCCccHHHHHHHHHc
Confidence 455565433332 3332 56899999999999999999999 79999999999998 788 999999999
Q ss_pred CCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCccc--chhHhHHHHH
Q 010304 147 GNLPSESQLTDWEFAVSQHSAVPQGILDIIQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYK--SKQVRDKQIA 224 (513)
Q Consensus 147 G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~--~~~~~~~~~~ 224 (513)
|+|||++|+++|+++|.+++.+|+.+.++|++||.++|||++|++++++|+.+.... ++ ...+... ......++++
T Consensus 94 G~LPt~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vs~L~~~~~~~-~~-y~~~~~~~~~~~~~~~~~~ 171 (428)
T cd06106 94 GKVPTFEQARGLSKELAERGKLPHYIEKLLDSLPKTLHPMTQLSIGVAALNHDSKFA-AA-YEKGIKKTEYWEPTLEDSL 171 (428)
T ss_pred CcCCCHHHHHHHHHHHHHcCCCCHHHHHHHHhCCCCCCHHHHHHHHHHhccccchhh-hh-cccCcccccchHHHHHHHH
Confidence 999999999999999999999999999999999999999999999999998632100 00 0001101 1233467899
Q ss_pred HHHhhhHHHHHHHHHHHcCC--CCCCCCCCCCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCC-CChhhHHHH
Q 010304 225 RILGKAPTIAAAAYLRMAGR--PPVLPSNNLSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHE-MNCSTSAAR 301 (513)
Q Consensus 225 rliak~ptiaA~~y~~~~G~--~~~~p~~~lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHe-lN~ST~aaR 301 (513)
||+||+|+|+|++||++.|+ ++++|++++||++||||||+ ..|+|..+++||++|||||||| +|+||||+|
T Consensus 172 rLiAk~ptI~A~~yr~~~g~~~~~~~p~~~ls~a~NFL~Mlg------~~p~~~~~~~l~~~LiL~ADHeg~NaSTfaar 245 (428)
T cd06106 172 NLIARLPALAARIYRNVYGEGHGLGKIDPEVDWSYNFTSMLG------YGDNLDFVDLLRLYIALHGDHEGGNVSAHTTH 245 (428)
T ss_pred HHHHHHHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHHhC------CCCChHHHHHHHHHHhhhcccCCccchHHHHH
Confidence 99999999999999999865 78889999999999999994 3578999999999999999999 899999999
Q ss_pred HHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHHH----hCC---CCCHHHHHHHHHhcCCcccccCCCCCCCCCch
Q 010304 302 HLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLNE----IGT---VENIPEFIEGVKNRKRKMSGFGHRVYKNYDPR 374 (513)
Q Consensus 302 vvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~e----I~~---~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPR 374 (513)
++|||++|+|+||+|||+||+||+|||||++|++||++ |++ ++++++||++.+++|++||||||||||++|||
T Consensus 246 vvaST~ad~ysav~agi~aL~GPlHGGAne~v~~~l~e~~~~ig~~~~~~~~~~~i~~~l~~g~~i~GfGHrvYk~~DPR 325 (428)
T cd06106 246 LVGSALSDPYLSYSAGLMGLAGPLHGLAAQEVLRWILEMQKNIGSKATDQDIRDYLWKTLKSGRVVPGYGHAVLRKPDPR 325 (428)
T ss_pred HHhccCCCHHHHHHHHHHhcCCCcccChHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHhCCCcccCCCCCCCCCCCCC
Confidence 99999999999999999999999999999999997655 463 47999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhc--cccccccCCCCchhhHHHHHHHHcCCCC-CchhhHhhhhhhhhhH
Q 010304 375 AKVIRKLAEEVFSIVGRDPLIEVAVALEKAALS--DEYFVKRKLYPNVDFYSGLIYRAMGFPT-EFFPVLFAIPRMAGYL 451 (513)
Q Consensus 375 A~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~--d~yf~~r~LyPNVDfysg~i~~alGiP~-~~~t~lFai~R~~Gwi 451 (513)
|++|+++++++.+. +.++++++++++|+++.+ ++||+.||+|||||||+|++|++||||+ +|||+||++||++||+
T Consensus 326 a~~l~~~~~~l~~~-~~~~~~~~a~~ie~~~~~~l~~~~~~~~l~pNVDfysg~v~~~lGip~~~~ft~lFaisR~~GW~ 404 (428)
T cd06106 326 FTALMEFAQTRPEL-ENDPVVQLVQKLSEIAPGVLTEHGKTKNPFPNVDAASGVLFYHYGIREFLYYTVIFGVSRALGPL 404 (428)
T ss_pred cHHHHHHHHHHHhc-cCCHHHHHHHHHHHHHHHHHHHhccccCCCCCchhHHHHHHHHcCCChhhcchHHHHHHHHHHHH
Confidence 99999999998654 457999999999999876 7789999999999999999999999998 7899999999999999
Q ss_pred HHHHhhhcCCCCCccCCccc
Q 010304 452 AHWRESLDDPDTKIMRPQQV 471 (513)
Q Consensus 452 AH~~Eq~~~~~~ki~RPr~~ 471 (513)
|||+||... +++|+||||+
T Consensus 405 AHi~eq~~~-~~~I~RP~s~ 423 (428)
T cd06106 405 TQLVWDRIL-GLPIERPKSL 423 (428)
T ss_pred HHHHHHHhC-CCCCcCCCcc
Confidence 999999854 5789999986
No 22
>PRK12349 citrate synthase 3; Provisional
Probab=100.00 E-value=2e-101 Score=805.73 Aligned_cols=363 Identities=36% Similarity=0.619 Sum_probs=342.6
Q ss_pred eecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHH
Q 010304 96 LYDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDI 175 (513)
Q Consensus 96 ~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~ 175 (513)
+|||||.|+++++|+||+|||++|+|+||||||+||+++++||||+||||+|+||++.|++.|+..|..++.+|+.+.++
T Consensus 4 ~~~~Gl~g~~~~~S~IS~id~~~g~L~YRGydi~dLa~~~sFeeva~LL~~G~LP~~~e~~~f~~~L~~~~~~p~~v~~~ 83 (369)
T PRK12349 4 KFSPGLDGVIAAETKISFLDTVKGEIVIQGYDLIELSKTKEYLDIVHLLLEEHLPNEDEKATLEKKLKEEYAVPEGVFNI 83 (369)
T ss_pred cCCCccCCCeeeeeeceeEeCCCCEEEECCccHHHHHccCCHHHHHHHHHCCCCCCHHHHHHHHHHHHhccCCCHHHHHH
Confidence 69999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCH
Q 010304 176 IQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSY 255 (513)
Q Consensus 176 i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy 255 (513)
++.+|++.|||.+|+++++++++++++... .+......+++++|+++|+|+|++||+..|++++.|+++++|
T Consensus 84 l~~~p~~~~pm~~l~~~vs~l~~~d~~~~~--------~~~~~~~~~a~~lia~~p~i~a~~~r~~~g~~~~~p~~~l~~ 155 (369)
T PRK12349 84 LKALPKETHPMDGLRTGVSALAGYDNDIED--------RSLEVNKSRAYKLLSKVPNIVANSYHILNNEEPIEPLKELSY 155 (369)
T ss_pred HHhCCCCCCHHHHHHHHHHHhcccCccccc--------cCcHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCCCCcCCCH
Confidence 999999999999999999999998876421 123334668899999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHH
Q 010304 256 SENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLK 335 (513)
Q Consensus 256 ~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~ 335 (513)
++|||+|+++ .+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+||+||+||||||+|++
T Consensus 156 a~nfl~ml~g-----~~p~~~~~~~~~~~Lvl~ADH~lnaStfa~Rv~aSt~ad~~~av~agl~al~GplHGGA~e~~~~ 230 (369)
T PRK12349 156 SANFLYMLTG-----KKPTELEEKIFDRSLVLYSEHEMPNSTFTARVIASTQSDLYGALTGAVASLKGSLHGGANEAVMY 230 (369)
T ss_pred HHHHHHHHhC-----CCCCHHHHHHHHHHHHHHhCcCccHHHHHHHHHHccCccHHHHHHHHHHhccCccccChHHHHHH
Confidence 9999999986 47899999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHHhcCCcccccCCCCC-CCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhcccccccc
Q 010304 336 MLNEIGTVENIPEFIEGVKNRKRKMSGFGHRVY-KNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKR 414 (513)
Q Consensus 336 mL~eI~~~~~i~~~i~~~~~~~~rl~GFGHrVY-k~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r 414 (513)
||++|+++++++++|++.+++|++||||||||| |..|||+++|+++++++.+..+..+++++++++|+++.+ .+
T Consensus 231 ~l~~i~~~~~~~~~v~~~l~~~~~i~GFGH~vy~~~~DPRa~~l~~~~~~l~~~~~~~~~~~~~~~~e~~~~~-----~~ 305 (369)
T PRK12349 231 MLLEAGTVEKFEELLQKKLYNKEKIMGFGHRVYMKKMDPRALMMKEALKQLCDVKGDYTLYEMCEAGEKIMEK-----EK 305 (369)
T ss_pred HHHHcCCHHHHHHHHHHHHhcCCcccCCCCCCCCCCCCCcHHHHHHHHHHHHHHcCchHHHHHHHHHHHHHHH-----hc
Confidence 999999999999999999999999999999999 778999999999999998777777899999999988864 68
Q ss_pred CCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCc
Q 010304 415 KLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMR 478 (513)
Q Consensus 415 ~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r 478 (513)
|+|||||||+|++++.||||+++|+++|+++|++||+|||+||+.+ ++|+|||++|+|+.++
T Consensus 306 gl~pNvD~~~a~l~~~lG~p~~~~~~lf~i~R~~Gw~AH~~Eq~~~--~~l~RP~~~Y~G~~~~ 367 (369)
T PRK12349 306 GLYPNLDYYAAPVYWMLGIPIQLYTPIFFSSRTVGLCAHVIEQHAN--NRLFRPRVNYIGERHV 367 (369)
T ss_pred CCCCCcHHHHHHHHHHcCCChhhhhHHHHHHHHHHHHHHHHHHHhc--CCCccccceeeCCCcC
Confidence 9999999999999999999999999999999999999999999985 8999999999998654
No 23
>PRK09569 type I citrate synthase; Reviewed
Probab=100.00 E-value=8.7e-102 Score=819.81 Aligned_cols=366 Identities=28% Similarity=0.425 Sum_probs=335.1
Q ss_pred ecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhc---------CCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCC
Q 010304 97 YDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAES---------SSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSA 167 (513)
Q Consensus 97 ~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~---------~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~ 167 (513)
+.+||.|+.+++|+||+|||++| |+||||+|+||+++ ++||||+||||||+|||++|+++|+++|.+++.
T Consensus 38 ~~~GL~gv~~~~t~IS~iDg~~G-l~YRGy~I~dL~~~~p~~~~~~~~~fEev~~LLl~G~LPt~~el~~f~~~L~~~~~ 116 (437)
T PRK09569 38 CIGGARDIRSLVTDISYLDPQEG-IRFRGKTIPETFEALPKAPGSEYPTVESFWYFLLTGEVPTQEQVQEVVAEWKKRQN 116 (437)
T ss_pred hcccccCCeecceeceeecCCCc-eeECCccHHHHHhhCccccccCCCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHcCC
Confidence 55899999999999999999998 79999999999999 499999999999999999999999999999999
Q ss_pred CcHHHHHHHHhCCCCCChhhHHHHHHHHh------hccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHH
Q 010304 168 VPQGILDIIQAMPHDAHPMGVLVSAMSAL------SIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRM 241 (513)
Q Consensus 168 l~~~v~~~i~~~p~~~hPm~~l~a~v~al------~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~ 241 (513)
+|+.+.+++++||+++|||++|++++++| +.+|++..-. .. .+.+...++++||||++|+|+|++||++
T Consensus 117 lp~~v~~~i~~~p~~~hPM~~L~~~vs~l~~~s~~~~~y~~~~~~--~~---~~~~~~~~~~~rliA~~p~i~A~~yr~~ 191 (437)
T PRK09569 117 VPQYVIDAIRALPRDSHPMVMLSVGILAMQRESKFAKFYNEGKFN--KM---DAWEYMYEDASDLVARIPVIAAYIYNLK 191 (437)
T ss_pred CCHHHHHHHHhCCCCCCHHHHHHHHHHhccccchhhhhccccccc--cc---ccHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999997 8777664210 01 1224456789999999999999999999
Q ss_pred c-CCCCCCCCCCCCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCC-CChhhHHHHHHhccCCCHHHHHHHHhh
Q 010304 242 A-GRPPVLPSNNLSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHE-MNCSTSAARHLASSGVDVYTALAGAVG 319 (513)
Q Consensus 242 ~-G~~~~~p~~~lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHe-lN~ST~aaRvvaStgadlyaavaagi~ 319 (513)
. |.++++|++++||++|||+||++ .+..+++||++|||||||| +|+||||+|++|||++|+|+||+|||+
T Consensus 192 ~~g~~~~~p~~~ls~a~NFl~Ml~~--------~~~~~~~l~~~LiL~ADHe~~naSTfaaRvvaSt~ad~ysav~Agi~ 263 (437)
T PRK09569 192 YKGDKQIPSDPELDYGANFAHMIGQ--------PKPYKDVARMYFILHSDHESGNVSAHTTHLVASALSDAYYSYSAGLN 263 (437)
T ss_pred hCCCCCCCCCCCcCHHHHHHHHhcC--------CchHHHHHHHHHhhhhccCCCcchHHHHHHHhccCCCHHHHHHHHHH
Confidence 5 88999999999999999999985 2456899999999999999 799999999999999999999999999
Q ss_pred cccCCccCChHHHHHHHHHHhC--------CCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCC
Q 010304 320 ALYGPLHGGANEAVLKMLNEIG--------TVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGR 391 (513)
Q Consensus 320 AL~GPlHGGAneav~~mL~eI~--------~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~ 391 (513)
||+||+||||||+|++||++|. +++++++||++++++|++||||||||||.+||||++|+++++++. +.
T Consensus 264 aL~GplHGGA~e~v~~~l~~i~~~~~~~~~~~~~~~~~v~~~l~~~~ri~GFGHrvyk~~DPRa~~L~~~a~~~~---~~ 340 (437)
T PRK09569 264 GLAGPLHGLANQEVLGWIQQFQEKLGGEEPTKEQVEQALWDTLNAGQVIPGYGHAVLRKTDPRYTAQREFCLKHL---PD 340 (437)
T ss_pred hccCCccCCchHHHHHHHHHHHHhhccCCCCHHHHHHHHHHHHhcCCcccCCCCCCCCCCCCchHHHHHHHHHHc---CC
Confidence 9999999999999999998775 557899999999999999999999999999999999999999984 56
Q ss_pred CcHHHHHHHHHHHHhc--cccccccCCCCchhhHHHHHHHHcCCC-CCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCC
Q 010304 392 DPLIEVAVALEKAALS--DEYFVKRKLYPNVDFYSGLIYRAMGFP-TEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRP 468 (513)
Q Consensus 392 ~~ll~iA~~lE~~a~~--d~yf~~r~LyPNVDfysg~i~~alGiP-~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RP 468 (513)
++++++++++|+++.+ ++||+.||+|||||||+|+||++|||| +++||++|++||++||+|||+||+. .+++|+||
T Consensus 341 ~~~~~ia~~~e~v~~~~~~~~~~~~~l~pNVD~~sg~l~~~lGip~~~~~t~lFaisR~~Gw~AH~iEq~~-~~~~i~RP 419 (437)
T PRK09569 341 DPLFKLVAMIFEVAPGVLTEHGKTKNPWPNVDAQSGVIQWYYGVKEWDFYTVLFGVGRALGVMANITWDRG-LGYAIERP 419 (437)
T ss_pred CHHHHHHHHHHHHHHHHHHHhcccCCCCCChHHHHHHHHHHcCCCchhhhHHHHHHHHHHHHHHHHHHHHh-CCCCccCC
Confidence 7899999999998865 889999999999999999999999999 6999999999999999999999995 35789999
Q ss_pred cccccCCCCccc
Q 010304 469 QQVYTGVWMRHY 480 (513)
Q Consensus 469 r~~Y~G~~~r~~ 480 (513)
|++|+|+....+
T Consensus 420 ~~~Y~G~~~~~~ 431 (437)
T PRK09569 420 KSVTTEMLEKWA 431 (437)
T ss_pred ccccchHHHHHH
Confidence 999999765443
No 24
>TIGR01800 cit_synth_II 2-methylcitrate synthase/citrate synthase II. Members of this family are dimeric enzymes with activity as 2-methylcitrate synthase, citrate synthase, or both. Many Gram-negative species have a hexameric citrate synthase, termed citrate synthase I (TIGR01798). Members of this family (TIGR01800) appear as a second citrate synthase isozyme but typically are associated with propionate metabolism and synthesize 2-methylcitrate from propionyl-CoA; citrate synthase activity may be incidental. A number of species, including Thermoplasma acidophilum, Pyrococcus furiosus, and the Antarctic bacterium DS2-3R have a bifunctional member of this family as the only citrate synthase isozyme.
Probab=100.00 E-value=5.6e-101 Score=802.83 Aligned_cols=368 Identities=42% Similarity=0.725 Sum_probs=349.3
Q ss_pred CCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHh
Q 010304 99 PGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQA 178 (513)
Q Consensus 99 pG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~ 178 (513)
|||.|+++|+|+||+||+++|+|+||||||+||+++.+||||+||||+|+||++.|++.|...|..++.+|+.+.++++.
T Consensus 1 ~Gl~g~~~~~t~Is~id~~~g~l~yRG~~i~dL~~~~~feeva~LL~~G~lP~~~e~~~f~~~l~~~~~~p~~~~~~~~~ 80 (368)
T TIGR01800 1 KGLEGVIADETALSTIDGSEGILTYRGYDIEDLAEHASFEEVAYLLLHGKLPTRSELRKFKTELAKLRGLPDEVIELIEA 80 (368)
T ss_pred CCCCCCeeeeeeceEEECCcceEEECCeeHHHHHhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHh
Confidence 69999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 010304 179 MPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYSEN 258 (513)
Q Consensus 179 ~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~eN 258 (513)
||.+.|||.+|+++++++++++++.. + .+.......++|+++++|+|+|++|+++.|+++++|+++++|++|
T Consensus 81 ~p~~~~pm~~l~~~ls~l~~~d~~~~----~----~~~~~~~~~a~~lia~~p~i~a~~~~~~~g~~~~~p~~~~~~~~n 152 (368)
T TIGR01800 81 LPAESHPMDALRTAVSYLGALDPEAF----G----HTPEEARDIAIRLIAKLPTIVAYWYRIRNGLEIVAPKEDDSHAAN 152 (368)
T ss_pred CCCCCCcHHHHHHHHHHhhccCcccc----c----CCHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCcCCCCCccHHHH
Confidence 99999999999999999999887642 1 123445678899999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHH
Q 010304 259 FLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLN 338 (513)
Q Consensus 259 fL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~ 338 (513)
||+|+++ .+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+||+||+||||++.|++||+
T Consensus 153 ~l~ml~g-----~~p~~~~~~~l~~~Lvl~ADHg~n~St~aaRv~aSt~adl~~av~agl~al~Gp~HGGA~~~~~~~l~ 227 (368)
T TIGR01800 153 FLYMLHG-----EEPSKEEEKAMDIALILYAEHEFNASTFAARVAASTLSDMYSAITAAIGALKGPLHGGANEAVMAMLD 227 (368)
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHhHhccCCCchHHHHHHHHhccCCCHHHHHHHHHhhcCCccccCHHHHHHHHHH
Confidence 9999986 37899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccCCCC
Q 010304 339 EIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRKLYP 418 (513)
Q Consensus 339 eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~LyP 418 (513)
+|++.+++++||++.+++|++||||||||||+.|||+++|+++++++.+..+.++++++++++|+++.+ .+|+||
T Consensus 228 ~i~~~~~~~~~v~~~l~~~~~i~GfGH~vy~~~DPRa~~L~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-----~~~l~p 302 (368)
T TIGR01800 228 EIGDPDKAEAWIRKALENKERIMGFGHRVYKTYDPRAKILKEYAKKLSAKEGDSKWYEIAERLEDVMEK-----EKGIYP 302 (368)
T ss_pred HhcChHHHHHHHHHHHHCCCccCCCCCCCCCCCCchHHHHHHHHHHHHHhhCCCHHHHHHHHHHHHHHH-----hcCCCC
Confidence 999989999999999999999999999999999999999999999987766778999999999998875 589999
Q ss_pred chhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCccccccccc
Q 010304 419 NVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPLKER 486 (513)
Q Consensus 419 NVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~~~R 486 (513)
|||||+|+|++.||||+++|+++|+++|++||+|||+||+.+ ++|+||+++|+|+.+|+|+|+++|
T Consensus 303 NvD~~~a~l~~~lg~p~~~~~~lf~~~R~~Gw~AH~~Eq~~~--~~l~Rp~~~Y~G~~~~~~~~~~~r 368 (368)
T TIGR01800 303 NVDFYSGSVYYSMGIPTDLFTPIFAMSRVSGWTAHIIEQVEN--NRLIRPRADYVGPEERKYVPIEER 368 (368)
T ss_pred ChHHHHHHHHHHcCcCHHHhhhHHHHHHHHHHHHHHHHHHhc--CCccCccccccCCCCCCCCCcCCC
Confidence 999999999999999999999999999999999999999964 789999999999999999999887
No 25
>PRK14033 citrate synthase; Provisional
Probab=100.00 E-value=6.6e-101 Score=802.88 Aligned_cols=367 Identities=36% Similarity=0.594 Sum_probs=348.3
Q ss_pred ecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHH
Q 010304 97 YDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDII 176 (513)
Q Consensus 97 ~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i 176 (513)
++|||.||++++|+||+||+++|+|+||||+|+||++++|||||+||||+|++|++.|++.|...|.+++.+|+.+.+++
T Consensus 9 ~~~GL~gv~v~~S~Is~id~~~g~L~yRG~di~dLa~~~sfeeva~LL~~G~lP~~~el~~f~~~l~~~~~~p~~v~~~~ 88 (375)
T PRK14033 9 IKKGLAGVVVDTTAISKVVPETNSLTYRGYPVQDLAARCSFEEVAYLLWNGELPTDAELALFSQRERAYRRLDRSVLSLI 88 (375)
T ss_pred CCCCCCCceEeeccCeEEECCCCeEEECCccHHHHHhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHccCCCHHHHHHH
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHH
Q 010304 177 QAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYS 256 (513)
Q Consensus 177 ~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~ 256 (513)
+.||+++|||.+|+++++++++++++... .+.......++++++++|+|+|++|+++.|+++++|+++++|+
T Consensus 89 ~~~p~~~~pm~~l~~~vs~l~~~d~~~~~--------~~~~~~~~~a~~lia~~~~i~a~~~~~~~g~~~~~p~~~~s~a 160 (375)
T PRK14033 89 DKLPTTCHPMDVVRTAVSYLGAEDPEADD--------SSPEANLAKALRLFAVLPTIVAADQRRRRGLDPIAPRSDLGYA 160 (375)
T ss_pred HhCCCCCCHHHHHHHHHHHhccCCccccc--------CCHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCccCCCCCCCHH
Confidence 99999999999999999999998876531 1334456788999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHH
Q 010304 257 ENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKM 336 (513)
Q Consensus 257 eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~m 336 (513)
+|||+|+++ .+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+||+||+||||+|+|++|
T Consensus 161 ~nfl~ml~g-----~~p~~~~~~~l~~~Lvl~ADHgln~StfaaRv~aSt~adl~~av~agl~al~GplHGGA~e~~~~~ 235 (375)
T PRK14033 161 ENFLHMCFG-----EVPEPEVVRAFEVSLILYAEHSFNASTFTARVITSTLSDIYSAVTGAIGALKGPLHGGANEAVMHT 235 (375)
T ss_pred HHHHHHHhC-----CCCCHHHHHHHHHHHHHHhccCCCcHHHHHHHHhccCCCHHHHHHHHHhhccCccccChHHHHHHH
Confidence 999999986 478999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccCC
Q 010304 337 LNEIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRKL 416 (513)
Q Consensus 337 L~eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~L 416 (513)
|++|++++++++||++.+++|++||||||||||..|||+++|++++.++.++.+.++++++++++|+++.+ .+|+
T Consensus 236 l~ei~~~~~~~~~v~~~~~~~~~l~GFGH~vyk~~DPRa~~L~~~l~~l~~~~~~~~~~~~~~~i~~~~~~-----~~gl 310 (375)
T PRK14033 236 MLEIGDPARAAEWLRDALARKEKVMGFGHRVYKHGDSRVPTMKAALRRVAAVRDGQRWLDIYEALEKAMAE-----ATGI 310 (375)
T ss_pred HHHhCChhHHHHHHHHHHhCCCceecCCCCCCCCCCchHHHHHHHHHHHHHhcCccHHHHHHHHHHHHHHH-----HhCC
Confidence 99999999999999999999999999999999999999999999999987765667899999999998864 5899
Q ss_pred CCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCcccccc
Q 010304 417 YPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRHYMPL 483 (513)
Q Consensus 417 yPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~ 483 (513)
|||||||+|+|++.||||+++|++||+++|++||+|||+||+.+ ++|+||+++|+|+..|+|+||
T Consensus 311 ~pNvD~~~a~l~~~lGip~~~~~~lf~~~R~~Gw~AH~~Eq~~~--~~l~RP~~~YvG~~~~~~~~~ 375 (375)
T PRK14033 311 KPNLDFPAGPAYYLMGFDIDFFTPIFVMSRITGWTAHIMEQRAS--NALIRPLSEYNGPEQREVPPI 375 (375)
T ss_pred CCCcHHHHHHHHHHcCcCchhhhHHHHHHHHHHHHHHHHHHHhc--CCccccCceecCCCCCCCCCC
Confidence 99999999999999999999999999999999999999999974 799999999999999999986
No 26
>cd06103 ScCS-like Saccharomyces cerevisiae (Sc) citrate synthase (CS)-like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) with oxaloacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). Some CS proteins function as 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. There are two types of CSs: type I CS and type II CSs. Type I CSs are found in eukarya, gram-positive bacteria, archaea, and in some gram-negative bacteria and are homo
Probab=100.00 E-value=3.8e-101 Score=813.42 Aligned_cols=363 Identities=28% Similarity=0.402 Sum_probs=328.8
Q ss_pred eecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcC---------CHHHHHHHHHcCCCCCHHHHHHHHHHHhhcC
Q 010304 96 LYDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESS---------SFLEVAYLLMYGNLPSESQLTDWEFAVSQHS 166 (513)
Q Consensus 96 ~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~---------sFeEva~LL~~G~LPt~~el~~f~~~l~~~~ 166 (513)
.+++||.|+++|+|+||+|||++| |+||||+|+||++++ +||||+||||+|+|||++|+++|+.+|.+++
T Consensus 35 ~~~~GL~gv~~~~t~Is~iDg~~G-l~YRGy~I~dLa~~~~~~~~~~~~~fEev~yLLl~G~LPt~~el~~f~~~L~~~~ 113 (426)
T cd06103 35 QVIGGMRGMKGLVYETSVLDPDEG-IRFRGKTIPECQELLPKADGGGEPLPEGLFWLLLTGEVPTEEQVDELSKEWAKRA 113 (426)
T ss_pred hhccCcCCCeeeeeeCeeEcCCCC-eEECCccHHHHHhhCccccccCcCcHHHHHHHHHCCCCCCHHHHHHHHHHHHHcC
Confidence 488999999999999999999988 589999999999986 2999999999999999999999999999999
Q ss_pred CCcHHHHHHHHhCCCCCChhhHHHHHHHHhhccCCC--CCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHc--
Q 010304 167 AVPQGILDIIQAMPHDAHPMGVLVSAMSALSIFHPD--ANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMA-- 242 (513)
Q Consensus 167 ~l~~~v~~~i~~~p~~~hPm~~l~a~v~al~~~~~~--~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~-- 242 (513)
.+|+.+.+++++||+++|||.+|++++++|+++++. ..+.. ..+.........++++||+||+|+|+|++||++.
T Consensus 114 ~lp~~v~~~i~~~p~~~hPM~~L~~~vs~L~~~~~~~~~~~~~-~~~~~~~~~~~~~~a~~liA~~p~I~A~~yr~~~~~ 192 (426)
T cd06103 114 EVPSHVVKMIDNLPRNLHPMTQLSAAILALQSESKFAKAYAEG-KINKTTYWEYVYEDAMDLIAKLPVVAAKIYRRKYRK 192 (426)
T ss_pred CCCHHHHHHHHhCCCCCChHHHHHHHHHhccccccchhhcccc-cccccccHHHHHHHHHHHHHHHHHHHHHHHHHHhcC
Confidence 999999999999999999999999999999986531 11100 0000012344577899999999999999999974
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCC-CChhhHHHHHHhccCCCHHHHHHHHhhcc
Q 010304 243 GRPPVLPSNNLSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHE-MNCSTSAARHLASSGVDVYTALAGAVGAL 321 (513)
Q Consensus 243 G~~~~~p~~~lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHe-lN~ST~aaRvvaStgadlyaavaagi~AL 321 (513)
|+++++|++++||++|||+||++ + +|..+++||++|||||||| +|+||||+|++|||++|+|+||+|||+||
T Consensus 193 g~~~~~p~~~ls~aeNfl~ml~~------~-~~~~~~~l~~~LiL~ADHe~~NaSTfaaRvvaSt~ad~ysav~agi~aL 265 (426)
T cd06103 193 GGEIGAIDSKLDWSANFAHMLGY------E-DEEFTDLMRLYLTLHSDHEGGNVSAHTSHLVGSALSDPYLSFSAALNGL 265 (426)
T ss_pred CCCccCCCCCcCHHHHHHHHhCC------C-CHHHHHHHHHHHhhhhccCCccchHHHHHHHhccCCCHHHHHHHHHhhc
Confidence 99999999999999999999963 2 2788999999999999999 89999999999999999999999999999
Q ss_pred cCCccCChHHHHHHHHHHhC-------CCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcH
Q 010304 322 YGPLHGGANEAVLKMLNEIG-------TVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPL 394 (513)
Q Consensus 322 ~GPlHGGAneav~~mL~eI~-------~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~l 394 (513)
+||+|||||++|++||++|+ +++++++||++++++|++||||||||||++||||++|+++++++.. .+++
T Consensus 266 ~GplHGGA~e~v~~~l~ei~~~ig~~~~~~~~~~~v~~~l~~~~~i~GfGHrvYk~~DPRa~~L~~~~~~~~~---~~~~ 342 (426)
T cd06103 266 AGPLHGLANQEVLKWLLKMQKELGKDVSDEELEKYIWDTLNSGRVVPGYGHAVLRKTDPRFTCQREFALKHLP---DDPL 342 (426)
T ss_pred CCCcccchHHHHHHHHHHHHHhccCCCCHHHHHHHHHHHHHCCCcccCCCCCCCCCCCCchHHHHHHHHHHhc---CCHH
Confidence 99999999999999998775 5679999999999999999999999999999999999999999853 5689
Q ss_pred HHHHHHHHHHHhc--cccccccCCCCchhhHHHHHHHHcCCC-CCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCccc
Q 010304 395 IEVAVALEKAALS--DEYFVKRKLYPNVDFYSGLIYRAMGFP-TEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQV 471 (513)
Q Consensus 395 l~iA~~lE~~a~~--d~yf~~r~LyPNVDfysg~i~~alGiP-~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~ 471 (513)
+++++++|+++.+ +++|+.||+|||||||+|+||++|||| .++||+||+++|++||+|||+||+.+ +.+|+||+|.
T Consensus 343 ~~~a~~ie~~~~~~~~~~~~~k~l~pNVDfysa~v~~~lGip~~~~ft~lFa~sR~~Gw~AH~~Eq~~~-~~~i~RP~s~ 421 (426)
T cd06103 343 FKLVAQCYKIIPGVLKEHGKVKNPYPNVDAHSGVLLQHYGMTEPQYYTVLFGVSRALGVLAQLVWSRAL-GLPIERPKSM 421 (426)
T ss_pred HHHHHHHHHHHHHHHHHhcccCCCCCChHhHHHHHHHHcCCChhhhhhHHHhHhhcchHHHHHHHHHhC-CCCCCCCCcc
Confidence 9999999999876 789999999999999999999999999 58999999999999999999999976 4779999986
No 27
>cd06111 DsCS_like Cold-active citrate synthase (CS) from an Antarctic bacterial strain DS2-3R (Ds)-like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). 2-methylcitrate synthase (2MCS) catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. DsCS, compared with CS from the hyperthermophile Pyrococcus furiosus (not included in this group), has an increase in the size of surface loops, a higher proline content in the loop regions, a more accessible active site, and a highe
Probab=100.00 E-value=2.7e-100 Score=795.41 Aligned_cols=361 Identities=37% Similarity=0.605 Sum_probs=341.9
Q ss_pred CCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHh
Q 010304 99 PGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQA 178 (513)
Q Consensus 99 pG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~ 178 (513)
+||.|+++++|+||+||+++|+|+||||||+||+++++||||+||||+|++|++.|++.|...+.+++.+|+++.++++.
T Consensus 1 ~Gl~gv~~~~s~Is~i~~~~g~L~yRG~di~dLa~~~~feeva~LL~~G~lP~~~e~~~f~~~l~~~~~lp~~~~~~~~~ 80 (362)
T cd06111 1 KGLAGVVADTTAISKVMPETNSLTYRGYPVQDLAENCSFEEVAYLLWNGELPNAAQLAEFSQRERSYRRLDRNLLSLIAS 80 (362)
T ss_pred CCCCCceEecccceEEECCCCeEEECCccHHHHHccCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHccCCCHHHHHHHHh
Confidence 69999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 010304 179 MPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYSEN 258 (513)
Q Consensus 179 ~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~eN 258 (513)
||.++|||.+|+++++++++++++..+ .+.+....+++|+++++|+|+|++|+++.|+++++|+.+++|++|
T Consensus 81 ~p~~~~pm~~l~~~vs~l~~~d~~~~~--------~~~~~~~~~a~~lia~~~~i~a~~~~~~~g~~~~~p~~~ls~a~n 152 (362)
T cd06111 81 LPKNCHPMDVLRTAVSVLGAEDSETDD--------SSPDANLAKAIRLLAQLPTVVAADIRRRKGLDPIPPDSDLGIAEN 152 (362)
T ss_pred CCCCCChHHHHHHHHHHhhccCccccc--------CCHHHHHHHHHHHHHHHHHHHHHHHHHcCCCCCcCCCCCcCHHHH
Confidence 999999999999999999998876531 133445678899999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHH
Q 010304 259 FLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLN 338 (513)
Q Consensus 259 fL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~ 338 (513)
||+|+++ .+|++..+++||++||||||||+|+||||+|++|||++|+|+||+|||+||+||+||||||+|++||+
T Consensus 153 fl~m~~g-----~~p~~~~~~~l~~~Lvl~ADHg~n~St~aaR~~aSt~ad~~~av~agl~aL~GplHGGA~~~~~~~l~ 227 (362)
T cd06111 153 FLHMCFG-----EVPSPEVVRAFDVSLILYAEHSFNASTFTARVITSTLSDIYSAITGAIGALKGPLHGGANEAVMHMML 227 (362)
T ss_pred HHHHhhC-----CCCCHHHHHHHHHHHHHHhccCCchhHHHHHHHHccCCCHHHHHHHHHhhccCccccchHHHHHHHHH
Confidence 9999986 36899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccCCCC
Q 010304 339 EIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRKLYP 418 (513)
Q Consensus 339 eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~LyP 418 (513)
+|++++++++||++.+++|++||||||||||..|||+++|+++++++.++.+.+++++++++||+++. ..+|+||
T Consensus 228 ei~~~~~~~~~v~~~~~~~~~l~GFGH~vyk~~DPRa~~L~~~l~~l~~~~~~~~~~~~~~~i~~~~~-----~~~~l~p 302 (362)
T cd06111 228 EIDDPEKAAQWMLDALARKEKVMGFGHRVYKSGDSRVPTMEKALRRVAAVHDGQKWLAMYDALEDAMV-----AAKGIKP 302 (362)
T ss_pred HhCChhhHHHHHHHHHhcCCceecCCCCCCCCCCchHHHHHHHHHHHHhhcCccHHHHHHHHHHHHHH-----HhcCCCC
Confidence 99999999999999999999999999999999999999999999999877777799999999998765 4689999
Q ss_pred chhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccCCCCcc
Q 010304 419 NVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTGVWMRH 479 (513)
Q Consensus 419 NVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G~~~r~ 479 (513)
|||||+|+|++.||||+++|+++|+++|++||+|||+||+.+ ++|+|||++|+|+.+|+
T Consensus 303 NvD~~~a~l~~~lG~p~~~~~~lf~~~R~~Gw~AH~~Eq~~~--~~l~Rp~~~Y~G~~~~~ 361 (362)
T cd06111 303 NLDFPAGPAYYLMGFDIDFFTPIFVMARITGWTAHIMEQRAD--NALIRPLSEYNGPEQRP 361 (362)
T ss_pred ChHHHHHHHHHHcCcChhhhhhHHHHHHHHHHHHHHHHHHHc--CCcccCCceeeCCCCCC
Confidence 999999999999999999999999999999999999999985 79999999999998775
No 28
>cd06118 citrate_synt_like_1 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and
Probab=100.00 E-value=2.3e-98 Score=781.41 Aligned_cols=358 Identities=51% Similarity=0.837 Sum_probs=340.5
Q ss_pred CCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHh
Q 010304 99 PGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQA 178 (513)
Q Consensus 99 pG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~ 178 (513)
|||.||++++|+||+||+++|+|+||||+|+||+++.+||||+||||+|+||+++|++.|...|..++.+|+.+.++++.
T Consensus 1 ~Gl~g~~v~~s~is~id~~~g~l~YRG~~i~dL~~~~~feeva~LL~~G~lP~~~el~~f~~~L~~~~~~p~~v~~~~~~ 80 (358)
T cd06118 1 PGLEGVKAKETSISYIDGDEGILRYRGYDIEELAEKSSFEEVAYLLLYGKLPTKEELAEFKKKLASHRALPEHVVEILDL 80 (358)
T ss_pred CCCCCceeeeeeeeEEeCCCCeEEECCccHHHHHhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHccCCCHHHHHHHHh
Confidence 79999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 010304 179 MPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYSEN 258 (513)
Q Consensus 179 ~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~eN 258 (513)
+|++.|||.+|+++++++++++++.. + .+......+++++|+++|+|++++|+++.|++++.|+++++|++|
T Consensus 81 ~p~~~~pm~~l~~~~~~l~~~~~~~~----~----~~~~~~~~~a~~lia~~~~i~a~~~~~~~g~~~~~p~~~~~~~~~ 152 (358)
T cd06118 81 LPKNAHPMDVLRTAVSALGSFDPFAR----D----KSPEARYEKAIRLIAKLPTIAANIYRNREGLEIIAPDPDLSYAEN 152 (358)
T ss_pred cCCCCChHHHHHHHHHhhhccCCccc----c----CCHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCCCCCCCcccHHHH
Confidence 99999999999999999999886652 1 234455678899999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHH
Q 010304 259 FLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLN 338 (513)
Q Consensus 259 fL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~ 338 (513)
|++|+++ .+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+||+||+||||+++|++||+
T Consensus 153 ~~~~~~g-----~~p~~~~~~~l~~~Lvl~aDH~~n~Stfa~R~~aSt~ad~~~av~agl~al~GplHGGA~~~~~~~l~ 227 (358)
T cd06118 153 FLYMLFG-----EEPDPEEAKAMDLALILHADHEGNASTFTARVVASTLSDMYSAIAAAIAALKGPLHGGANEAVLKMLL 227 (358)
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHhhhcCCCCChHHHHHHHHHccCCCHHHHHHHHHHHccCccccChHHHHHHHHH
Confidence 9999986 36899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccCCCC
Q 010304 339 EIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRKLYP 418 (513)
Q Consensus 339 eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~LyP 418 (513)
+|++++++++||++.+++|++||||||||||+.|||+++|+++++++....+.++++++++++|+++.++.|| |++||
T Consensus 228 ~~~~~~~~~~~i~~~l~~~~~i~GfGH~vyk~~DPRa~~L~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~--r~l~p 305 (358)
T cd06118 228 EIGTPENVEAYIWKKLANKRRIMGFGHRVYKTYDPRAKILKELAEELAEEKGDDKLFEIAEELEEIALEVLGE--KGIYP 305 (358)
T ss_pred HhCCchHHHHHHHHHHhcCCeecCCCCCCCCCCCCchHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHHhhcC--CCCCc
Confidence 9999899999999999999999999999999999999999999999976666789999999999999998777 89999
Q ss_pred chhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccc
Q 010304 419 NVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVY 472 (513)
Q Consensus 419 NVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y 472 (513)
|||||+|+++++||||+++|+++|++||++||+|||+||+.++ .||+|||++|
T Consensus 306 Nvd~~~~~l~~~lg~p~~~~~~lf~i~R~~Gw~AH~~Eq~~~~-~~iiRP~~~Y 358 (358)
T cd06118 306 NVDFYSGVVYKALGFPTELFTPLFAVSRAVGWLAHIIEYRENN-QRLIRPRAEY 358 (358)
T ss_pred ChHHHHHHHHHHcCcCHHHHhHHHHHHHHhHHHHHHHHHHhCC-CCccCCcccC
Confidence 9999999999999999999999999999999999999999874 5999999998
No 29
>cd06110 BSuCS-II_like Bacillus subtilis (Bs) citrate synthase (CS)-II_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. This group contains proteins similar to BsCS-II, the major CS of the gram-positive bacterium Bacillus subtilis. A mutation in the gene which encodes BsCS-II (citZ gene) has been described which resulted in a significant loss of CS activity, partial glutamate auxotrophy, and a sporulation deficiency, a
Probab=100.00 E-value=7.7e-98 Score=776.69 Aligned_cols=356 Identities=44% Similarity=0.750 Sum_probs=337.9
Q ss_pred CCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHh
Q 010304 99 PGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQA 178 (513)
Q Consensus 99 pG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~ 178 (513)
|||.|+++++|+||+||+++|+|+|||||++||+++.+||||+||||+|++|+++|++.|...|..++.+|+.+.++++.
T Consensus 1 ~Gl~g~~~~~T~IS~id~~~g~L~yRG~di~dL~~~~~feeva~LL~~G~lP~~~e~~~f~~~l~~~~~~p~~v~~~~~~ 80 (356)
T cd06110 1 KGLEGVIAADSKISYIDGDAGILIYRGYDIHDLAENSTFEEVAYLLWNGELPTAEELDAFKAQLAAERELPAEIIDLLKL 80 (356)
T ss_pred CCCCCCeeeeeeceEEECCCCeEEECCeeHHHHHhcCCHHHHHHHHHcCcCCCHHHHHHHHHhhhhccCCCHHHHHHHHh
Confidence 79999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 010304 179 MPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYSEN 258 (513)
Q Consensus 179 ~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~eN 258 (513)
||+++|||.+|+++++++++++++..+ .+......+++++++++|+|+|++|++..|.++++|+++++|++|
T Consensus 81 ~p~~~~pm~~l~~~v~~l~~~~~~~~~--------~~~~~~~~~a~~lla~~p~i~a~~~~~~~~~~~~~p~~~~~~a~~ 152 (356)
T cd06110 81 LPKDAHPMDVLRTAVSALALYDPEADD--------MSREANLRKAIRLIAKMPTIVAAFHRIRNGLEPVAPDPDLSHAAN 152 (356)
T ss_pred CCCCCCchHHHHHHHHhhhhcCCCccc--------CCHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCCCCCCCCCCHHHH
Confidence 999999999999999999998766531 123444678899999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHH
Q 010304 259 FLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLN 338 (513)
Q Consensus 259 fL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~ 338 (513)
||+|+++ .+|++..+++||++||||||||+|+||||+|+++||++|+|+||+|||+||+||+|||||++|++||+
T Consensus 153 ~l~~l~g-----~~p~~~~~~~l~~~Lvl~aDHg~n~Stfa~Rv~aSt~ad~~~av~agl~al~GplHGgA~~~~~~~l~ 227 (356)
T cd06110 153 FLYMLTG-----EKPSEEAARAFDVALILHADHELNASTFAARVVASTLSDMYSAVTAAIGALKGPLHGGANERVMKMLL 227 (356)
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHhccCCCchhHHHHHHHHhcCCCHHHHHHHHHhhcCCCcccCcHHHHHHHHH
Confidence 9999986 47899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccCCCC
Q 010304 339 EIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRKLYP 418 (513)
Q Consensus 339 eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~LyP 418 (513)
+|++.++++++|++.+++|++||||||||||+.|||+++|+++++++.+..+.++++++++++|+++.++ +|+||
T Consensus 228 ~~~~~~~~~~~v~~~~~~~~~i~GfGH~vy~~~DPRa~~L~~~~~~~~~~~~~~~~~~~~~~ie~~~~~~-----~~l~p 302 (356)
T cd06110 228 EIGSVDNVAAYVKDKLANKEKIMGFGHRVYKTGDPRAKHLREMSRRLGKETGEPKWYEMSEAIEQAMRDE-----KGLNP 302 (356)
T ss_pred HhCCHHHHHHHHHHHHhcCCeecCCCCccCCCCCChHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHc-----cCCCc
Confidence 9999899999999999999999999999999999999999999999976667789999999999998863 89999
Q ss_pred chhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccC
Q 010304 419 NVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTG 474 (513)
Q Consensus 419 NVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G 474 (513)
|||||+|+|+++||||+++||++|+++|++||+|||+||+++ +||+|||++|+|
T Consensus 303 Nvd~~~a~l~~~lg~p~~~~~~lf~i~R~~Gw~AH~~Eq~~~--~~iiRP~~~Y~G 356 (356)
T cd06110 303 NVDFYSASVYYMLGIPVDLFTPIFAISRVSGWCAHILEQYFN--NRLIRPRAEYVG 356 (356)
T ss_pred ChHHHHHHHHHHcCcChhhhhHHHHHHHHHHHHHHHHHHHHc--CCccCCccccCC
Confidence 999999999999999999999999999999999999999985 899999999998
No 30
>TIGR01793 cit_synth_euk citrate (Si)-synthase, eukaryotic. This model includes both mitochondrial and peroxisomal forms of citrate synthase. Citrate synthase is the entry point to the TCA cycle from acetyl-CoA. Peroxisomal forms, such as SP:P08679 from yeast (recognized by the C-terminal targeting motif SKL) act in the glyoxylate cycle. Eukaryotic homologs excluded by the high trusted cutoff of this model include a Tetrahymena thermophila citrate synthase that doubles as a filament protein, a putative citrate synthase from Plasmodium falciparum (no TCA cycle), and a methylcitrate synthase from Aspergillus nidulans.
Probab=100.00 E-value=5.8e-98 Score=787.95 Aligned_cols=362 Identities=28% Similarity=0.433 Sum_probs=326.2
Q ss_pred ecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHh---hcCC------HHHHHHHHHcCCCCCHHHHHHHHHHHhhcCC
Q 010304 97 YDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELA---ESSS------FLEVAYLLMYGNLPSESQLTDWEFAVSQHSA 167 (513)
Q Consensus 97 ~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa---~~~s------FeEva~LL~~G~LPt~~el~~f~~~l~~~~~ 167 (513)
+.+|+.|+.+|.|+||+|||++| |+||||+|+||+ ++++ ||||+||||+|+|||++|+++|+.+|.+++.
T Consensus 39 ~~~Glrgv~~~~t~iS~iD~~~G-l~yRGy~I~dl~~~~~~~~~~~~~~fEev~~LLl~G~lPt~~el~~f~~~L~~~~~ 117 (427)
T TIGR01793 39 VYGGMRGMKGLVWETSVLDPEEG-IRFRGLSIPECQKLLPKAKGGEEPLPEGLLWLLLTGKVPSEEQVDALSAEWRARAD 117 (427)
T ss_pred ccCccCCCcccceeceEEcCCCC-eEECCeeHHHHHHHhccCCccccCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHcCC
Confidence 66899999999999999999998 799999999984 4777 9999999999999999999999999999999
Q ss_pred CcHHHHHHHHhCCCCCChhhHHHHHHHHhhccCCCCCCcc-cCCCcccchhHhHHHHHHHHhhhHHHHHHHHHH--HcCC
Q 010304 168 VPQGILDIIQAMPHDAHPMGVLVSAMSALSIFHPDANPAL-KGQDIYKSKQVRDKQIARILGKAPTIAAAAYLR--MAGR 244 (513)
Q Consensus 168 l~~~v~~~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~-~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~--~~G~ 244 (513)
+|+.+.++|++||++.|||.+|++++++|+++.... ++. .|.+....++...+++++||||+|+|+|++||+ +.|+
T Consensus 118 lp~~v~~~i~~~p~~~hPM~~L~~~vsaL~~~~~f~-~~y~~~~~~~~~~~~~~e~~~~LiAk~P~i~A~~yr~~~~~g~ 196 (427)
T TIGR01793 118 LPEHVYKTIDALPVTLHPMAQFATAVMALQVESEFA-KAYAKGIHKTKYWEYTYEDSMDLIAKLPTVAAYIYRNMYKDGQ 196 (427)
T ss_pred CCHHHHHHHHhCCCCCCHHHHHHHHHHhcccccchh-hhcccCccccccHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999999998764321 110 111100112345778999999999999999995 5688
Q ss_pred CCCCCCCCCCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCC-CChhhHHHHHHhccCCCHHHHHHHHhhcccC
Q 010304 245 PPVLPSNNLSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHE-MNCSTSAARHLASSGVDVYTALAGAVGALYG 323 (513)
Q Consensus 245 ~~~~p~~~lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHe-lN~ST~aaRvvaStgadlyaavaagi~AL~G 323 (513)
+ ++|+++++|++|||+||++ |++..+++||++|||||||| +|+||||+|+||||++|+|+||+|||+||+|
T Consensus 197 ~-i~p~~~l~~a~Nfl~Ml~~-------~~~~~~~~l~~~LiLhADHeg~NaSTfaarvvaSt~ad~y~~v~Agi~aL~G 268 (427)
T TIGR01793 197 S-ISIDDSKDYSANFAHMLGY-------DSPSFQELMRLYLTIHSDHEGGNVSAHTGHLVGSALSDPYLSFAAALNGLAG 268 (427)
T ss_pred c-cCCCCCccHHHHHHHHhcC-------CCHHHHHHHHHHHhhhcccccccchhHHHHHhhccCCCHHHHHHHHHhhccC
Confidence 7 8999999999999999962 68999999999999999999 8999999999999999999999999999999
Q ss_pred CccCChHHHHHHHHHHh----C---CCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHH
Q 010304 324 PLHGGANEAVLKMLNEI----G---TVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIE 396 (513)
Q Consensus 324 PlHGGAneav~~mL~eI----~---~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~ 396 (513)
|+||||||+|++||+++ + +++++++||++.+++|++||||||||||..|||+.+|++++.+.+ +.+++++
T Consensus 269 PlHGgAn~~vl~~l~ei~~~ig~~~s~~~v~~~i~~~l~~g~~i~GfGH~vyr~~DPRa~~l~~~~~~~~---~~~~~~~ 345 (427)
T TIGR01793 269 PLHGLANQEVLLWLKSVVSECGENVTKEQLKDYIWKTLNSGKVVPGYGHAVLRKTDPRYICQREFALKHL---PDDPLFK 345 (427)
T ss_pred CccCCcHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHhCCCcccCCCCCCCCCCCCCcHHHHHHHHHHc---CCChHHH
Confidence 99999999999999996 3 557899999999999999999999999999999999999998753 6789999
Q ss_pred HHHHHHHHHhc--cccccccCCCCchhhHHHHHHHHcCCC-CCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccc
Q 010304 397 VAVALEKAALS--DEYFVKRKLYPNVDFYSGLIYRAMGFP-TEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVY 472 (513)
Q Consensus 397 iA~~lE~~a~~--d~yf~~r~LyPNVDfysg~i~~alGiP-~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y 472 (513)
++.++|+++.+ +++++.+|+|||||||+|+||++|||| .++||+||++||++||+|||+||+.. +.+|+||++.-
T Consensus 346 ~~~~~~~~a~~~l~~~~~~~~~~pNVD~~sg~l~~~lGip~~~~~t~lFavsR~~Gw~AH~ieq~~~-~~~I~RP~s~~ 423 (427)
T TIGR01793 346 LVSNLYKIVPGILTELGKVKNPWPNVDAHSGVLLQYYGLTEARYYTVLFGVSRALGILSQLIWDRAL-GLPLERPKSVS 423 (427)
T ss_pred HHHHHHHHHHHHHHHhhcccCCCCCcHHHHHHHHHHcCCCchhhhhhHhhhhccchHHHHHHHHHHc-CCCccCCcccc
Confidence 99999998865 678889999999999999999999999 69999999999999999999999974 57899999863
No 31
>cd06113 citrate_synt_like_1_2 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) a carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) h
Probab=100.00 E-value=1.4e-97 Score=784.42 Aligned_cols=359 Identities=35% Similarity=0.562 Sum_probs=327.4
Q ss_pred cccceeeeeeeeE------eCC----CCeeEEcccCHHHHhhcC------CHHHHHHHHHcCCCCCHHHHHHHHHHHhhc
Q 010304 102 LNTAPVRSSICYI------DGD----EGILRYRGYPIEELAESS------SFLEVAYLLMYGNLPSESQLTDWEFAVSQH 165 (513)
Q Consensus 102 ~~t~~~~S~IT~I------dg~----~G~L~YRGy~i~eLa~~~------sFeEva~LL~~G~LPt~~el~~f~~~l~~~ 165 (513)
.|+.+|+|+||+| ||+ +|+|+||||+|+||++++ +||||+||||+|+|||++|+++|+++|.++
T Consensus 9 ~gv~~~~t~is~i~~~~~idg~~~~~~G~L~yRGy~I~dLa~~~p~~~~~sFEev~yLLl~G~LPt~~el~~f~~~L~~~ 88 (406)
T cd06113 9 TGVLAGLTNISDVVGYKIIDGEKVPCPGKLYYRGYDVEDLVNGAQKENRFGFEETAYLLLFGYLPNKEELEEFCEILSSY 88 (406)
T ss_pred CceEeecceeeeeeeeeecCCcccCCCCeeeECCCcHHHHHhhcccccCCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHh
Confidence 3577899999999 899 999999999999999886 999999999999999999999999999999
Q ss_pred CCCcHHH-HHHHHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHc--
Q 010304 166 SAVPQGI-LDIIQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMA-- 242 (513)
Q Consensus 166 ~~l~~~v-~~~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~-- 242 (513)
+.+|+.+ ..+++++|. .|||++|++++++|+.++++... .+.+...++++||||++|+|+|++||.+.
T Consensus 89 ~~lp~~~~~~~i~~~p~-~hpM~~L~a~v~~l~~~~~~~~~--------~~~~~~~~~a~rLiA~~p~i~A~~yr~~~~~ 159 (406)
T cd06113 89 RTLPDNFVEDVILKAPS-KDIMNKLQRSVLALYSYDDKPDD--------ISLENVLRQSIQLIARLPTIAVYAYQAKRHY 159 (406)
T ss_pred cCCCHHHHHHHHHhCCC-cCHHHHHHHHHHhccccCCCccc--------CCHHHHHHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 9999986 569999995 89999999999999999876431 12344577889999999999999999643
Q ss_pred --CC--CCCCCCCCCCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCC-CChhhHHHHHHhccCCCHHHHHHHH
Q 010304 243 --GR--PPVLPSNNLSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHE-MNCSTSAARHLASSGVDVYTALAGA 317 (513)
Q Consensus 243 --G~--~~~~p~~~lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHe-lN~ST~aaRvvaStgadlyaavaag 317 (513)
|+ ++.+|++++||++|||+||++. .+|++..+++||++|||||||| +|+||||+|+++||++|+|+||+||
T Consensus 160 ~~~~~~~~~~p~~~ls~a~nfl~ml~g~----~~p~~~~~~~l~~~Lvl~ADHg~~naST~aaRv~aSt~ad~~~avaag 235 (406)
T cd06113 160 YDGESLYIHHPQPELSTAENILSMLRPD----KKYTELEAKLLDLCLVLHAEHGGGNNSTFTTRVVSSSGTDTYSAIAAA 235 (406)
T ss_pred ccCCCccccCCCCCCCHHHHHHHHhccC----CCCCHHHHHHHHHHHhhhhccCCCcchHHHHHHHHccCCCHHHHHHHH
Confidence 44 3678999999999999999852 3689999999999999999999 8999999999999999999999999
Q ss_pred hhcccCCccCChHHHHHHHHHHhC-------CCCCHHHHHHHHHhcC-----CcccccCCCCCCCCCchHHHHHHHHHHH
Q 010304 318 VGALYGPLHGGANEAVLKMLNEIG-------TVENIPEFIEGVKNRK-----RKMSGFGHRVYKNYDPRAKVIRKLAEEV 385 (513)
Q Consensus 318 i~AL~GPlHGGAneav~~mL~eI~-------~~~~i~~~i~~~~~~~-----~rl~GFGHrVYk~~DPRA~iL~~~a~~l 385 (513)
|+||+||+||||||+|++||++|+ +++++++||+++++++ ++||||||||||+.|||+++|+++++++
T Consensus 236 i~al~GplHGGA~e~v~~~l~~i~~~~~~~~~~~~v~~~v~~~l~~~~~~~~~~l~GFGHrvyk~~DPRa~~L~~~~~~l 315 (406)
T cd06113 236 IGSLKGPRHGGANIKVMEMLEDIKENVKDWTDEDEVRAYLRKILNKEAFDKSGLIYGMGHAVYTLSDPRAVVLKKYARSL 315 (406)
T ss_pred HHHccCccccChHHHHHHHHHHHHhhccCCCCHHHHHHHHHHHHhccccccCceeecCCCCCCCCCCccHHHHHHHHHHH
Confidence 999999999999999999999996 3678999999998776 5999999999999999999999999999
Q ss_pred HHHhCCCcHHHHHHHHHHHHhc---cccccccCCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCC
Q 010304 386 FSIVGRDPLIEVAVALEKAALS---DEYFVKRKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPD 462 (513)
Q Consensus 386 ~~~~~~~~ll~iA~~lE~~a~~---d~yf~~r~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~ 462 (513)
.+..+.++++++++++|+++.+ ++||+.|++|||||||+|+|+++||||+++||++|+++|++||+|||+||+.+ +
T Consensus 316 ~~~~~~~~~~~~~~~ie~~~~~~~~~~~~~~r~l~pNvD~~sa~l~~~lG~p~~~~t~lF~isR~~Gw~AH~~Eq~~~-~ 394 (406)
T cd06113 316 AKEKGREEEFALYERIERLAPEVIAEERGIGKTVCANVDFYSGFVYKMLGIPQELYTPLFAVARIVGWCAHRIEELLN-S 394 (406)
T ss_pred HHhcCcchHHHHHHHHHHHHHHHHHHhhccCCCCCCChHHHHHHHHHHcCCChhhhhhHHHHHhHHHHHHHHHHHHhc-C
Confidence 8777777899999999998754 67899999999999999999999999999999999999999999999999865 4
Q ss_pred CCccCCcccccC
Q 010304 463 TKIMRPQQVYTG 474 (513)
Q Consensus 463 ~ki~RPr~~Y~G 474 (513)
++|+|||+.|+|
T Consensus 395 ~~l~RP~~~Y~G 406 (406)
T cd06113 395 GRIIRPAYKYVG 406 (406)
T ss_pred CceeccccccCC
Confidence 899999999998
No 32
>PF00285 Citrate_synt: Citrate synthase; InterPro: IPR002020 Citrate synthase 2.3.3.1 from EC is a member of a small family of enzymes that can directly form a carbon-carbon bond without the presence of metal ion cofactors. It catalyses the first reaction in the Krebs' cycle, namely the conversion of oxaloacetate and acetyl-coenzyme A into citrate and coenzyme A. This reaction is important for energy generation and for carbon assimilation. The reaction proceeds via a non-covalently bound citryl-coenzyme A intermediate in a 2-step process (aldol-Claisen condensation followed by the hydrolysis of citryl-CoA). Citrate synthase enzymes are found in two distinct structural types: type I enzymes (found in eukaryotes, Gram-positive bacteria and archaea) form homodimers and have shorter sequences than type II enzymes, which are found in Gram-negative bacteria and are hexameric in structure. In both types, the monomer is composed of two domains: a large alpha-helical domain consisting of two structural repeats, where the second repeat is interrupted by a small alpha-helical domain. The cleft between these domains forms the active site, where both citrate and acetyl-coenzyme A bind. The enzyme undergoes a conformational change upon binding of the oxaloacetate ligand, whereby the active site cleft closes over in order to form the acetyl-CoA binding site []. The energy required for domain closure comes from the interaction of the enzyme with the substrate. Type II enzymes possess an extra N-terminal beta-sheet domain, and some type II enzymes are allosterically inhibited by NADH []. This entry represents types I and II citrate synthase enzymes, as well as the related enzymes 2-methylcitrate synthase and ATP citrate synthase. 2-methylcitrate (2.3.3.5 from EC) synthase catalyses the conversion of oxaloacetate and propanoyl-CoA into (2R,3S)-2-hydroxybutane-1,2,3-tricarboxylate and coenzyme A. This enzyme is induced during bacterial growth on propionate, while type II hexameric citrate synthase is constitutive []. ATP citrate synthase (2.3.3.8 from EC) (also known as ATP citrate lyase) catalyses the MgATP-dependent, CoA-dependent cleavage of citrate into oxaloacetate and acetyl-CoA, a key step in the reductive tricarboxylic acid pathway of CO2 assimilation used by a variety of autotrophic bacteria and archaea to fix carbon dioxide []. ATP citrate synthase is composed of two distinct subunits. In eukaryotes, ATP citrate synthase is a homotetramer of a single large polypeptide, and is used to produce cytosolic acetyl-CoA from mitochondrial produced citrate [].; GO: 0046912 transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer, 0044262 cellular carbohydrate metabolic process; PDB: 2C6X_D 3L96_B 1OWB_B 1NXG_A 1K3P_A 1OWC_B 3L97_B 1NXE_A 3L98_A 3L99_A ....
Probab=100.00 E-value=9.8e-98 Score=776.43 Aligned_cols=355 Identities=49% Similarity=0.833 Sum_probs=310.6
Q ss_pred CCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHhC
Q 010304 100 GYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQAM 179 (513)
Q Consensus 100 G~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~~ 179 (513)
||.||++++|+||+|||++|+|+||||+|+||+++++||||+||||+|+|||++|+++|+.++.+++.+|+.+.++++++
T Consensus 1 Gl~gv~v~~T~Is~id~~~G~L~YRGy~i~dL~~~~sfeeva~LL~~g~lP~~~el~~f~~~l~~~~~lpe~v~~~i~~l 80 (356)
T PF00285_consen 1 GLRGVPVCETSISFIDGEKGILRYRGYDIEDLAENASFEEVAYLLWYGELPTAEELEEFSAELKERRALPEEVIEVIEAL 80 (356)
T ss_dssp GGTTEEEEEESSEEEETTTTEEEETTEEHHHHHHHSBHHHHHHHHHHSS--BHHHHHHHHHHHHCTTS--HHHHHHHHCS
T ss_pred CCCCCeEeeeeCeEEeCCCCEEEEcCeEHHHHHhcCCHHHHHHHHHhccCCChhhhccchhHHHhhcchhHHHHHHHhhc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHHHHHHhhccCCC-CCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 010304 180 PHDAHPMGVLVSAMSALSIFHPD-ANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYSEN 258 (513)
Q Consensus 180 p~~~hPm~~l~a~v~al~~~~~~-~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~eN 258 (513)
|+++|||.+|++++++|++++++ .. ..+.+...++++++++++|+|+|++|++..|+++.+|+.+++|++|
T Consensus 81 p~~~~pm~~L~~~vs~l~~~~~~~~~--------~~~~~~~~~~~~~liA~~p~i~a~~~~~~~g~~~~~p~~~~~~~~n 152 (356)
T PF00285_consen 81 PRDAHPMDVLRAAVSALSAFDPDPLY--------DNSPEDVLEDAIRLIAKIPTIVAAIYRHRRGQPPIPPDPDLSYAEN 152 (356)
T ss_dssp TTTS-HHHHHHHHHHHHHHHSTTGTC--------TTSHHHHHHHHHHHHHHHHHHHHHHHHHHTTS------TTSSHHHH
T ss_pred CCCCCchHHHHHHHhhhhhhhhcccc--------ccchhHHHHHHHHHhhcchHHHHHHHHHhCCCCccccccchHHHHH
Confidence 99999999999999999999887 21 1245666889999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHH
Q 010304 259 FLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLN 338 (513)
Q Consensus 259 fL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~ 338 (513)
|++|++.. +.+|+|..+++||++||||||||+|+||||+|+++||++|+|+||+|||+||+||+||||+++|++||+
T Consensus 153 ~l~~l~~~---g~~p~~~~~~~l~~~lvl~aDH~~~~St~aaR~~aSt~~~~~~av~agl~al~G~~hgga~~~~~~~l~ 229 (356)
T PF00285_consen 153 FLYMLGVT---GREPDPEEARALDAALVLHADHGLNPSTFAARVAASTGADLYSAVAAGLAALSGPLHGGANEAAMRMLQ 229 (356)
T ss_dssp HHHHHH-H---SSB--HHHHHHHHHHHHHHS--SSSHHHHHHHHHHTTT--HHHHHHHHHHHHCSTTTTTHHHHHHHHHH
T ss_pred HHHHhhcc---ccCCChHHHHHHHHHHHhhcCCCCCccchhhhhhhccCcchhHHHHhhhhhccCcccccccHHHHHHHH
Confidence 99999532 246899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccCCCC
Q 010304 339 EIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRKLYP 418 (513)
Q Consensus 339 eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~LyP 418 (513)
+|+++++++++|++++++|++||||||||||+.|||+++|+++++++.++.+.++++++++++|+++.++ |++||+||
T Consensus 230 ~i~~~~~~~~~v~~~l~~~~~i~GfGH~vy~~~DPRa~~l~~~~~~~~~~~~~~~~~~~~~~ie~~~~~~--~~~~~l~p 307 (356)
T PF00285_consen 230 EIGSPENVEEYVEERLAKGERIPGFGHRVYKNGDPRAEALLALARELGEEFPDGPLVELAEAIEEAAPED--FKERKLYP 307 (356)
T ss_dssp HHSSGGGHHHHHHHHHHTTSTTTTBCESSSSS--HHHHHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHH--HHHHTESB
T ss_pred HHHhhHHHHHHHHHHHhccccccccCCCcCCCCCCChHHHHHHHHHhhhccCCCHHHHHHHHHHHHHHHH--HhhccccC
Confidence 9999999999999999999999999999999999999999999999987777789999999999999886 78899999
Q ss_pred chhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCC
Q 010304 419 NVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRP 468 (513)
Q Consensus 419 NVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RP 468 (513)
|||||+|+|+++||||+++++++|+++|++||+|||+||+. .+++|+||
T Consensus 308 Nvd~~~a~l~~~lG~p~~~~~~if~~~R~~Gw~AH~~Eq~~-~~~~i~RP 356 (356)
T PF00285_consen 308 NVDFYSAALLRALGFPPELFTAIFALSRTAGWIAHILEQRQ-LNNKIIRP 356 (356)
T ss_dssp -THHHHHHHHHHTT--GGGHHHHHHHHHHHHHHHHHHHHHH-CT------
T ss_pred chhhHHHHHHHHHhcchhhchHHHHHHHHHHHHHHHHHHHh-cCCCCCCc
Confidence 99999999999999999999999999999999999999998 46899998
No 33
>cd06101 citrate_synt Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the
Probab=100.00 E-value=1.4e-83 Score=645.18 Aligned_cols=263 Identities=58% Similarity=0.940 Sum_probs=252.6
Q ss_pred CCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHh
Q 010304 99 PGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQA 178 (513)
Q Consensus 99 pG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~ 178 (513)
|||.||++|+|+||+||+++|.|+||||||+||++++||+||+||||+|+||
T Consensus 1 ~gl~~~~~~~t~is~id~~~g~l~yRGy~i~dL~~~~~f~ev~~LL~~G~lP---------------------------- 52 (265)
T cd06101 1 PGLRGVAALESEISVIDGDEGGLRYRGYPIEELAENSSFEEVAYLLLTGELP---------------------------- 52 (265)
T ss_pred CCCCCcceeeeEEEEEeCCCCEEEECCeeHHHHHhcCCHHHHHHHHHcCCCC----------------------------
Confidence 7999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 010304 179 MPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYSEN 258 (513)
Q Consensus 179 ~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~eN 258 (513)
+|++|
T Consensus 53 ---------------------------------------------------------------------------~~~~n 57 (265)
T cd06101 53 ---------------------------------------------------------------------------SYAEN 57 (265)
T ss_pred ---------------------------------------------------------------------------cHHHH
Confidence 89999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHH
Q 010304 259 FLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLN 338 (513)
Q Consensus 259 fL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~ 338 (513)
||+|+++. +|++.++++||++||||||||+|+||||+|+++||++|+|+||+|||++|+||+||||+++|++||+
T Consensus 58 fl~m~~g~-----~p~~~~~~~l~~~Lvl~aDHg~naST~aaRv~aSt~ad~~~av~agl~al~Gp~HGGA~e~~~~~l~ 132 (265)
T cd06101 58 FLYMLGGE-----EPDPEFAKAMDLALILHADHEGNASTFTARVVGSTLSDPYSAIAAAIAALKGPLHGGANEAVLKMLE 132 (265)
T ss_pred HHHHhcCC-----CCCHHHHHHHHHHHhhhcCCCCchHHHHHHHHHccCCcHHHHHHHHHHhCCCCCcCCHHHHHHHHHH
Confidence 99999863 7899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCC--CCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccCC
Q 010304 339 EIGTV--ENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRKL 416 (513)
Q Consensus 339 eI~~~--~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~L 416 (513)
+|++. ++++++|++.+++|++||||||||||+.|||+++|+++++++....+.++++++++++|+++.++.|| |++
T Consensus 133 ~i~~~~~~~~~~~v~~~~~~~~~i~GFGH~vy~~~DPRa~~L~~~~~~l~~~~~~~~~~~~a~~~e~~~~~~~~~--k~l 210 (265)
T cd06101 133 EIGTPKNEPAEAYIRKKLNSKRVLMGFGHRVYKKYDPRATVLKKFAEKLLKEKGLDPMFELAAELEKIAPEVLYE--KKL 210 (265)
T ss_pred HhCccccccHHHHHHHHHhcCCCccCCCCCCCCCCCCChHHHHHHHHHHHHhhCCCHHHHHHHHHHHHHHHHhhc--cCC
Confidence 99987 89999999999999999999999999999999999999999977666789999999999999887766 899
Q ss_pred CCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccc
Q 010304 417 YPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVY 472 (513)
Q Consensus 417 yPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y 472 (513)
|||||||+|+|+++||||+++|+++|+++|++||+|||+||+.++ .+|+|||++|
T Consensus 211 ~pNvd~~~a~v~~~lG~p~~~~~~lf~i~R~~Gw~AH~~Eq~~~~-~~i~RP~~~Y 265 (265)
T cd06101 211 YPNVDFYSGVLYKAMGFPTELFTPLFAVSRAVGWLAHLIEQREDG-QRIIRPRAEY 265 (265)
T ss_pred CCChHHHHHHHHHHhCCChHhhhhHHHHHhHhHHHHHHHHHHhcC-CCccCCCccC
Confidence 999999999999999999999999999999999999999999864 5999999998
No 34
>KOG2617 consensus Citrate synthase [Energy production and conversion]
Probab=100.00 E-value=3.9e-83 Score=651.79 Aligned_cols=443 Identities=40% Similarity=0.588 Sum_probs=401.5
Q ss_pred HHhhhcCCCcccccccccccccCCCCCCCCCCCCccEEEEeccCCeEEEeeeeeCCCcchhhhhhhhcCCCCcceeeecC
Q 010304 20 LTAHLASTESNQGRLIEPWCTSAQSMVPPPGNLKGSLTVVDERTGKRYQIPVSQEGTVKATDFKKITTGKNDKGLKLYDP 99 (513)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~r~g~~~~~pi~~~~~~~a~di~~l~~~~~~~g~~~~dp 99 (513)
+++||..+.. ...+..++.+. .. . ..|+.|++++.+++++|.-|+.+.|++..++|+++...-.+.++..+|+
T Consensus 2 ~~~~l~~~~~--~~~~~~~~~~~--~~-~--~LK~~l~~~ip~~~~~~k~~~~ehG~vg~v~i~~i~gGmrg~~~~~~e~ 74 (458)
T KOG2617|consen 2 LSRHLSVSQV--LPAIENWCASI--SA-A--TLKGNLAIVIPRTGDEYKKFVSEHGTVGNVTLKKIYGGMRGKGLLLWET 74 (458)
T ss_pred chhhhccccc--ccccccccccc--cc-c--cHHHHHHhhChhhHHHhhhhHhhcCcccceeHHHhhcccCCCCceeecC
Confidence 4566665522 23345555221 11 1 2689999999999999999999988999999999987666678889999
Q ss_pred CCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHhC
Q 010304 100 GYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQAM 179 (513)
Q Consensus 100 G~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~~ 179 (513)
++.++. +.|.|+++..++++||++++++.+|. ++|+++|||++|++||++|+++|+.+|.+++.+|+.+.++|+++
T Consensus 75 s~Ld~~---~gI~frg~~i~e~q~~lp~~~~~~e~-lpe~~~wLL~tG~vPt~~Q~~~~~~~~a~rs~vP~~v~~~idsm 150 (458)
T KOG2617|consen 75 SVLDPE---EGIRFRGGDIPECQKRLPPAEEGAEP-LPEELFWLLLTGNVPTQSQVAALSFELAQRSAVPQGVLDMIDSM 150 (458)
T ss_pred cccchh---hCeeecCCCHHHHHhhCCCCccCCcC-CHHHHHHHHHhCCCCCHHHHHHHHHHHHHhccccHHHHHHHHhC
Confidence 999987 89999999999999999999999998 99999999999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 010304 180 PHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYSENF 259 (513)
Q Consensus 180 p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~eNf 259 (513)
|.+.|||..+.+++++|..+++.+++...|.+.++.+..+++++++||||.|+|||.+|++..+.+...|+.+++|++||
T Consensus 151 P~d~HPM~q~~~a~~al~~~s~fa~ay~~G~~k~~yw~~~~ed~l~Liak~p~iAa~iY~~~~~dg~~~~~~~~dys~Nf 230 (458)
T KOG2617|consen 151 PKDLHPMAQLAAAVLALKIFSPFAKAYLRGIGKYKYWQYTYEDCLVLIAKLPTIAAAIYRNIYADGIPKPDPNLDYSANF 230 (458)
T ss_pred CcccchHHHHHHHHHhccccccchhhhhhccchhhcccccHHHHHHHHHhccHHHHHHHHHHhcCCCCCCCcccchhHhH
Confidence 99999999999999999999999999888988887888889999999999999999999999999988899999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHH-
Q 010304 260 LYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLN- 338 (513)
Q Consensus 260 L~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~- 338 (513)
++|+.. .+|.++++||.++++|||||+||+|.++++..+|+-|||.+++||+++|.||+||+|||+|++||.
T Consensus 231 ~~mlg~-------~~~~f~~lmrly~~iHadHE~gnVsAh~~HLvGSaldpyls~aa~~~GLaGPLHGlAnqEvl~~L~~ 303 (458)
T KOG2617|consen 231 ARMLGS-------RQPDFAQLMRLYVGIHADHEGGNVSAHTGHLVGSALDPYLSFAAGMNGLAGPLHGLANQEVLRFLGK 303 (458)
T ss_pred HHHHcc-------CChHHHHHHHHeeeeecccccCcHHHHhccccccccchhHHHHHhhcccccccccCchHHHHHHHHH
Confidence 999975 358999999999999999999887777776555445999999999999999999999999999998
Q ss_pred ---HhC---CCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHH--hcccc
Q 010304 339 ---EIG---TVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAA--LSDEY 410 (513)
Q Consensus 339 ---eI~---~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a--~~d~y 410 (513)
||+ +.+++++||++.++.|+++|||||+||+++|||.+++++++.+. +++||+++++..|++++ .-++|
T Consensus 304 ~~~Eig~~~s~e~ikeyiw~~ln~~rvvpGyGHavlr~tDPR~~~~~efA~k~---~~~d~l~~l~~~l~~~~p~vl~e~ 380 (458)
T KOG2617|consen 304 LIEEIGKDLSKENIKEYIWKTLNSGRVVPGYGHAVLRKTDPRYKVQREFALKH---LPDDPLFLLVSALYKIAPGVLTEH 380 (458)
T ss_pred hHHHhccccchhhhhHhhHHhhcccccccccccccccCCCchhhHHHHHHHhc---CCCCcchhhhHHHHHhChHHHHHh
Confidence 888 67899999999999999999999999999999999999999887 47899999999999999 56899
Q ss_pred ccccCCCCchhhHHHHHHHHcCCCCCch-hhHhhhhhhhhhHHH--HHhhhcCCCCCccCCcccccCCCCccccccccc
Q 010304 411 FVKRKLYPNVDFYSGLIYRAMGFPTEFF-PVLFAIPRMAGYLAH--WRESLDDPDTKIMRPQQVYTGVWMRHYMPLKER 486 (513)
Q Consensus 411 f~~r~LyPNVDfysg~i~~alGiP~~~~-t~lFai~R~~GwiAH--~~Eq~~~~~~ki~RPr~~Y~G~~~r~~~p~~~R 486 (513)
|+.||+|||||++||++++++|++...| |+||+++|++|.++| |.+.+..| |.||.+.|++...+.+.++++|
T Consensus 381 gk~knp~PNVD~~SGvll~~yGl~e~~fyTVLFgVsRa~Gvlsqliw~ralg~p---ieRPks~~t~~~~~~~~~~~~~ 456 (458)
T KOG2617|consen 381 GKVKNPYPNVDAHSGVLLQYYGLPELFFYTVLFGVSRALGVLSQLIWDRALGLP---IERPKSVSTDWLHRFTNMVRER 456 (458)
T ss_pred cccCCCCCcHHHHHHHHHHhcCCcHHHHHHHHHHHhhhHHHHHHHHHHHHhCCc---ccCccccchHHHHHHHHHhhcc
Confidence 9999999999999999999999997766 999999999999999 99999765 9999999999999988887665
No 35
>cd06102 citrate_synt_like_2 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and
Probab=100.00 E-value=4.1e-74 Score=579.36 Aligned_cols=272 Identities=34% Similarity=0.463 Sum_probs=244.5
Q ss_pred eeeecCCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHH
Q 010304 94 LKLYDPGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGIL 173 (513)
Q Consensus 94 ~~~~dpG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~ 173 (513)
-.+.++| +++++|+||.|+. |.|+|||||+.||+++.|||||++|||.|++|
T Consensus 11 ~~~~~~g---~~~~~t~It~i~~--~~~~yRG~da~~L~~~~~~e~va~LLw~g~~~----------------------- 62 (282)
T cd06102 11 AAALDWG---EPVLESAITLITE--GRLFYRGRDAVELAETATLEEVAALLWDGDEA----------------------- 62 (282)
T ss_pred ccccccC---CceEEeeeEEEeC--CeeEEcCccHHHHHhcCCHHHHHHHHHcCCch-----------------------
Confidence 3456666 8999999999985 57999999999999999999999999999998
Q ss_pred HHHHhCCCCCChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCC
Q 010304 174 DIIQAMPHDAHPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNL 253 (513)
Q Consensus 174 ~~i~~~p~~~hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~l 253 (513)
. .+++++ +++.- + .+..+.
T Consensus 63 -------------~----------------------------------~~l~~~------~~~~~----~----~~~~~~ 81 (282)
T cd06102 63 -------------A----------------------------------RLLRLL------AAALL----G----AAPSDA 81 (282)
T ss_pred -------------H----------------------------------HHHHHH------HHHhc----c----CCCCcc
Confidence 0 112222 22211 1 233467
Q ss_pred CHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHH
Q 010304 254 SYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAV 333 (513)
Q Consensus 254 sy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav 333 (513)
++.+||++|+++ ++..+++||++||||||||+|+|||++|+++||++|+|+||+|||++|+||+||||++.|
T Consensus 82 ~~~~~~~~~~~~--------~~~~~~~l~~~LVL~ADHgln~St~aaRv~AStgadl~~avaagl~al~Gp~HGGA~~~a 153 (282)
T cd06102 82 PVHRRLARAWGL--------DPAAADLLRRALVLLADHELNASTFAARVAASTGASLYAAVLAGLAALSGPRHGGATARV 153 (282)
T ss_pred cHHHHHHHHhcC--------CHHHHHHHHHHHHHHhccCCCcHHHHHHHHhccCCcHHHHHHHHHHhCCCCCccCHHHHH
Confidence 999999999964 568899999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccc
Q 010304 334 LKMLNEIGTVENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVK 413 (513)
Q Consensus 334 ~~mL~eI~~~~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~ 413 (513)
++||+++.+.++++++|++.+++|++||||||||||+.|||+++|+++++++.. +++++++++|+++.+ .
T Consensus 154 ~~~l~e~~~~~~~~~~v~~~l~~g~~ipGFGH~vy~~~DPRa~~L~~~~~~~~~-----~~~~~a~~ve~~~~~-----~ 223 (282)
T cd06102 154 EALLDEALRAGDAEAAVRERLRRGEALPGFGHPLYPDGDPRAAALLAALRPLGP-----AAPPAARALIEAARA-----L 223 (282)
T ss_pred HHHHHHhcCCccHHHHHHHHHHcCCcccCCCCCCCCCCCccHHHHHHHHHHHhh-----HHHHHHHHHHHHHHH-----H
Confidence 999999999889999999999999999999999999999999999999998752 899999999998875 4
Q ss_pred cCCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccccC
Q 010304 414 RKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVYTG 474 (513)
Q Consensus 414 r~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y~G 474 (513)
+|++||||||+++|++.||||+++++++|+++|++||+|||+||+.+ ++++|||++|+|
T Consensus 224 ~gl~pNvD~a~a~l~~~lG~p~~~~~~lF~~~R~~GwiAH~~Eq~~~--~~liRP~~~Y~G 282 (282)
T cd06102 224 TGARPNIDFALAALTRALGLPAGAAFALFALGRSAGWIAHALEQRAQ--GKLIRPRARYVG 282 (282)
T ss_pred HCCCCChHHHHHHHHHHcCCChhhcchHHHHHHHHHHHHHHHHHHhc--CCCcCCCcccCC
Confidence 79999999999999999999999999999999999999999999985 799999999998
No 36
>cd06099 CS_ACL-C_CCL Citrate synthase (CS), citryl-CoA lyase (CCL), the C-terminal portion of the single-subunit type ATP-citrate lyase (ACL) and the C-terminal portion of the large subunit of the two-subunit type ACL. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) from citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. Some CS proteins function as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. CCL cleaves citryl-CoA (CiCoA) to AcCoA and OAA. ACLs catalyze an ATP- and a CoA- dependant cleavage of citrate to form AcCoA and OAA; they do this in a multistep reaction, the final step of which is likely to involve the cleavage of CiCoA to generate AcCoA and OAA. The overall CS reaction is thought to proceed through three partial reactions and i
Probab=100.00 E-value=2.3e-65 Score=498.56 Aligned_cols=211 Identities=58% Similarity=0.945 Sum_probs=200.7
Q ss_pred CHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHH
Q 010304 254 SYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAV 333 (513)
Q Consensus 254 sy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav 333 (513)
||++|||+|+++ .+|++.++++||++||||||||+|+||||+|+++||++|+|+||+|||++++||+||||+++|
T Consensus 1 ~~~~~fl~ml~g-----~~p~~~~~~~l~~~lvl~aDHg~~~St~aar~~aSt~ad~~~av~Agl~al~Gp~hGGa~~~a 75 (213)
T cd06099 1 SYAENFLYMLGG-----EEPDPEFARAMDLALILHADHEGNASTFTARVVGSTGSDPYSAIAAAIGALKGPLHGGANEAV 75 (213)
T ss_pred CHHHHHHHHhcC-----CCCCHHHHHHHHHHHHHhcCCCCchhhHHHHHHhccCCCHHHHHHHHHHHcCCCCcCCHHHHH
Confidence 699999999987 379999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCC--CCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccc
Q 010304 334 LKMLNEIGTV--ENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYF 411 (513)
Q Consensus 334 ~~mL~eI~~~--~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf 411 (513)
++||+++++. ++++++|++.+++|++||||||||||+.|||+++|+++++++....+.+++++++++||+++.++.|+
T Consensus 76 ~~~l~e~~~~~~~~~~~~v~~~~~~~~~ipGFGH~vy~~~DPRa~~L~~~~~~l~~~~~~~~~~~~a~~le~~~~~~~~~ 155 (213)
T cd06099 76 LKMLEEIGTPKNEPAEAYIRKKLESKRVIMGFGHRVYKKYDPRATVLKKFAEELLKEDGDDPMFELAAELEKIAEEVLYE 155 (213)
T ss_pred HHHHHHhCCcccccHHHHHHHHHhCCCcccCCCCCCCCCCCcchHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhc
Confidence 9999999887 78999999999999999999999999999999999999999976655679999999999999887765
Q ss_pred cccCCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCcccc
Q 010304 412 VKRKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQQVY 472 (513)
Q Consensus 412 ~~r~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr~~Y 472 (513)
|+++||||||+|++++.||||+++++++|+++|++||+|||+||+.++ .+|+||+++|
T Consensus 156 --r~l~~Nvd~~~a~l~~~lG~p~~~~~~lf~~~R~~Gw~AH~~Eq~~~~-~~l~RP~~~Y 213 (213)
T cd06099 156 --KKLYPNVDFYSGVLYKAMGFPTELFTPLFAVARAVGWLAHLIEQLEDN-FKIIRPRSEY 213 (213)
T ss_pred --cCCCCChHHHHHHHHHHcCcCHHhhhHHHHHHHHHHHHHHHHHHHhCC-CCccCCcccC
Confidence 899999999999999999999999999999999999999999999863 5999999998
No 37
>PRK06224 citrate synthase; Provisional
Probab=100.00 E-value=3e-62 Score=490.68 Aligned_cols=243 Identities=33% Similarity=0.457 Sum_probs=216.4
Q ss_pred cceeeeeeeeEeCCCCeeEEcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCCCcHHHHHHHHhCCCCC
Q 010304 104 TAPVRSSICYIDGDEGILRYRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSAVPQGILDIIQAMPHDA 183 (513)
Q Consensus 104 t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~l~~~v~~~i~~~p~~~ 183 (513)
+.-++|+||+||+++ |+|||||++||+++.+|+|++||||+|++|+++|++
T Consensus 6 ~~~~~T~i~~~~~~~--l~yrG~~~~dL~~~~sf~e~~~lll~G~lP~~~e~r--------------------------- 56 (263)
T PRK06224 6 TKWWRTSISDVTPEE--IYVRGYDLEDLIGKLSFTDMIFLLLRGRLPTPNEAR--------------------------- 56 (263)
T ss_pred CCCCceeeeeecCCe--eEECCccHHHHhhcCCHHHHHHHHHcCCCCCHHHHH---------------------------
Confidence 457899999999864 999999999999999999999999999998876632
Q ss_pred ChhhHHHHHHHHhhccCCCCCCcccCCCcccchhHhHHHHHHHHhhhHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 010304 184 HPMGVLVSAMSALSIFHPDANPALKGQDIYKSKQVRDKQIARILGKAPTIAAAAYLRMAGRPPVLPSNNLSYSENFLYML 263 (513)
Q Consensus 184 hPm~~l~a~v~al~~~~~~~~pa~~g~~~~~~~~~~~~~~~rliak~ptiaA~~y~~~~G~~~~~p~~~lsy~eNfL~ml 263 (513)
T Consensus 57 -------------------------------------------------------------------------------- 56 (263)
T PRK06224 57 -------------------------------------------------------------------------------- 56 (263)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHhcCCCCChhhHHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHHHhCC-
Q 010304 264 DSLGNRAYKPNPRLARVLDVLFILHAEHEMNCSTSAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLNEIGT- 342 (513)
Q Consensus 264 ~~~~~~~~~p~p~~~~~Ld~~LILhADHelN~ST~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~eI~~- 342 (513)
+|+.+||++||||+|+|||++|+++||++|+|+||+|||+++ ||+||||+++|++||++++.
T Consensus 57 ----------------~f~a~Lv~~adHg~~~St~aar~~ast~~~l~~av~agl~a~-G~~hgGa~~~a~~~l~e~~~~ 119 (263)
T PRK06224 57 ----------------LLDAVLVALVDHGLTPSAAAARMTASGGESLQGAVAAGLLAL-GSVHGGAGEQAAELLQEIAAA 119 (263)
T ss_pred ----------------HHHHHHHHHhccCCCcHHHHHHHHHhcCccHHHHHHHHHhhc-ccccCChhHHHHHHHHHHHhh
Confidence 344557889999999999999999999999999999999999 99999999999999999862
Q ss_pred ------C-CCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccC
Q 010304 343 ------V-ENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRK 415 (513)
Q Consensus 343 ------~-~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~ 415 (513)
. ++++++|++.++++++||||||||||..|||+++|+++++++. ..+++++++++||+++.+. +.|+
T Consensus 120 ~~~~~~~~~~~~~~v~~~~~~~~~ipGFGH~~y~~~DPRa~~L~~~~~~~~---~~~~~~~~a~~~~~~~~~~---~~~~ 193 (263)
T PRK06224 120 ADAGADLDAAARAIVAEYRAAGKRVPGFGHPLHKPVDPRAPRLLALAREAG---VAGRHCRLAEALEAALAAA---KGKP 193 (263)
T ss_pred ccccccHHHHHHHHHHHHHHcCCCcCCCCCCCCCCCCchHHHHHHHHHHhc---cCCHHHHHHHHHHHHHHHh---cCCC
Confidence 2 3577899999999999999999999999999999999999874 2468999999999987652 3477
Q ss_pred CCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCc------ccccCCCCccc
Q 010304 416 LYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQ------QVYTGVWMRHY 480 (513)
Q Consensus 416 LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr------~~Y~G~~~r~~ 480 (513)
++||||||+|+|++.||||+++|++||+++|++||+|||+||+.++ +++||+ ..|+|+.+|+.
T Consensus 194 l~~Nvd~~~a~l~~~lG~p~~~~~~lf~~~R~~G~~AH~~Eq~~~~--~~~r~~~~~~~~~~Y~G~~~r~~ 262 (263)
T PRK06224 194 LPLNVDGAIAAILADLGFPPALARGLFVISRAAGLVAHVWEELQQP--IGFRIWDPAEEAVEYTGPPPREL 262 (263)
T ss_pred CCccHHHHHHHHHHHcCCChHHHhHHHHHHHHHHHHHHHHHHHhCC--CCcCCCCChhhcceecCCCCCCC
Confidence 9999999999999999999999999999999999999999999864 445554 89999988764
No 38
>cd06100 CCL_ACL-C Citryl-CoA lyase (CCL), the C-terminal portion of the single-subunit type ATP-citrate lyase (ACL) and the C-terminal portion of the large subunit of the two-subunit type ACL. CCL cleaves citryl-CoA (CiCoA) to acetyl-CoA (AcCoA) and oxaloacetate (OAA). ACL catalyzes an ATP- and a CoA- dependant cleavage of citrate to form AcCoA and OAA in a multistep reaction, the final step of which is likely to involve the cleavage of CiCoA to generate AcCoA and OAA. In fungi, yeast, plants, and animals ACL is cytosolic and generates AcCoA for lipogenesis. ACL may be required for fruiting body maturation in the filamentous fungus Sordaria macrospore. In several groups of autotrophic prokaryotes and archaea, ACL carries out the citrate-cleavage reaction of the reductive tricarboxylic acid (rTCA) cycle. In the family Aquificaceae this latter reaction in the rTCA cycle is carried out via a two enzyme system the second enzyme of which is CCL; the first enzyme is citryl-CoA synthetase (CC
Probab=100.00 E-value=8.2e-54 Score=421.22 Aligned_cols=204 Identities=31% Similarity=0.440 Sum_probs=189.4
Q ss_pred CCCHHHHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCC-ChhhHHHHHHhccC-CCHHHHHHHHhhcccCCccCCh
Q 010304 252 NLSYSENFLYMLDSLGNRAYKPNPRLARVLDVLFILHAEHEM-NCSTSAARHLASSG-VDVYTALAGAVGALYGPLHGGA 329 (513)
Q Consensus 252 ~lsy~eNfL~ml~~~~~~~~~p~p~~~~~Ld~~LILhADHel-N~ST~aaRvvaStg-adlyaavaagi~AL~GPlHGGA 329 (513)
+.+|.+||++|+++ ..|++.+.++||.+||++||||+ |+|||++|+++||+ +|+|+||+||++++ ||+||||
T Consensus 10 ~~sf~e~~~lml~G-----~~P~~~e~~~f~~~Lvl~adhg~~~~St~aar~~astg~~~~~~~vaag~~a~-G~~hgga 83 (227)
T cd06100 10 KISFGDVLYLLLKG-----RLPTPYEARLLEALLVALADHGPATPSAHAARLTASAGPEDLQSAVAAGLLGI-GDRFGGA 83 (227)
T ss_pred CCCHHHHHHHHhCC-----CCCCHHHHHHHHHHHHHhccCCCCCchHHHHHHHHHcCCccHHHHHHHHHhcc-CCcccCh
Confidence 47999999999986 47999999999999999999999 99999999999999 99999999999999 9999999
Q ss_pred HHHHHHHHHHhCCC-----CCHHHHHHHHHhcCCcccccCCCCCCCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHH
Q 010304 330 NEAVLKMLNEIGTV-----ENIPEFIEGVKNRKRKMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKA 404 (513)
Q Consensus 330 neav~~mL~eI~~~-----~~i~~~i~~~~~~~~rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~ 404 (513)
+|++++||+++.+. ++++++|++.+++|++||||||||||+.|||+++|+++++++. ..+|+++++.+||++
T Consensus 84 ~e~~~~~l~~~~~~~~~~~~~~~~~v~~~~~~~~~ipGfGH~v~~~~DPRa~~L~~~~~~~~---~~~~~~~~~~~~~~~ 160 (227)
T cd06100 84 GEGAARLFKEAVDSGDALDAAAAEFVAEYRAAKKRIPGFGHPVHKNPDPRVPRLLELARELG---PAGPHLDYALAVEKA 160 (227)
T ss_pred HHHHHHHHHHHHhcccchHHHHHHHHHHHHHcCCCCCCCCCCCCCCCCchHHHHHHHHHHhc---cCCHHHHHHHHHHHH
Confidence 99999999999877 7999999999999999999999999999999999999999874 235899999999998
Q ss_pred HhccccccccCCCCchhhHHHHHHHHcCCCCCchhhHhhhhhhhhhHHHHHhhhcCCCCCccCCc
Q 010304 405 ALSDEYFVKRKLYPNVDFYSGLIYRAMGFPTEFFPVLFAIPRMAGYLAHWRESLDDPDTKIMRPQ 469 (513)
Q Consensus 405 a~~d~yf~~r~LyPNVDfysg~i~~alGiP~~~~t~lFai~R~~GwiAH~~Eq~~~~~~ki~RPr 469 (513)
+.++. .|+++||||||+|+|++.||||+++++++|+++|++||+|||+||..+ +..+||.
T Consensus 161 ~~~~~---~~~l~~Nvd~~~a~~~~~lG~p~~~~~~lf~~~R~~G~~AH~~Eq~~~--~~~~~~~ 220 (227)
T cd06100 161 LTAAK---GKPLPLNVDGAIAAILLDLGFPPGALRGLFVLGRSPGLIAHALEEKRL--GQPLYRH 220 (227)
T ss_pred HHhcc---CCCCcccHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHhc--cCCCCCC
Confidence 87753 358999999999999999999999999999999999999999999975 4556653
No 39
>PLN02522 ATP citrate (pro-S)-lyase
Probab=100.00 E-value=3.8e-53 Score=462.22 Aligned_cols=175 Identities=26% Similarity=0.386 Sum_probs=161.7
Q ss_pred HHHHHHHHHHHhcCCCCChhh-HHHHHHhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHHHhCCC-CCHHHHHHHHH
Q 010304 277 LARVLDVLFILHAEHEMNCST-SAARHLASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLNEIGTV-ENIPEFIEGVK 354 (513)
Q Consensus 277 ~~~~Ld~~LILhADHelN~ST-~aaRvvaStgadlyaavaagi~AL~GPlHGGAneav~~mL~eI~~~-~~i~~~i~~~~ 354 (513)
.+++||++||||||||+|+|| |++|+++||++|+|+||+|||+++ ||+||||+|.|++||+++.+. .++++||++.+
T Consensus 399 ~~~~ld~~Lvl~ADHG~~aSt~~aarv~AStg~dl~savaaGl~al-Gp~hGGA~e~a~~~l~ei~~~~~~~~~~V~~~~ 477 (608)
T PLN02522 399 CTKFIEMCIMLCADHGPCVSGAHNTIVTARAGKDLVSSLVSGLLTI-GPRFGGAIDDAARYFKDAYDRGLTPYEFVEGMK 477 (608)
T ss_pred HHHHHHHHHHHhccCCCCccHHHHHHHhhccCCcHHHHHHHHHHhc-CCcccchHHHHHHHHHHHhccccCHHHHHHHHH
Confidence 345788899999999999999 589999999999999999999998 999999999999999999874 58999999999
Q ss_pred hcCCcccccCCCCC--CCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccCCCCchhhHHHHHHHHcC
Q 010304 355 NRKRKMSGFGHRVY--KNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRKLYPNVDFYSGLIYRAMG 432 (513)
Q Consensus 355 ~~~~rl~GFGHrVY--k~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~LyPNVDfysg~i~~alG 432 (513)
++|++||||||||| ++.|||+++|++++++++ ...+++++|+++|+++.++ +|+|+||||||+|+|+..||
T Consensus 478 ~~~~~IpGFGHrvy~~~~~DpRa~~L~~~~~~~~---~~~~~~~~a~~vE~~~~~~----~k~L~~NVDga~a~i~~~lg 550 (608)
T PLN02522 478 KKGIRVPGIGHRIKSRDNRDKRVELLQKYARTHF---PSVKYMEYAVQVETYTLSK----ANNLVLNVDGAIGSLFLDLL 550 (608)
T ss_pred hCCCccccCCCCCCCCCCCChhHHHHHHHHHHhc---cccHHHHHHHHHHHHHhhc----cCCCCcCcHhHHHHHHHHcC
Confidence 99999999999999 688999999999999875 3468999999999987653 58999999999999999999
Q ss_pred CCCCchh--------------hHhhhhhhhhhHHHHHhhhc
Q 010304 433 FPTEFFP--------------VLFAIPRMAGYLAHWRESLD 459 (513)
Q Consensus 433 iP~~~~t--------------~lFai~R~~GwiAH~~Eq~~ 459 (513)
+|.+||| ++|+++|++||+|||+||..
T Consensus 551 ~p~~~ft~~e~~~~~~~~~~~~lF~l~R~~GwiAH~~Eq~~ 591 (608)
T PLN02522 551 AGSGMFTKQEIDEIVEIGYLNGLFVLARSIGLIGHTFDQKR 591 (608)
T ss_pred CCcccCccccccccccccccceEEEeehHHHHHHHHHHHHH
Confidence 9999998 89999999999999999964
No 40
>KOG1254 consensus ATP-citrate lyase [Energy production and conversion]
Probab=99.40 E-value=1.4e-13 Score=145.20 Aligned_cols=176 Identities=21% Similarity=0.343 Sum_probs=145.8
Q ss_pred HHHHHHHHHHHHhcCCCCChhhHHHHH-HhccCCCHHHHHHHHhhcccCCccCChHHHHHHHHHHh-CCCCCHHHHHHHH
Q 010304 276 RLARVLDVLFILHAEHEMNCSTSAARH-LASSGVDVYTALAGAVGALYGPLHGGANEAVLKMLNEI-GTVENIPEFIEGV 353 (513)
Q Consensus 276 ~~~~~Ld~~LILhADHelN~ST~aaRv-vaStgadlyaavaagi~AL~GPlHGGAneav~~mL~eI-~~~~~i~~~i~~~ 353 (513)
-..+.||.++.+.|||+-.+|-.---+ .+.+++|+++++++|+.. .|++.|||-..+.+++..- ...-.+-+|+.+.
T Consensus 390 Ya~kfie~~~m~~aDhgp~Vsga~ntI~~~ra~kdl~sslv~gLlt-igdRfggald~aaR~f~~ayd~GL~~m~fv~~~ 468 (600)
T KOG1254|consen 390 YARKFIEICTMLTADHGPAVSGAGNTIANFRAGKDLFSSLVRGLLT-IGDRFGGALDIAARRFGPAYDKGLAPMRFVGKM 468 (600)
T ss_pred HHHHHHHHHhhccCCCCceeEeccCceEEeccHHHHHHHHHHHHhh-hhhhhcchhhHHHHhcChhhhccCchHHHhhhh
Confidence 345799999999999998877655333 467889999999999998 7999999888888877654 3334678899999
Q ss_pred HhcCCcccccCCCCC--CCCCchHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHhccccccccCCCCchhhHHHHHHHHc
Q 010304 354 KNRKRKMSGFGHRVY--KNYDPRAKVIRKLAEEVFSIVGRDPLIEVAVALEKAALSDEYFVKRKLYPNVDFYSGLIYRAM 431 (513)
Q Consensus 354 ~~~~~rl~GFGHrVY--k~~DPRA~iL~~~a~~l~~~~~~~~ll~iA~~lE~~a~~d~yf~~r~LyPNVDfysg~i~~al 431 (513)
++.+.++||.|||+- -+.|-|..++++.+++.| +..|+++.|.++|++..+ ++-||--|||...|+++-.|
T Consensus 469 ~k~~~~V~Gighriksi~n~d~rv~~lk~~~~~~f---p~~~~~~yal~ve~~t~~----k~~nlilnvdg~i~~~fvd~ 541 (600)
T KOG1254|consen 469 RKVPIEVYGIGHRIKSINNPDKRVEILKAFARKNF---PATPLLDYALEVEKITTS----KKPNLILNVDGAIAVLFVDL 541 (600)
T ss_pred hCCCceecCCcceeeccCCcccchhhHHHHHHhhC---CCchHHHhhhhheeeecc----CCCCEEEeccchhHHHHHHH
Confidence 999999999999985 467889999999998765 567999999999998776 35689999999999998776
Q ss_pred CCCCCc--------------hhhHhhhhhhhhhHHHHHhhhc
Q 010304 432 GFPTEF--------------FPVLFAIPRMAGYLAHWRESLD 459 (513)
Q Consensus 432 GiP~~~--------------~t~lFai~R~~GwiAH~~Eq~~ 459 (513)
=-...| ...||.++|..|+|.|+++|..
T Consensus 542 l~~~g~ft~~e~~e~i~ig~lng~fvl~rsig~igh~~dqkr 583 (600)
T KOG1254|consen 542 LRNSGMFTKEEADEYINIGALNGLFVLGRSIGFIGHYLDQKR 583 (600)
T ss_pred HhccCCccHHHhhhheecccccceEEeeeecchhhhhccHhh
Confidence 544444 4579999999999999999975
No 41
>cd06100 CCL_ACL-C Citryl-CoA lyase (CCL), the C-terminal portion of the single-subunit type ATP-citrate lyase (ACL) and the C-terminal portion of the large subunit of the two-subunit type ACL. CCL cleaves citryl-CoA (CiCoA) to acetyl-CoA (AcCoA) and oxaloacetate (OAA). ACL catalyzes an ATP- and a CoA- dependant cleavage of citrate to form AcCoA and OAA in a multistep reaction, the final step of which is likely to involve the cleavage of CiCoA to generate AcCoA and OAA. In fungi, yeast, plants, and animals ACL is cytosolic and generates AcCoA for lipogenesis. ACL may be required for fruiting body maturation in the filamentous fungus Sordaria macrospore. In several groups of autotrophic prokaryotes and archaea, ACL carries out the citrate-cleavage reaction of the reductive tricarboxylic acid (rTCA) cycle. In the family Aquificaceae this latter reaction in the rTCA cycle is carried out via a two enzyme system the second enzyme of which is CCL; the first enzyme is citryl-CoA synthetase (CC
Probab=98.10 E-value=6.8e-05 Score=74.35 Aligned_cols=72 Identities=19% Similarity=0.318 Sum_probs=51.9
Q ss_pred ccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhh---cCCCcHHHH--HHHHhCCCC-CChhhHHHHHHHHhhc
Q 010304 125 GYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQ---HSAVPQGIL--DIIQAMPHD-AHPMGVLVSAMSALSI 198 (513)
Q Consensus 125 Gy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~---~~~l~~~v~--~~i~~~p~~-~hPm~~l~a~v~al~~ 198 (513)
|||+.||+++.+|+|++||+|+|++|++.|++.|...|.. |..-..... .+..+ .. +++...+.+++++++.
T Consensus 1 G~~~~dL~~~~sf~e~~~lml~G~~P~~~e~~~f~~~Lvl~adhg~~~~St~aar~~as--tg~~~~~~~vaag~~a~G~ 78 (227)
T cd06100 1 GYDLSDLIGKISFGDVLYLLLKGRLPTPYEARLLEALLVALADHGPATPSAHAARLTAS--AGPEDLQSAVAAGLLGIGD 78 (227)
T ss_pred CCCHHHHHhCCCHHHHHHHHhCCCCCCHHHHHHHHHHHHHhccCCCCCchHHHHHHHHH--cCCccHHHHHHHHHhccCC
Confidence 8999999999999999999999999999999999997743 332122222 22222 22 5666777777766643
No 42
>cd06099 CS_ACL-C_CCL Citrate synthase (CS), citryl-CoA lyase (CCL), the C-terminal portion of the single-subunit type ATP-citrate lyase (ACL) and the C-terminal portion of the large subunit of the two-subunit type ACL. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) from citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. Some CS proteins function as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. CCL cleaves citryl-CoA (CiCoA) to AcCoA and OAA. ACLs catalyze an ATP- and a CoA- dependant cleavage of citrate to form AcCoA and OAA; they do this in a multistep reaction, the final step of which is likely to involve the cleavage of CiCoA to generate AcCoA and OAA. The overall CS reaction is thought to proceed through three partial reactions and i
Probab=81.30 E-value=38 Score=33.34 Aligned_cols=58 Identities=17% Similarity=0.334 Sum_probs=39.6
Q ss_pred CHHHHHHHHHcCCCCCHHHHHHHHHHHhh---cCCCcHHHH--HHHHhCCCCCChhhHHHHHHHHh
Q 010304 136 SFLEVAYLLMYGNLPSESQLTDWEFAVSQ---HSAVPQGIL--DIIQAMPHDAHPMGVLVSAMSAL 196 (513)
Q Consensus 136 sFeEva~LL~~G~LPt~~el~~f~~~l~~---~~~l~~~v~--~~i~~~p~~~hPm~~l~a~v~al 196 (513)
+|-|..++++.|+.|++.+.+.|..-|.- |.. +.... .+..+ ..++|-.-+.++++++
T Consensus 1 ~~~~~fl~ml~g~~p~~~~~~~l~~~lvl~aDHg~-~~St~aar~~aS--t~ad~~~av~Agl~al 63 (213)
T cd06099 1 SYAENFLYMLGGEEPDPEFARAMDLALILHADHEG-NASTFTARVVGS--TGSDPYSAIAAAIGAL 63 (213)
T ss_pred CHHHHHHHHhcCCCCCHHHHHHHHHHHHHhcCCCC-chhhHHHHHHhc--cCCCHHHHHHHHHHHc
Confidence 58899999999999999999888886643 333 33222 23333 3456777777777766
No 43
>cd06111 DsCS_like Cold-active citrate synthase (CS) from an Antarctic bacterial strain DS2-3R (Ds)-like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). 2-methylcitrate synthase (2MCS) catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. DsCS, compared with CS from the hyperthermophile Pyrococcus furiosus (not included in this group), has an increase in the size of surface loops, a higher proline content in the loop regions, a more accessible active site, and a highe
Probab=61.83 E-value=1.1e+02 Score=32.80 Aligned_cols=62 Identities=16% Similarity=0.244 Sum_probs=40.3
Q ss_pred cCCHHHHHHHHHcCCCCCHHHHHHHHHHHh---hcCCCc-HHHHHHHHhCCCCCChhhHHHHHHHHhh
Q 010304 134 SSSFLEVAYLLMYGNLPSESQLTDWEFAVS---QHSAVP-QGILDIIQAMPHDAHPMGVLVSAMSALS 197 (513)
Q Consensus 134 ~~sFeEva~LL~~G~LPt~~el~~f~~~l~---~~~~l~-~~v~~~i~~~p~~~hPm~~l~a~v~al~ 197 (513)
+.+|-|..+++++|+.|++++.+.|...|. .|..=+ .....++.+- .++|-..+.+++++|+
T Consensus 146 ~ls~a~nfl~m~~g~~p~~~~~~~l~~~Lvl~ADHg~n~St~aaR~~aSt--~ad~~~av~agl~aL~ 211 (362)
T cd06111 146 DLGIAENFLHMCFGEVPSPEVVRAFDVSLILYAEHSFNASTFTARVITST--LSDIYSAITGAIGALK 211 (362)
T ss_pred CcCHHHHHHHHhhCCCCCHHHHHHHHHHHHHHhccCCchhHHHHHHHHcc--CCCHHHHHHHHHhhcc
Confidence 358999999999999999999888887653 333211 2222344442 3456666777766653
No 44
>PRK14037 citrate synthase; Provisional
Probab=60.67 E-value=35 Score=36.73 Aligned_cols=70 Identities=19% Similarity=0.236 Sum_probs=45.5
Q ss_pred ccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcC--CCcHHHHH--HHHhCCCCCChhhHHHHHHHHh
Q 010304 125 GYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHS--AVPQGILD--IIQAMPHDAHPMGVLVSAMSAL 196 (513)
Q Consensus 125 Gy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~--~l~~~v~~--~i~~~p~~~hPm~~l~a~v~al 196 (513)
|.++...-.+.+|-|..+++++|+.|++.+.+.|...|.-+. .++..... ++.+ ..++|-+-+.+++++|
T Consensus 140 g~~~~~p~~~~s~a~nfl~ml~G~~p~~~~~~~l~~~Lil~ADHg~naST~aarv~aS--t~ad~ysav~agi~al 213 (377)
T PRK14037 140 GNKPRIPEPSDSFAESFLLASFAREPTAEEIKAMDAALILYTDHEVPASTTAALVAAS--TLSDMYSCITAALAAL 213 (377)
T ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCcHHHHHHHHHHHhHhcccCCchHhHHHHHhhc--cCCCHHHHHHHHHHhc
Confidence 333333334568999999999999999999988888764332 13433332 2233 3456777777777766
No 45
>PRK14035 citrate synthase; Provisional
Probab=59.71 E-value=1.2e+02 Score=32.67 Aligned_cols=62 Identities=15% Similarity=0.177 Sum_probs=41.7
Q ss_pred cCCHHHHHHHHHcCCCCCHHHHHHHHHHHhh---cCCC-cHHHHHHHHhCCCCCChhhHHHHHHHHhh
Q 010304 134 SSSFLEVAYLLMYGNLPSESQLTDWEFAVSQ---HSAV-PQGILDIIQAMPHDAHPMGVLVSAMSALS 197 (513)
Q Consensus 134 ~~sFeEva~LL~~G~LPt~~el~~f~~~l~~---~~~l-~~~v~~~i~~~p~~~hPm~~l~a~v~al~ 197 (513)
..+|-|..+++++|+.|++.+.+.|..-|.- |..- +.....++.+ ..++|.+.+.+++++|.
T Consensus 149 ~ls~~~nfl~ml~g~~p~~~~~~~l~~~LvL~ADHg~naST~aaRv~aS--t~ad~~sav~Agi~al~ 214 (371)
T PRK14035 149 DLSYAANFLYMLRGELPTDIEVEAFNKALVLHADHELNASTFTARCAVS--SLSDMYSGVVAAVGSLK 214 (371)
T ss_pred CCCHHHHHHHHhccCCCCHHHHHHHHHHHHHhccCCCCchHHHHHHHHh--cCCcHHHHHHHHHHhcc
Confidence 3589999999999999999998888877643 3221 2222233333 33567777777777653
No 46
>PRK14034 citrate synthase; Provisional
Probab=59.41 E-value=1.1e+02 Score=32.98 Aligned_cols=63 Identities=16% Similarity=0.187 Sum_probs=41.1
Q ss_pred hcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCC--Cc--HHHHHHHHhCCCCCChhhHHHHHHHHhh
Q 010304 133 ESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSA--VP--QGILDIIQAMPHDAHPMGVLVSAMSALS 197 (513)
Q Consensus 133 ~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~--l~--~~v~~~i~~~p~~~hPm~~l~a~v~al~ 197 (513)
.+.+|-|..+++++|+.|++.+.+.|...|.-+.. +. .....++.+ ..++|.+.+.+++++|.
T Consensus 148 ~~ls~a~nfl~ml~g~~p~~~~~~~l~~~Lvl~aDHg~n~ST~aaRv~aS--t~~d~ysav~agi~al~ 214 (372)
T PRK14034 148 KDLSLAANFLYMLNGEEPDEVEVEAFNKALVLHADHELNASTFTARVCVA--TLSDVYSGITAAIGALK 214 (372)
T ss_pred CCCCHHHHHHHHhcCCCCCHHHHHHHHHHHhHhccCCCCccHHHHHHHhc--cCCcHHHHHHHHhcccC
Confidence 34589999999999999999998888887643321 22 222233333 33557777766666543
No 47
>PRK14033 citrate synthase; Provisional
Probab=57.31 E-value=1.8e+02 Score=31.28 Aligned_cols=61 Identities=16% Similarity=0.242 Sum_probs=40.6
Q ss_pred cCCHHHHHHHHHcCCCCCHHHHHHHHHHHhh---cCCCc-HHHHHHHHhCCCCCChhhHHHHHHHHh
Q 010304 134 SSSFLEVAYLLMYGNLPSESQLTDWEFAVSQ---HSAVP-QGILDIIQAMPHDAHPMGVLVSAMSAL 196 (513)
Q Consensus 134 ~~sFeEva~LL~~G~LPt~~el~~f~~~l~~---~~~l~-~~v~~~i~~~p~~~hPm~~l~a~v~al 196 (513)
+.+|-+..+++++|+.|++.+.+.|...|.- |..=+ .....++.+ ..++|-+.+.+++++|
T Consensus 156 ~~s~a~nfl~ml~g~~p~~~~~~~l~~~Lvl~ADHgln~StfaaRv~aS--t~adl~~av~agl~al 220 (375)
T PRK14033 156 DLGYAENFLHMCFGEVPEPEVVRAFEVSLILYAEHSFNASTFTARVITS--TLSDIYSAVTGAIGAL 220 (375)
T ss_pred CCCHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhccCCCcHHHHHHHHhc--cCCCHHHHHHHHHhhc
Confidence 4689999999999999999998888876633 32212 222233333 3356677777777766
No 48
>TIGR01800 cit_synth_II 2-methylcitrate synthase/citrate synthase II. Members of this family are dimeric enzymes with activity as 2-methylcitrate synthase, citrate synthase, or both. Many Gram-negative species have a hexameric citrate synthase, termed citrate synthase I (TIGR01798). Members of this family (TIGR01800) appear as a second citrate synthase isozyme but typically are associated with propionate metabolism and synthesize 2-methylcitrate from propionyl-CoA; citrate synthase activity may be incidental. A number of species, including Thermoplasma acidophilum, Pyrococcus furiosus, and the Antarctic bacterium DS2-3R have a bifunctional member of this family as the only citrate synthase isozyme.
Probab=56.96 E-value=2.6e+02 Score=29.90 Aligned_cols=61 Identities=13% Similarity=0.128 Sum_probs=40.7
Q ss_pred CCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcC--CCc--HHHHHHHHhCCCCCChhhHHHHHHHHhh
Q 010304 135 SSFLEVAYLLMYGNLPSESQLTDWEFAVSQHS--AVP--QGILDIIQAMPHDAHPMGVLVSAMSALS 197 (513)
Q Consensus 135 ~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~--~l~--~~v~~~i~~~p~~~hPm~~l~a~v~al~ 197 (513)
.+|.|..+++++|+.|++.+.+.|...|.-+. .+. .....++.+ ..++|-+.+.+++++|+
T Consensus 147 ~~~~~n~l~ml~g~~p~~~~~~~l~~~Lvl~ADHg~n~St~aaRv~aS--t~adl~~av~agl~al~ 211 (368)
T TIGR01800 147 DSHAANFLYMLHGEEPSKEEEKAMDIALILYAEHEFNASTFAARVAAS--TLSDMYSAITAAIGALK 211 (368)
T ss_pred ccHHHHHHHHhcCCCCCHHHHHHHHHHHhHhccCCCchHHHHHHHHhc--cCCCHHHHHHHHHhhcC
Confidence 48999988899999999999888887764332 122 222334444 33567777777777663
No 49
>PRK12349 citrate synthase 3; Provisional
Probab=55.86 E-value=2.6e+02 Score=30.01 Aligned_cols=60 Identities=18% Similarity=0.319 Sum_probs=40.7
Q ss_pred CCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcC--CCcHHHH--HHHHhCCCCCChhhHHHHHHHHh
Q 010304 135 SSFLEVAYLLMYGNLPSESQLTDWEFAVSQHS--AVPQGIL--DIIQAMPHDAHPMGVLVSAMSAL 196 (513)
Q Consensus 135 ~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~--~l~~~v~--~~i~~~p~~~hPm~~l~a~v~al 196 (513)
-+|-+..+++++|+.|++.+.+.|...|.-+. .++.... .++.+ ..++|-+.+.+++++|
T Consensus 153 l~~a~nfl~ml~g~~p~~~~~~~~~~~Lvl~ADH~lnaStfa~Rv~aS--t~ad~~~av~agl~al 216 (369)
T PRK12349 153 LSYSANFLYMLTGKKPTELEEKIFDRSLVLYSEHEMPNSTFTARVIAS--TQSDLYGALTGAVASL 216 (369)
T ss_pred CCHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCcCccHHHHHHHHHHc--cCccHHHHHHHHHHhc
Confidence 48999999999999999999988888763332 1333222 23333 3356777777777766
No 50
>PF09350 DUF1992: Domain of unknown function (DUF1992); InterPro: IPR018961 This entry represents a family of proteins that may have a role in protein folding or as a chaperone. DnaJ is a member of the J-protein family, which are defined by the presence of a J domain that can regulate the activity of 70kDa heat-shock proteins []. Some of the proteins in this entry contain a J domain.
Probab=52.53 E-value=44 Score=27.39 Aligned_cols=59 Identities=20% Similarity=0.300 Sum_probs=41.1
Q ss_pred HHHHHHHHHhcCC--cccccCCCCCCCCC-chHHHHHHHHHHHHHHhCC-CcHHHHHHHHHHH
Q 010304 346 IPEFIEGVKNRKR--KMSGFGHRVYKNYD-PRAKVIRKLAEEVFSIVGR-DPLIEVAVALEKA 404 (513)
Q Consensus 346 i~~~i~~~~~~~~--rl~GFGHrVYk~~D-PRA~iL~~~a~~l~~~~~~-~~ll~iA~~lE~~ 404 (513)
+++-|+++.++|+ .|||.|-++=...+ |....=..++.++++..|- -|++++-.+|++.
T Consensus 2 ~e~~I~~A~~~GeFdnLpG~GKPL~~~~~~~~~~~~~~~~~~iLk~~g~lPp~i~l~kei~~l 64 (71)
T PF09350_consen 2 AERRIREAMARGEFDNLPGAGKPLPLDDDNPYWPAEERMANRILKNAGYLPPWIELRKEIEEL 64 (71)
T ss_pred HHHHHHHHHHcCCccCCCCCCCCCCCCCCCcCCCHHHHHHHHhhcccCCCCHHHHHHHHHHHH
Confidence 4567888888887 89999998865444 5555555566666654454 4688888888763
No 51
>PRK14036 citrate synthase; Provisional
Probab=51.18 E-value=1.9e+02 Score=31.20 Aligned_cols=62 Identities=11% Similarity=0.186 Sum_probs=41.0
Q ss_pred cCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcC--CCcHH--HHHHHHhCCCCCChhhHHHHHHHHhh
Q 010304 134 SSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHS--AVPQG--ILDIIQAMPHDAHPMGVLVSAMSALS 197 (513)
Q Consensus 134 ~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~--~l~~~--v~~~i~~~p~~~hPm~~l~a~v~al~ 197 (513)
+-+|-+..++++.|+.|++.+.+.|...|.-+. .+... ...++.+ ..++|...+.+++++|.
T Consensus 151 ~l~~a~nfl~ml~g~~p~~~~~~~l~~~Lil~ADHg~naST~aaRv~aS--t~ad~ys~v~agi~aL~ 216 (377)
T PRK14036 151 DLDYAANFLYMLTEREPDPLAARIFDRCLILHAEHTINASTFSARVTAS--TLTDPYAVIASAVGTLA 216 (377)
T ss_pred CCCHHHHHHHHhcCCCCCHHHHHHHHHHHhhhccCCCCchHHHHHHHHh--cCCcHHHHHHHHHHHcc
Confidence 458999999999999999999988888764332 12222 2223332 23567777777766553
No 52
>PTZ00096 40S ribosomal protein S15; Provisional
Probab=49.44 E-value=14 Score=34.50 Aligned_cols=24 Identities=29% Similarity=0.390 Sum_probs=20.7
Q ss_pred eeEEcccCHHHHhhcCCHHHHHHHH
Q 010304 120 ILRYRGYPIEELAESSSFLEVAYLL 144 (513)
Q Consensus 120 ~L~YRGy~i~eLa~~~sFeEva~LL 144 (513)
.-.||||+++||-+ .+.+|.+-||
T Consensus 14 ~f~yRG~~l~~L~~-m~~~e~~~L~ 37 (143)
T PTZ00096 14 KFTYRGVELEKLLA-LPEEELVELF 37 (143)
T ss_pred eeeeecCCHHHHHc-CCHHHHHHHc
Confidence 46899999999997 5789988877
No 53
>PRK04038 rps19p 30S ribosomal protein S19P; Provisional
Probab=46.19 E-value=16 Score=33.75 Aligned_cols=24 Identities=54% Similarity=0.762 Sum_probs=20.7
Q ss_pred eeEEcccCHHHHhhcCCHHHHHHHH
Q 010304 120 ILRYRGYPIEELAESSSFLEVAYLL 144 (513)
Q Consensus 120 ~L~YRGy~i~eLa~~~sFeEva~LL 144 (513)
.-.|||++++||-+ .+.+|.+-||
T Consensus 6 ~f~yrG~~l~~L~~-m~~~~~~~l~ 29 (134)
T PRK04038 6 EFTYRGYTLEELQE-MSLEEFAELL 29 (134)
T ss_pred eeeecccCHHHHHc-CCHHHHHHHc
Confidence 46899999999997 5899988887
No 54
>PRK10203 hypothetical protein; Provisional
Probab=44.74 E-value=73 Score=29.04 Aligned_cols=57 Identities=12% Similarity=0.130 Sum_probs=33.8
Q ss_pred HHHHHHHHHhcCC--cccccCCCCCCCCCchHHHHHHHHHHHHHHhCC-CcHHHHHHHHH
Q 010304 346 IPEFIEGVKNRKR--KMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGR-DPLIEVAVALE 402 (513)
Q Consensus 346 i~~~i~~~~~~~~--rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~-~~ll~iA~~lE 402 (513)
++.-|+++.++|+ .|||.|.|+=...||-...=..+...+++..|- -|++++-.+++
T Consensus 8 ~E~~I~eA~~~GefdnLpG~GKPL~~~d~~~~p~e~r~~~rilknag~lP~el~LrKE~~ 67 (122)
T PRK10203 8 AERHILEAQRKGEFDNLPGSGEPLILDDDSHVPPELRAGYRLLKNAGCLPPELEQRREAI 67 (122)
T ss_pred HHHHHHHHHHcCCccCCCCCCCCCCCccCCCCCHHHHHHHHHHhhCCCCCHHHHHHHHHH
Confidence 4567778888887 999999999655565322222223334443343 34566555555
No 55
>KOG2617 consensus Citrate synthase [Energy production and conversion]
Probab=43.22 E-value=16 Score=39.59 Aligned_cols=56 Identities=23% Similarity=0.351 Sum_probs=39.7
Q ss_pred chhhhhhhhcCCCCcceeeec---CCCcccceeeeeeeeEeCCCCeeEEcccCHHHHhhc
Q 010304 78 KATDFKKITTGKNDKGLKLYD---PGYLNTAPVRSSICYIDGDEGILRYRGYPIEELAES 134 (513)
Q Consensus 78 ~a~di~~l~~~~~~~g~~~~d---pG~~~t~~~~S~IT~Idg~~G~L~YRGy~i~eLa~~ 134 (513)
...++++++......|-.++| -|-.+....-.+-|++|+++|| +|||++|.|+...
T Consensus 38 ~~~~~k~~~~ehG~vg~v~i~~i~gGmrg~~~~~~e~s~Ld~~~gI-~frg~~i~e~q~~ 96 (458)
T KOG2617|consen 38 TGDEYKKFVSEHGTVGNVTLKKIYGGMRGKGLLLWETSVLDPEEGI-RFRGGDIPECQKR 96 (458)
T ss_pred hHHHhhhhHhhcCcccceeHHHhhcccCCCCceeecCcccchhhCe-eecCCCHHHHHhh
Confidence 456777777643333444444 3666677777777899999886 9999999999864
No 56
>TIGR01025 rpsS_arch ribosomal protein S19(archaeal)/S15(eukaryotic). This model represents eukaryotic ribosomal protein S15 and its archaeal equivalent. It excludes bacterial and organellar ribosomal protein S19. The nomenclature for the archaeal members is unresolved and given variously as S19 (after the more distant bacterial homologs) or S15.
Probab=39.54 E-value=23 Score=32.82 Aligned_cols=24 Identities=54% Similarity=0.850 Sum_probs=20.2
Q ss_pred eeEEcccCHHHHhhcCCHHHHHHHH
Q 010304 120 ILRYRGYPIEELAESSSFLEVAYLL 144 (513)
Q Consensus 120 ~L~YRGy~i~eLa~~~sFeEva~LL 144 (513)
.-.|||++++||-+ .+.+|.+-||
T Consensus 4 ~f~yrG~~l~~L~~-m~~~e~~~l~ 27 (135)
T TIGR01025 4 EFRYRGYTLEELQD-MSLEELAKLL 27 (135)
T ss_pred eEeecccCHHHHHc-CCHHHHHHHc
Confidence 35799999999997 5788988776
No 57
>PLN03085 nucleobase:cation symporter-1; Provisional
Probab=38.69 E-value=95 Score=30.99 Aligned_cols=60 Identities=13% Similarity=0.161 Sum_probs=39.8
Q ss_pred HHHHHHHHHhcCC--cccccCCCCCCCCCchHHHHHHHHHHHHHHhCC-CcHHHHHHHHHHHH
Q 010304 346 IPEFIEGVKNRKR--KMSGFGHRVYKNYDPRAKVIRKLAEEVFSIVGR-DPLIEVAVALEKAA 405 (513)
Q Consensus 346 i~~~i~~~~~~~~--rl~GFGHrVYk~~DPRA~iL~~~a~~l~~~~~~-~~ll~iA~~lE~~a 405 (513)
+++-|++..++|+ .|||.|.++=...||=...=..++..++...|- -|++++-.+|....
T Consensus 93 aE~rI~eAm~~GeFdNLpG~GKPL~ldd~p~vp~e~r~~nRILknaG~lPpwIeL~KEI~~~i 155 (221)
T PLN03085 93 VEQRIWHSMEEGHFENLPGKGKPLNLSTNPHADPAEDTLYRILSKNGCAPEWVELNKEIRGQI 155 (221)
T ss_pred HHHHHHHHHHcCCCCCCCCCCCCCCCcccCCCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHH
Confidence 3556777777886 999999998644455333333445566655564 46888888877654
No 58
>cd06112 citrate_synt_like_1_1 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, an
Probab=37.32 E-value=68 Score=34.46 Aligned_cols=73 Identities=18% Similarity=0.187 Sum_probs=47.3
Q ss_pred EcccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcC--CCc--HHHHHHHHhCCCCCChhhHHHHHHHHhh
Q 010304 123 YRGYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHS--AVP--QGILDIIQAMPHDAHPMGVLVSAMSALS 197 (513)
Q Consensus 123 YRGy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~--~l~--~~v~~~i~~~p~~~hPm~~l~a~v~al~ 197 (513)
.||.+..+.-.+.+|-|..++++.|+.|++.+.+.|..-|.-+. .+. .....++.+- .++|...+.+++++|.
T Consensus 139 ~~g~~~~~p~~~ls~~~nfl~ml~g~~p~~~~~~~l~~~Lil~aDHg~n~STfaaRvvaSt--~ad~~s~~~aai~al~ 215 (373)
T cd06112 139 RNGDDPIEPRPDLDYAENFLYMLFGEEPDPATAKILDACLILHAEHTMNASTFSALVTGST--LADPYAVISSAIGTLS 215 (373)
T ss_pred HCCCCCcCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHhhcccCCCCchHHHHHHHHhc--CCcHHHHHHHHHHhcc
Confidence 45555444445569999999999999999999888888764332 122 2223344432 3567777777776653
No 59
>PRK12351 methylcitrate synthase; Provisional
Probab=37.16 E-value=5.2e+02 Score=27.91 Aligned_cols=60 Identities=18% Similarity=0.145 Sum_probs=40.4
Q ss_pred CCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCC--Cc--HHHHHHHHhCCCCCChhhHHHHHHHHh
Q 010304 135 SSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSA--VP--QGILDIIQAMPHDAHPMGVLVSAMSAL 196 (513)
Q Consensus 135 ~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~--l~--~~v~~~i~~~p~~~hPm~~l~a~v~al 196 (513)
-+|-|..+++++|+.|++.+.+.|...|.-+.. +. .....++.+ ..++|-.-+.+++++|
T Consensus 157 ls~a~Nfl~ml~g~~p~~~~~~~l~~~LvL~ADH~~naST~aaRvvaS--t~ad~~sav~agi~aL 220 (378)
T PRK12351 157 DSIGGHFLHLLHGKKPSESWVKAMHTSLILYAEHEFNASTFTARVIAG--TGSDMYSAITGAIGAL 220 (378)
T ss_pred CCHHHHHHHHhcCCCCCHHHHHHHHHHHHHhcccCCchHHHHHHHHhc--cCCCHHHHHHHHHHhc
Confidence 489999999999999999999988887644321 22 222233333 2346667777777766
No 60
>PRK14032 citrate synthase; Provisional
Probab=35.75 E-value=1.2e+02 Score=33.46 Aligned_cols=63 Identities=11% Similarity=0.119 Sum_probs=42.7
Q ss_pred hhcCCHHHHHHHHHcCC-CCCHHHHHHHHHHHh---hcCCCcH--HHHHHHHhCCCCCChhhHHHHHHHHh
Q 010304 132 AESSSFLEVAYLLMYGN-LPSESQLTDWEFAVS---QHSAVPQ--GILDIIQAMPHDAHPMGVLVSAMSAL 196 (513)
Q Consensus 132 a~~~sFeEva~LL~~G~-LPt~~el~~f~~~l~---~~~~l~~--~v~~~i~~~p~~~hPm~~l~a~v~al 196 (513)
-.+-+|-+..+.+++|+ .|++.+.+.|...|. .|..++. ....++.+- .++|-+-+.+++++|
T Consensus 201 ~~~ls~a~nfl~ml~g~~~p~~~~~~~ld~~LiL~ADHg~~naSTfaaRv~aSt--~ad~ysavaagi~aL 269 (447)
T PRK14032 201 KPELSTAENILYMLRPDNKYTELEARLLDLALVLHAEHGGGNNSTFTTRVVSSS--GTDTYSAIAAAIGSL 269 (447)
T ss_pred CCCCCHHHHHHHHhccCCCCCHHHHHHHHHHHHHHhccCCCchhHHHHHHHHcc--CCcHHHHHHHHHHhc
Confidence 34458999988888999 999999888887663 3442332 223344443 356777777777776
No 61
>PF13946 DUF4214: Domain of unknown function (DUF4214)
Probab=34.60 E-value=78 Score=25.91 Aligned_cols=32 Identities=19% Similarity=0.396 Sum_probs=28.8
Q ss_pred CCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcC
Q 010304 135 SSFLEVAYLLMYGNLPSESQLTDWEFAVSQHS 166 (513)
Q Consensus 135 ~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~ 166 (513)
..|.+.+|..+.|+-|+++.+.-|...|....
T Consensus 22 ~~fV~~lY~~~LgR~~D~~Gl~yw~~~L~~G~ 53 (75)
T PF13946_consen 22 EAFVNSLYQNILGREPDPEGLAYWLNQLNSGA 53 (75)
T ss_pred HHHHHHHHHHHHCCCCCHHHHHHHHHHHHcCC
Confidence 46889999999999999999999999998653
No 62
>cd06109 BsCS-I_like Bacillus subtilis (Bs) citrate synthase CS-I_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. This group contains proteins similar to BsCS-I, one of two CS isozymes in the gram-positive B. subtilis. The majority of CS activity in B. subtilis is provided by the other isozyme, BsCS-II (not included in this group). BsCS-
Probab=31.88 E-value=6.5e+02 Score=26.78 Aligned_cols=62 Identities=19% Similarity=0.222 Sum_probs=41.4
Q ss_pred cCCHHHHHHHHHcCCCCCHHHHHHHHHHHhh---cCCCc-HHHHHHHHhCCCCCChhhHHHHHHHHhh
Q 010304 134 SSSFLEVAYLLMYGNLPSESQLTDWEFAVSQ---HSAVP-QGILDIIQAMPHDAHPMGVLVSAMSALS 197 (513)
Q Consensus 134 ~~sFeEva~LL~~G~LPt~~el~~f~~~l~~---~~~l~-~~v~~~i~~~p~~~hPm~~l~a~v~al~ 197 (513)
..+|-|..+.++.|+.|++.+.+.|...|.- |..-+ .....++.+ ..++|-.-+.+++++|+
T Consensus 135 ~ls~a~nfl~ml~g~~p~~~~~~~l~~~Lvl~ADHg~n~ST~aaRv~aS--t~ad~~savaagi~al~ 200 (349)
T cd06109 135 SLSHAADYLRMLTGEPPSEAHVRALDAYLVTVADHGMNASTFTARVIAS--TEADLTSAVLGAIGALK 200 (349)
T ss_pred CCCHHHHHHHHhCCCCCChHHHHHHHHHHhHhcccCCCchhhHHHHHhc--cCCcHHHHHHHHHHhcc
Confidence 3589998888899999999998888887643 32222 222234333 33567777777777663
No 63
>cd06113 citrate_synt_like_1_2 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) a carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) h
Probab=30.15 E-value=2.5e+02 Score=30.61 Aligned_cols=64 Identities=9% Similarity=0.088 Sum_probs=43.1
Q ss_pred hhcCCHHHHHHHHHcC-CCCCHHHHHHHHHHHh---hcCCCc--HHHHHHHHhCCCCCChhhHHHHHHHHhh
Q 010304 132 AESSSFLEVAYLLMYG-NLPSESQLTDWEFAVS---QHSAVP--QGILDIIQAMPHDAHPMGVLVSAMSALS 197 (513)
Q Consensus 132 a~~~sFeEva~LL~~G-~LPt~~el~~f~~~l~---~~~~l~--~~v~~~i~~~p~~~hPm~~l~a~v~al~ 197 (513)
-.+-+|-+..+++++| +.|++.+.+.|..-|. .|..++ .....++.+- .++|..-+.+++++|+
T Consensus 171 ~~~ls~a~nfl~ml~g~~~p~~~~~~~l~~~Lvl~ADHg~~naST~aaRv~aSt--~ad~~~avaagi~al~ 240 (406)
T cd06113 171 QPELSTAENILSMLRPDKKYTELEAKLLDLCLVLHAEHGGGNNSTFTTRVVSSS--GTDTYSAIAAAIGSLK 240 (406)
T ss_pred CCCCCHHHHHHHHhccCCCCCHHHHHHHHHHHhhhhccCCCcchHHHHHHHHcc--CCCHHHHHHHHHHHcc
Confidence 3345899999999999 5999999888887664 344222 2233344443 3567777777777763
No 64
>PF00285 Citrate_synt: Citrate synthase; InterPro: IPR002020 Citrate synthase 2.3.3.1 from EC is a member of a small family of enzymes that can directly form a carbon-carbon bond without the presence of metal ion cofactors. It catalyses the first reaction in the Krebs' cycle, namely the conversion of oxaloacetate and acetyl-coenzyme A into citrate and coenzyme A. This reaction is important for energy generation and for carbon assimilation. The reaction proceeds via a non-covalently bound citryl-coenzyme A intermediate in a 2-step process (aldol-Claisen condensation followed by the hydrolysis of citryl-CoA). Citrate synthase enzymes are found in two distinct structural types: type I enzymes (found in eukaryotes, Gram-positive bacteria and archaea) form homodimers and have shorter sequences than type II enzymes, which are found in Gram-negative bacteria and are hexameric in structure. In both types, the monomer is composed of two domains: a large alpha-helical domain consisting of two structural repeats, where the second repeat is interrupted by a small alpha-helical domain. The cleft between these domains forms the active site, where both citrate and acetyl-coenzyme A bind. The enzyme undergoes a conformational change upon binding of the oxaloacetate ligand, whereby the active site cleft closes over in order to form the acetyl-CoA binding site []. The energy required for domain closure comes from the interaction of the enzyme with the substrate. Type II enzymes possess an extra N-terminal beta-sheet domain, and some type II enzymes are allosterically inhibited by NADH []. This entry represents types I and II citrate synthase enzymes, as well as the related enzymes 2-methylcitrate synthase and ATP citrate synthase. 2-methylcitrate (2.3.3.5 from EC) synthase catalyses the conversion of oxaloacetate and propanoyl-CoA into (2R,3S)-2-hydroxybutane-1,2,3-tricarboxylate and coenzyme A. This enzyme is induced during bacterial growth on propionate, while type II hexameric citrate synthase is constitutive []. ATP citrate synthase (2.3.3.8 from EC) (also known as ATP citrate lyase) catalyses the MgATP-dependent, CoA-dependent cleavage of citrate into oxaloacetate and acetyl-CoA, a key step in the reductive tricarboxylic acid pathway of CO2 assimilation used by a variety of autotrophic bacteria and archaea to fix carbon dioxide []. ATP citrate synthase is composed of two distinct subunits. In eukaryotes, ATP citrate synthase is a homotetramer of a single large polypeptide, and is used to produce cytosolic acetyl-CoA from mitochondrial produced citrate [].; GO: 0046912 transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer, 0044262 cellular carbohydrate metabolic process; PDB: 2C6X_D 3L96_B 1OWB_B 1NXG_A 1K3P_A 1OWC_B 3L97_B 1NXE_A 3L98_A 3L99_A ....
Probab=28.78 E-value=2.5e+02 Score=29.82 Aligned_cols=72 Identities=18% Similarity=0.256 Sum_probs=42.4
Q ss_pred cccCHHHHhhcCCHHHHHHHHH--cCCCCCHHHHHHHHHHHhhcC--CCcHH--HHHHHHhCCCCCChhhHHHHHHHHhh
Q 010304 124 RGYPIEELAESSSFLEVAYLLM--YGNLPSESQLTDWEFAVSQHS--AVPQG--ILDIIQAMPHDAHPMGVLVSAMSALS 197 (513)
Q Consensus 124 RGy~i~eLa~~~sFeEva~LL~--~G~LPt~~el~~f~~~l~~~~--~l~~~--v~~~i~~~p~~~hPm~~l~a~v~al~ 197 (513)
+|.+..+--.+.+|-|..+.+| .|+-|++++.+.|...|.-+. .+... ...++.+ ..++|...+.+++++++
T Consensus 136 ~g~~~~~p~~~~~~~~n~l~~l~~~g~~p~~~~~~~l~~~lvl~aDH~~~~St~aaR~~aS--t~~~~~~av~agl~al~ 213 (356)
T PF00285_consen 136 RGQPPIPPDPDLSYAENFLYMLGVTGREPDPEEARALDAALVLHADHGLNPSTFAARVAAS--TGADLYSAVAAGLAALS 213 (356)
T ss_dssp TTS------TTSSHHHHHHHHHH-HSSB--HHHHHHHHHHHHHHS--SSSHHHHHHHHHHT--TT--HHHHHHHHHHHHC
T ss_pred CCCCccccccchHHHHHHHHHhhccccCCChHHHHHHHHHHHhhcCCCCCccchhhhhhhc--cCcchhHHHHhhhhhcc
Confidence 4555555445579999888888 899999999999988764332 23322 2334443 45678888888887764
No 65
>cd06108 Ec2MCS_like Escherichia coli (Ec) 2-methylcitrate synthase (2MCS)_like. 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and oxalacetate (OAA) to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and OAA to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). This group contains proteins similar to the E. coli 2MCS, EcPrpC. EcPrpC is one of two CS isozymes in the gram-negative E. coli. EcPrpC is a dimeric (type I ) CS; it is induced during growth on propionate and prefers PrCoA as a substrate though it has partial CS activity with AcCoA. This group also includes Salmonella typhimurium PrpC and Ralstonia eutropha (Re) 2-MCS1 which are also induced during growth on propionate and prefer PrCoA as substrate, but can also use AcCoA. Re 2-MCS1 can use butyryl-CoA and valeryl-CoA at a lower rate. A second Ralstonia eutropha 2MC
Probab=28.18 E-value=2e+02 Score=30.83 Aligned_cols=62 Identities=11% Similarity=0.132 Sum_probs=41.5
Q ss_pred hcCCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcCC--Cc--HHHHHHHHhCCCCCChhhHHHHHHHHh
Q 010304 133 ESSSFLEVAYLLMYGNLPSESQLTDWEFAVSQHSA--VP--QGILDIIQAMPHDAHPMGVLVSAMSAL 196 (513)
Q Consensus 133 ~~~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~~--l~--~~v~~~i~~~p~~~hPm~~l~a~v~al 196 (513)
.+.+|-|..+.+++|+.|++.+.+.|...|.-+.. +. .....++.+ ..++|-.-+.+++++|
T Consensus 143 ~~~s~a~nfl~ml~g~~p~~~~~~~l~~~LvL~ADH~~n~St~aaRv~aS--t~ad~~sav~agi~al 208 (363)
T cd06108 143 DEDSIAGHFLHLLHGKKPGELEIKAMDVSLILYAEHEFNASTFAARVTAS--TLSDFYSAITGAIGTL 208 (363)
T ss_pred CCCCHHHHHHHHhcCCCCCHHHHHHHHHHhhhhccCCCcchHHHHHHHhc--cCCCHHHHHHHHHHhc
Confidence 34589999999999999999998888887643321 22 222233333 3456777777777765
No 66
>PF07583 PSCyt2: Protein of unknown function (DUF1549); InterPro: IPR011444 The function is not known. It is found associated with IPR022655 from INTERPRO. It is also found associated with the Planctomycete cytochrome C domain IPR011429 from INTERPRO.
Probab=26.50 E-value=53 Score=32.44 Aligned_cols=36 Identities=22% Similarity=0.367 Sum_probs=30.5
Q ss_pred ccCHHHHhhcCCHHHHHHHHHcCCCCCHHHHHHHHH
Q 010304 125 GYPIEELAESSSFLEVAYLLMYGNLPSESQLTDWEF 160 (513)
Q Consensus 125 Gy~i~eLa~~~sFeEva~LL~~G~LPt~~el~~f~~ 160 (513)
|.....+|...+|.==+||=+.|.+||.+|...|.+
T Consensus 15 gl~ps~~add~~~lRRv~LDL~G~~PT~eEv~~Fl~ 50 (208)
T PF07583_consen 15 GLTPSPPADDATFLRRVYLDLTGLPPTPEEVRAFLA 50 (208)
T ss_pred CCCCCCCCCHHHHHHHHHHHHhCCCcCHHHHHHHHh
Confidence 455556677778888899999999999999999987
No 67
>cd06118 citrate_synt_like_1 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and
Probab=23.14 E-value=4.3e+02 Score=28.14 Aligned_cols=61 Identities=15% Similarity=0.247 Sum_probs=42.4
Q ss_pred CCHHHHHHHHHcCCCCCHHHHHHHHHHHhhcC--CCcH--HHHHHHHhCCCCCChhhHHHHHHHHhh
Q 010304 135 SSFLEVAYLLMYGNLPSESQLTDWEFAVSQHS--AVPQ--GILDIIQAMPHDAHPMGVLVSAMSALS 197 (513)
Q Consensus 135 ~sFeEva~LL~~G~LPt~~el~~f~~~l~~~~--~l~~--~v~~~i~~~p~~~hPm~~l~a~v~al~ 197 (513)
-+|-+..+.+++|+.|++.+.+.|..-|.-+. .++. ....++.+- .++|-..+.+++++|+
T Consensus 147 ~~~~~~~~~~~~g~~p~~~~~~~l~~~Lvl~aDH~~n~Stfa~R~~aSt--~ad~~~av~agl~al~ 211 (358)
T cd06118 147 LSYAENFLYMLFGEEPDPEEAKAMDLALILHADHEGNASTFTARVVAST--LSDMYSAIAAAIAALK 211 (358)
T ss_pred ccHHHHHHHHhcCCCCCHHHHHHHHHHHhhhcCCCCChHHHHHHHHHcc--CCCHHHHHHHHHHHcc
Confidence 47899888888999999999888888664332 1233 233455543 3678888888888774
No 68
>KOG1182 consensus Branched chain alpha-keto acid dehydrogenase complex, alpha subunit [Energy production and conversion]
Probab=22.11 E-value=55 Score=34.61 Aligned_cols=19 Identities=32% Similarity=0.829 Sum_probs=17.1
Q ss_pred CCCeeEEcccCHHHHhhcC
Q 010304 117 DEGILRYRGYPIEELAESS 135 (513)
Q Consensus 117 ~~G~L~YRGy~i~eLa~~~ 135 (513)
+.|.|.||||++++.+..|
T Consensus 146 EaGVLlwRgftle~f~~qC 164 (432)
T KOG1182|consen 146 EAGVLLWRGFTLEEFMNQC 164 (432)
T ss_pred cCceEEEcCccHHHHHHHh
Confidence 4799999999999998876
No 69
>cd06110 BSuCS-II_like Bacillus subtilis (Bs) citrate synthase (CS)-II_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. This group contains proteins similar to BsCS-II, the major CS of the gram-positive bacterium Bacillus subtilis. A mutation in the gene which encodes BsCS-II (citZ gene) has been described which resulted in a significant loss of CS activity, partial glutamate auxotrophy, and a sporulation deficiency, a
Probab=21.08 E-value=4.8e+02 Score=27.78 Aligned_cols=61 Identities=16% Similarity=0.202 Sum_probs=41.5
Q ss_pred cCCHHHHHHHHHcCCCCCHHHHHHHHHHHhh---cCCC-cHHHHHHHHhCCCCCChhhHHHHHHHHh
Q 010304 134 SSSFLEVAYLLMYGNLPSESQLTDWEFAVSQ---HSAV-PQGILDIIQAMPHDAHPMGVLVSAMSAL 196 (513)
Q Consensus 134 ~~sFeEva~LL~~G~LPt~~el~~f~~~l~~---~~~l-~~~v~~~i~~~p~~~hPm~~l~a~v~al 196 (513)
+.+|-|..++++.|+.|++.+.+.|...|.- |..- +.....++.+-. ++|-..+.+++++|
T Consensus 146 ~~~~a~~~l~~l~g~~p~~~~~~~l~~~Lvl~aDHg~n~Stfa~Rv~aSt~--ad~~~av~agl~al 210 (356)
T cd06110 146 DLSHAANFLYMLTGEKPSEEAARAFDVALILHADHELNASTFAARVVASTL--SDMYSAVTAAIGAL 210 (356)
T ss_pred CCCHHHHHHHHhcCCCCCHHHHHHHHHHHHHhccCCCchhHHHHHHHHhcC--CCHHHHHHHHHhhc
Confidence 4589999999999999999998888876643 3221 222334555543 56777777777765
No 70
>PF11591 2Fe-2S_Ferredox: Ferredoxin chloroplastic transit peptide; InterPro: IPR023383 This entry represent the N-terminal transit peptide of a number of algal petF genes. The peptide is removed during transit into the chloroplast lumen. The structure of chloroplast ferredoxin in water is unstructured however in a 30:70 molar-ratio mixture of 2,2,2-trifluoroethanol, residues 3 to 13 form an alpha-helix. The rest of the peptide remains unstructured []. This domain is the N-terminal of the [2Fe-2S), ferredoxin, from, C.reinhardtii:, petF., This, protein, catalyses, the, final, reaction, in, a, pathway, which, allows, the, production, of, H(2), from, water, in, the, chloroplast, ]. ; PDB: 1FCT_A.
Probab=20.30 E-value=47 Score=22.99 Aligned_cols=10 Identities=40% Similarity=0.295 Sum_probs=7.8
Q ss_pred hhHHHHHHhc
Q 010304 296 STSAARHLAS 305 (513)
Q Consensus 296 ST~aaRvvaS 305 (513)
|||++|++++
T Consensus 7 ssfaarvaga 16 (34)
T PF11591_consen 7 SSFAARVAGA 16 (34)
T ss_dssp HHHHHHT-TS
T ss_pred HHHHHHHccC
Confidence 8899999876
Done!